
<html lang="en"     class="pb-page"  data-request-id="93a78215-d325-4d22-80ab-330d7bbe163d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01378;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2016.59.issue-3;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="99mTc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging" /></meta><meta name="dc.Creator" content="Dan  Li" /></meta><meta name="dc.Creator" content="Yuanyuan  Chen" /></meta><meta name="dc.Creator" content="Xia  Wang" /></meta><meta name="dc.Creator" content="Winnie  Deuther-Conrad" /></meta><meta name="dc.Creator" content="Xin  Chen" /></meta><meta name="dc.Creator" content="Bing  Jia" /></meta><meta name="dc.Creator" content="Chengyan  Dong" /></meta><meta name="dc.Creator" content="Jörg  Steinbach" /></meta><meta name="dc.Creator" content="Peter  Brust" /></meta><meta name="dc.Creator" content="Boli  Liu" /></meta><meta name="dc.Creator" content="Hongmei  Jia" /></meta><meta name="dc.Description" content="We have designed and synthesized a series of cyclopentadienyl tricarbonyl rhenium complexes containing a 5,6-dimethoxyisoindoline or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore as ..." /></meta><meta name="Description" content="We have designed and synthesized a series of cyclopentadienyl tricarbonyl rhenium complexes containing a 5,6-dimethoxyisoindoline or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore as ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 26, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01378" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01378" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01378" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01378" /></link>
        
    
    

<title>99mTc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01378" /></meta><meta property="og:title" content="99mTc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0001.jpeg" /></meta><meta property="og:description" content="We have designed and synthesized a series of cyclopentadienyl tricarbonyl rhenium complexes containing a 5,6-dimethoxyisoindoline or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore as σ2 receptor ligands. Rhenium compound 20a possessed low nanomolar σ2 receptor affinity (Ki = 2.97 nM) and moderate subtype selectivity (10-fold). Moreover, it showed high selectivity toward vesicular acetylcholine transporter (2374-fold), dopamine D2L receptor, NMDA receptor, opiate receptor, dopamine transporter, norepinephrine transporter, and serotonin transporter. Its corresponding radiotracer [99mTc]20b showed high uptake in a time- and dose-dependent manner in DU145 prostate cells and C6 glioma cells. In addition, this tracer exhibited high tumor uptake (5.92% ID/g at 240 min) and high tumor/blood and tumor/muscle ratios (21 and 16 at 240 min, respectively) as well as specific binding to σ receptors in nude mice bearing C6 glioma xenografts. Small animal SPECT/CT imaging of [99mTc]20b in the C6 glioma xenograft model demonstrated a clear visualization of the tumor at 180 min after injection." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01378"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01378">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01378&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01378&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01378&amp;href=/doi/10.1021/acs.jmedchem.5b01378" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 934-946</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01354" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01402" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><sup>99m</sup>Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Li">Dan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuanyuan++Chen">Yuanyuan Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xia++Wang">Xia Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Winnie++Deuther-Conrad">Winnie Deuther-Conrad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Chen">Xin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Jia">Bing Jia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chengyan++Dong">Chengyan Dong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Steinbach">Jörg Steinbach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Brust">Peter Brust</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boli++Liu">Boli Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongmei++Jia">Hongmei Jia</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Key Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institute of Radiopharmaceutical Cancer Research/Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Medical and Healthy Analytical Center, Peking University, Beijing 100191, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Interdisciplinary Laboratory, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86-10-58808891. Fax: +86-10-58808891. E-mail: <a href="/cdn-cgi/l/email-protection#e78f8a8d8e86a7858992c9828392c98489"><span class="__cf_email__" data-cfemail="2d454047444c6d4f435803484958034e43">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01378&amp;href=/doi/10.1021%2Facs.jmedchem.5b01378" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 934–946</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 7, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 September 2015</li><li><span class="item_label"><b>Published</b> online</span>26 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01378" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01378</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01378"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1644</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01378" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;99mTc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yuanyuan&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xia&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Winnie&quot;,&quot;last_name&quot;:&quot;Deuther-Conrad&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Jia&quot;},{&quot;first_name&quot;:&quot;Chengyan&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Steinbach&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Brust&quot;},{&quot;first_name&quot;:&quot;Boli&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Hongmei&quot;,&quot;last_name&quot;:&quot;Jia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;934-946&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01378&quot;},&quot;abstract&quot;:&quot;We have designed and synthesized a series of cyclopentadienyl tricarbonyl rhenium complexes containing a 5,6-dimethoxyisoindoline or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore as σ2 receptor ligands. Rhenium compound 20a possessed low nanomolar σ2 receptor affinity (Ki = 2.97 nM) and moderate subtype selectivity (10-fold). Moreover, it showed high selectivity toward vesicular acetylcholine transporter (2374-fold), dopamine D2L receptor, NMDA receptor, opiate receptor, dopamine transporter, norepinephrine transporter, and serotonin transporter. Its corresponding radiotracer [99mTc]20b showed high uptake in a time- and dose-dependent manner in DU145 prostate cells and C6 glioma cells. In addition, this tracer exhibited high tumor uptake (5.92% ID/g at 240 min) and high tumor/blood and tumor/muscle ratios (21 and 16 at 240 min, respectively) as well as specific binding to σ receptors in nude mice bearing C6 glioma xenografts. Small animal SPECT/CT imaging of [99mTc]20b in the C6 glioma xenograf&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01378&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01378" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01378&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01378" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01378&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01378" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01378&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01378&amp;href=/doi/10.1021/acs.jmedchem.5b01378" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01378" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01378" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01378%26sid%3Dliteratum%253Aachs%26pmid%3D26741785%26genre%3Darticle%26aulast%3DLi%26date%3D2016%26atitle%3D99mTc-Cyclopentadienyl%2BTricarbonyl%2BChelate-Labeled%2BCompounds%2Bas%2BSelective%2BSigma-2%2BReceptor%2BLigands%2Bfor%2BTumor%2BImaging%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D3%26spage%3D934%26epage%3D946%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290997" title="Biological imaging">Biological imaging</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/jmcmar.2016.59.issue-3/20160211/jmcmar.2016.59.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have designed and synthesized a series of cyclopentadienyl tricarbonyl rhenium complexes containing a 5,6-dimethoxyisoindoline or a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore as σ<sub>2</sub> receptor ligands. Rhenium compound <b>20a</b> possessed low nanomolar σ<sub>2</sub> receptor affinity (<i>K</i><sub>i</sub> = 2.97 nM) and moderate subtype selectivity (10-fold). Moreover, it showed high selectivity toward vesicular acetylcholine transporter (2374-fold), dopamine D<sub>2L</sub> receptor, NMDA receptor, opiate receptor, dopamine transporter, norepinephrine transporter, and serotonin transporter. Its corresponding radiotracer [<sup>99m</sup>Tc]<b>20b</b> showed high uptake in a time- and dose-dependent manner in DU145 prostate cells and C6 glioma cells. In addition, this tracer exhibited high tumor uptake (5.92% ID/g at 240 min) and high tumor/blood and tumor/muscle ratios (21 and 16 at 240 min, respectively) as well as specific binding to σ receptors in nude mice bearing C6 glioma xenografts. Small animal SPECT/CT imaging of [<sup>99m</sup>Tc]<b>20b</b> in the C6 glioma xenograft model demonstrated a clear visualization of the tumor at 180 min after injection.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68866" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68866" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Uncontrolled cell proliferation is one of the hallmarks of cancer, and its assessment will provide useful information to predict the tumor aggressiveness and prognosis of cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The sigma-2 (σ<sub>2</sub>) receptors are upregulated in a wide variety of human and rodent tumor cells.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> Moreover, they showed an approximately 10-fold higher expression in proliferating versus quiescent tumors.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Significant effort has been dedicated to the validation of the σ<sub>2</sub> receptor as a biomarker for the imaging of the proliferative status of solid tumors.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(7-15)</a> Currently, a promising radiotracer targeting σ<sub>2</sub> receptors, <i>N</i>-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)butyl)-2-(2-[<sup>18</sup>F]fluoroethoxy)-5-methylbenzamide ([<sup>18</sup>F]ISO-1), is under clinical trials.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Furthermore, a significant correlation between the uptake of this radiotracer and Ki-67 (the “gold standard” used in histological measurements of cell proliferation in tumor surgical and biopsy specimens) was observed in human studies.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These findings indicate that the σ<sub>2</sub> receptor is an important biomarker for determining the proliferative status of solid tumors using positron emission tomography (PET).<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a></div><div class="NLM_p">It is well-known that single photon emission computed tomography (SPECT) is an extremely helpful, widely used, and low cost clinical imaging modality. <sup>99m</sup>Tc is still the most widely used radionuclide in clinical nuclear medicine application. With the clinical implementation of quantitative SPECT in the future,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><sup>99m</sup>Tc-labeled radiotracers with high affinity, high selectivity, and specificity for σ<sub>2</sub> receptors will provide a unique tool for the early diagnosis of cancer and assessment of the proliferative status of solid tumors. Over the past few decades, a series of <sup>99m</sup>Tc-labeled radioligands targeting σ<sub>2</sub> receptors have been reported.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17-22)</a> However, there is a lack of ideal <sup>99m</sup>Tc-labeled radiotracers for imaging σ<sub>2</sub> receptors in human studies. Therefore, the development of <sup>99m</sup>Tc-labeled σ<sub>2</sub> receptor radioligands is very attractive.</div><div class="NLM_p">Previously, our structure–affinity relationship analyses indicated the high importance of the σ<sub>2</sub> preferring group to improve the selectivity for σ<sub>2</sub> receptors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Besides the 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline scaffold in ISO-1, the 5,6-dimethoxyisoindoline moiety was identified as a promising σ<sub>2</sub> preferring group with less lipophilicity.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Moreover, the [(Cp-R)Tc(CO)<sub>3</sub>] unit can be incorporated into selective receptor ligands without a significant change in the biological properties via an appropriate linker.<a onclick="showRef(event, 'ref22 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref25">(22, 25)</a> In the present study, our aim is to develop a <sup>99m</sup>Tc-labeled radioligand as a selective σ<sub>2</sub> receptor probe for tumor imaging with SPECT. The design concept is shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. In the first approach, we directly incorporate the [(Cp-R)M(CO)<sub>3</sub>] (M = Re, <sup>99m</sup>Tc) unit containing the carbonyl group in compound <b>1</b> with the σ<sub>2</sub> preferring group (5,6-dimethoxyisoindoline moiety in compound <b>2</b> or 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety in ISO-1) via different carbon chain lengths. In the second approach, the amide group was connected to the [(Cp-R)M(CO)<sub>3</sub>] (M = Re, <sup>99m</sup>Tc) unit in compound <b>1</b> first and then incorporated with a σ<sub>2</sub> preferring group. Both carbonyl and amide groups are electron-withdrawing groups and would allow the double ligand transfer (DLT) reaction for the efficient synthesis of the <sup>99m</sup>Tc-complex from the corresponding ferrocene precursor. In addition, different carbon chain lengths were used as the linker between the [(Cp-R)M(CO)<sub>3</sub>] unit with an electron-withdrawing group and the 5,6-dimethoxyisoindoline or 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline pharmacophore to find the optimal radiotracer with appropriate interaction on σ<sub>2</sub> receptors for <i>in vivo</i> tumor imaging. Herein, we report the syntheses of novel [(Cp-R)M(CO)<sub>3</sub>] (M = Re, <sup>99m</sup>Tc) complexes containing a 5,6-dimethoxyisoindoline or 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline motif, and we evaluated them as potential σ<sub>2</sub> receptor radioligands for tumor imaging <i>in vivo</i>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design concept of novel [(Cp-R)M(CO)<sub>3</sub>] (M = <sup>99m</sup>Tc, Re) complexes as potent σ<sub>2</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">For the characterization of <sup>99m</sup>Tc-labeled compounds, the surrogates of the corresponding rhenium complexes were prepared, and the synthetic routes are depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Intermediates <b>3</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>8</b>–<b>10</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>14</b>–<b>16</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>17</b>–<b>19</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>26</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were obtained according to the methods reported in the literature. <i>N</i>-Alkylation of compound <b>3</b> or <b>4</b> with compounds <b>17</b>–<b>19</b> gave compounds <b>20a</b>–<b>25a</b> (<b>20a</b>, <b>22a</b>, <b>23a</b>, and <b>25a</b>),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> respectively, with yields of 10–51%. It needs to be mentioned that compounds <b>22a</b> and <b>25a</b> could be obtained with higher yields in acetonitrile with K<sub>2</sub>CO<sub>3</sub> as base than in toluene with triethylamine. However, N-alkylation of compound <b>3</b> with bromine-substituted nitrile, followed by reduction with LiAlH<sub>4</sub> provided compounds <b>11</b>–<b>13</b>, respectively, with yields of 36–50%. The activated ester <b>26</b> reacted with the corresponding amine analogues <b>11</b>–<b>16</b> in anhydrous DMF at room temperature to afford the target rhenium analogues <b>27a</b>–<b>32a</b> (<b>27a</b>, <b>28a</b>, and <b>29a</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Complex <b>31a</b> could be recrystallized by slow evaporation of a mixture of methylene dichloride and hexane solution to afford X-ray diffraction crystals.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of the Rhenium Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 33% HBr/HOAc, rt (20 h)–65 °C (1 h), 32%; (b) tritylamine, DIEA, DMF, 60 °C, 2 h, 77%; (c) TFA, CHCl<sub>3</sub>/MeOH, 0 °C–rt, 1 h, 69%; (d) Br(CH<sub>2</sub>)<sub>m</sub>CN, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h, for <b>5</b>–<b>7</b>, 67–73%, for <b>8</b>–<b>10</b>, 59–70%; (e) LiAlH<sub>4</sub>, THF-Et<sub>2</sub>O, 0 °C–rt, 24 h, for <b>11</b>–<b>13</b>, 36–50%, for <b>14</b>–<b>16</b>, 27–40%; (f) toluene, <b>3</b> or <b>4</b>, KI, Et<sub>3</sub>N, 115 °C, 10% for <b>20a</b>, 10% for <b>21a</b>, 30% for <b>23a</b> and 36% for <b>24a</b>; (g) acetonitrile, <b>3</b> or <b>4</b>, KI, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 41% for <b>22a</b> and 51% for <b>25a</b>; (h)<b>11</b>–<b>16</b>, Et<sub>3</sub>N, anhydrous DMF, rt, 4 h, 38–48% for <b>27a</b>–<b>29a</b>, 74–83% for <b>30a</b>–<b>32a</b>.</p></p></figure><div class="NLM_p">To further confirm the chemical structure and examine the binding model of <sup>99m</sup>Tc-labeled cyclopentadienyl tricarbonyl complexes, the single X-ray crystal structure analysis of complex <b>31a</b> was performed. Crystal structure data together with details of the determinations are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Tables S1–5</a>. The crystal structure with the atomic numbering scheme of compound <b>31a</b> is shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. The central rhenium atom is η<sup>5</sup>-coordinated to the cyclopentadienyl ring, and the coordination sphere is completed by three carbonyl groups. The average bond lengths of Re–C (Cp) and Re–C (CO) are 2.30 and 1.91 Å, respectively. The bond angle of C–Re–C (between CO) is approximately 90°. The distance between the N atom and the center of the aromatic ring of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline residue is 3.70 Å. The distance between the N atom and the center of the Cp ring of the [CpM(CO)<sub>3</sub>] core is 5.05 Å.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of compound <b>31a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <i>In Vitro</i> Radioligand Competition Studies</h3><div class="NLM_p">The radioligand competition experiments were conducted as previously reported.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Typically, (+)-[<sup>3</sup>H]pentazocine was used for the σ<sub>1</sub> receptors, and [<sup>3</sup>H]1,3-di-<i>o</i>-tolyl-guanidine ([<sup>3</sup>H]DTG) in the presence of 10 μM dextrallorphan was used for the σ<sub>2</sub> receptors. The affinities of the rhenium complexes and ferrocene precursors for σ<sub>1</sub> and σ<sub>2</sub> receptors are listed in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. In general, the carbon length of the linker displayed significant influence on the affinity and subtype selectivity. Rhenium complexes with a carbonyl group displayed higher affinities for σ<sub>2</sub> receptors than those with an amide group (<b>20a</b>–<b>25a</b> vs <b>27a</b>–<b>32a</b>). Compound <b>20a</b> and <b>24a</b> possessed nanomolar affinity for σ<sub>2</sub> receptors and moderate subtype selectivity. Compounds <b>23a</b>,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><b>29a</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and <b>30a</b> displayed comparable affinity for σ<sub>2</sub> receptors and subtype selectivity to ISO-1. Similar to our previous findings, ferrocene precursors with a carbonyl group displayed comparable affinity for σ<sub>2</sub> receptors to the corresponding rhenium complexes (<b>36</b> vs <b>20a</b>, <b>38</b> vs <b>22a</b>, <b>39</b> vs <b>23a</b>, and <b>41</b> vs <b>25a</b>) and a little higher subtype selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities of Cyclopentadienyl Tricarbonyl Rhenium Complexes and Ferrocene Precursors for σ<sub>1</sub> and σ<sub>2</sub> Receptors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>(σ<sub>1</sub>) (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>(σ<sub>2</sub>) (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub>(σ<sub>1</sub>)/<i>K</i><sub>i</sub>(σ<sub>2</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">30.1 ± 11.3</td><td class="colsep0 rowsep0" align="left">2.96 ± 0.15</td><td class="colsep0 rowsep0" align="left">10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">6.67 ± 0.36</td><td class="colsep0 rowsep0" align="left">17.4 ± 2.2</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">5.99 ± 1.72</td><td class="colsep0 rowsep0" align="left">10.2 ± 4.2</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">121 ± 10</td><td class="colsep0 rowsep0" align="left">20.9 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">19.5 ± 4.2</td><td class="colsep0 rowsep0" align="left">7.42 ± 1.11</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="left">6.46 ± 1.45</td><td class="colsep0 rowsep0" align="left">13.9 ± 7.5</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left">167 ± 49</td><td class="colsep0 rowsep0" align="left">508 ± 132</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="left">524 ± 6</td><td class="colsep0 rowsep0" align="left">444 ± 242</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="left">296 ± 104</td><td class="colsep0 rowsep0" align="left">22.6 ± 0.5</td><td class="colsep0 rowsep0" align="left">13.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30a</b></td><td class="colsep0 rowsep0" align="left">309 ± 21</td><td class="colsep0 rowsep0" align="left">35.0 ± 10.1</td><td class="colsep0 rowsep0" align="left">8.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31a</b></td><td class="colsep0 rowsep0" align="left">146 ± 65</td><td class="colsep0 rowsep0" align="left">41.0 ± 10.5</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32a</b></td><td class="colsep0 rowsep0" align="left">187 ± 3</td><td class="colsep0 rowsep0" align="left">127 ± 48</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">137 ± 20</td><td class="colsep0 rowsep0" align="left">10.5 ± 0.7</td><td class="colsep0 rowsep0" align="left">13.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">19.2 ± 1.6</td><td class="colsep0 rowsep0" align="left">18.2 ± 3.3</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">240 ± 115</td><td class="colsep0 rowsep0" align="left">18.0 ± 1.4</td><td class="colsep0 rowsep0" align="left">13.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">13.3 ± 6.3</td><td class="colsep0 rowsep0" align="left">10.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">98 ± 39</td><td class="colsep0 rowsep0" align="left">15.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">1300 ± 305</td><td class="colsep0 rowsep0" align="left">60.2 ± 1.9</td><td class="colsep0 rowsep0" align="left">21.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">181 ± 25</td><td class="colsep0 rowsep0" align="left">30.0 ± 0.4</td><td class="colsep0 rowsep0" align="left">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">155 ± 27</td><td class="colsep0 rowsep0" align="left">23.5 ± 5.8</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISO-1</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">330 ± 25</td><td class="colsep0 rowsep0" align="left">6.95 ± 1.63</td><td class="colsep0 rowsep0" align="left">47.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>ISO-1</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">102 ± 15</td><td class="colsep0 rowsep0" align="left">28.2 ± 0.9</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">siramesine<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.69 ± 2.36</td><td class="colsep0 rowsep0" align="left">3.08 ± 0.68</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">siramesine<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">siramesine<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">10.5 ± 2.6</td><td class="colsep0 rowsep0" align="left">12.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">haloperidol<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">4.95 ± 1.74</td><td class="colsep0 rowsep0" align="left">20.7 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are the means ± standard deviation (SD) of at least two experiments performed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">From ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">From ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">IC<sub>50</sub> value, from ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">From ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">From ref <a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">33</a>.</p></div></div></div><div class="NLM_p last">Considering the low nanomolar affinity and subtype selectivity of compound <b>20a</b> for σ<sub>2</sub> receptors, its affinities for the additional receptors and transporters were further tested. Compound <b>20a</b> exhibited very low affinity for VAChT (<i>K</i><sub>i</sub>(VAChT) = 7026 ± 163 nM) and was thus characterized by an excellent selectivity for σ<sub>2</sub> receptors (<i>K</i><sub>i</sub>(VAChT)/<i>K</i><sub>i</sub>(σ<sub>2</sub>) = 2374). Moreover, this ligand also displayed low affinity for dopamine D<sub>2L</sub> receptors, NMDA receptors, opiate receptors, dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT) as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Table S6</a>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Radiolabeling</h3><div class="NLM_p">Considering the moderate to high affinity and selectivity of the rhenium complexes <b>20a</b>–<b>25a</b> and <b>29a</b>–<b>30a</b> for σ<sub>2</sub> receptors, the corresponding <sup>99m</sup>Tc-labeled radiotracers were prepared. The synthetic routes of the ferrocene precursors were similar to those of the corresponding rhenium compounds as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The desired <sup>99m</sup>Tc-labeled radiotracers were obtained via DLT reaction as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. After purification by semipreparative high performance liquid chromatography (HPLC), [<sup>99m</sup>Tc]<b>20b</b>–<b>25b</b> ([<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>22b</b>, [<sup>99m</sup>Tc]<b>23b</b> and [<sup>99m</sup>Tc]<b>25b</b>),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b> ([<sup>99m</sup>Tc]<b>29b</b>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> were obtained with radiochemical yields of 13–67% and a radiochemical purity of >99%.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for the Ferrocene Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, <b>3</b> or <b>4</b>, KI, Et<sub>3</sub>N, 115 °C, 16% for <b>36</b>, 19% for <b>37</b>, 33% for <b>39</b> and 22% for <b>40</b>; (b) acetonitrile, <b>3</b> or <b>4</b>, KI, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 44% for <b>38</b> and 78% for <b>41</b>; (c)<b>13</b>–<b>16</b>, Et<sub>3</sub>N, anhydrous DMF, rt, 4 h, 65% for <b>43</b>, 69% for <b>44</b>, 63% for <b>45</b>, 68% for <b>46</b>.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the <sup>99m</sup>Tc-Labeled Complexes from the Ferrocene Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>99m</sup>TcO<sub>4</sub><sup>–</sup>, Mn(CO)<sub>5</sub>, DMF, 140 °C, 1 h, 13<b>–</b>32% for [<sup>99m</sup>Tc]<b>20b</b>, 37<b>–</b>59% for [<sup>99m</sup>Tc]<b>21b</b>, 25<b>–</b>33% for [<sup>99m</sup>Tc]<b>22b</b>, 34<b>–</b>53% for [<sup>99m</sup>Tc]<b>23b</b>, 44<b>–</b>62% for [<sup>99m</sup>Tc]<b>24b</b>, 57<b>–</b>63% for [<sup>99m</sup>Tc]<b>25b</b>; (b) <sup>99m</sup>TcO<sub>4</sub><sup>–</sup>, Mn(CO)<sub>5</sub>, DMF, 150 °C, 1 h, 36<b>–</b>67% for [<sup>99m</sup>Tc]<b>29b</b>, 48<b>–</b>60% for [<sup>99m</sup>Tc]<b>30b</b>.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> <i>In Vitro</i> Evaluation of the <sup>99m</sup>Tc-labeled Complexes</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Lipophilicity</h4><div class="NLM_p last">For <i>in vitro</i> properties, the lipophilicity of the radiotracer is an important factor in the prediction of its free fraction in the plasma, the ability to cross the blood–brain barrier (BBB) and nonspecific binding <i>in vivo</i>.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> The measurement of the partition coefficients between 1-octanol and 0.05 M sodium phosphate buffer at pH 7.4 was executed using a shake flask method.<a onclick="showRef(event, 'ref22 ref36'); return false;" href="javascript:void(0);" class="ref ref22 ref36">(22, 36)</a> The log <i>D</i> values of [<sup>99m</sup>Tc]<b>20b</b>–<b>25b</b> and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b> were 2.56 ± 0.08,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> 2.44 ± 0.02, 2.56 ± 0.08,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> 2.61 ± 0.05, 2.92 ± 0.02, 2.60 ± 0.06, 2.39 ± 0.05,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and 1.72 ± 0.09, respectively. The moderate lipophilicity of the above radiotracers may lead to decreased nonspecific binding and enhanced specific binding signal <i>in vivo</i>.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vitro</i> Evaluation of the <sup>99m</sup>Tc-Labeled Complexes in DU145 Prostate Cells</h3><div class="NLM_p">It has been reported that DU145 prostate tumor cells exhibit high expression of both σ<sub>1</sub> and σ<sub>2</sub> receptors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Considering the affinity and subtype selectivity for σ<sub>2</sub> receptors, the binding assays of the radioligands [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b> in DU145 prostate tumor cells were performed. The results are summarized in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. After incubation for 120 min, the cellular association of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>23b</b> were 8.86% and 2.06%, respectively. For the complexes with an amide group, the cellular association of [<sup>99m</sup>Tc]<b>29b</b> and [<sup>99m</sup>Tc]<b>30b</b> reached 4.91% and 6.89% at 45 min and increased slightly afterward to 5.12% and 7.08% at 120 min, respectively. In blocking studies, treatment with haloperidol and ISO-1 significantly decreased the cellular association of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>23b</b> in a dose-dependent manner, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>23b</b> to σ<sub>2</sub> receptors in DU145 cells. Moreover, treatment with various concentrations of haloperidol led to decreased association of [<sup>99m</sup>Tc]<b>29b</b> and [<sup>99m</sup>Tc]<b>30b</b> in a dose-dependent manner. However, [<sup>99m</sup>Tc]<b>29b</b> showed a higher blocking percentage than [<sup>99m</sup>Tc]<b>30b</b> (66% vs 47%) at the same concentration of haloperidol (10<sup>–4</sup> M), suggesting a higher specific binding of [<sup>99m</sup>Tc]<b>29b</b> to σ receptors in DU145 cells.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> studies on cellular association of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, [<sup>99m</sup>Tc]<b>29b</b>, and [<sup>99m</sup>Tc]<b>30b</b> in DU145 prostate tumor cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>In Vitro</i> Evaluation of the <sup>99m</sup>Tc-Labeled Complexes in C6 Glioma Cells</h3><div class="NLM_p">C6 glioma tumor cells, with high expression of σ<sub>2</sub> receptors and low expression of σ<sub>1</sub> receptors,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> were selected for further evaluation of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>29b</b>. The results are shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. High cellular association of [<sup>99m</sup>Tc]<b>20b</b> was observed in a time-dependent manner. The association reached 25% after incubation for 120 min. Furthermore, coincubation with different concentrations of ISO-1 led to remarkably decreased association in a dose-dependent manner. The cellular association was significantly reduced by about 80% with 10<sup>–6</sup> M of ISO-1, suggesting high specific binding of [<sup>99m</sup>Tc]<b>20b</b> to σ<sub>2</sub> receptors in C6 glioma cells. However, much lower uptake of [<sup>99m</sup>Tc]<b>29b</b> (<b><</b>1.49%) was observed. Treatment with different concentrations of haloperidol also led to reduced association of [<sup>99m</sup>Tc]<b>29b</b>, but the blocking percentage was low (37% with 10<sup>–4</sup> M of haloperidol). In other words, [<sup>99m</sup>Tc]<b>20b</b> displayed higher association and higher specific binding to σ<sub>2</sub> receptors than [<sup>99m</sup>Tc]<b>29b</b> in C6 glioma cells.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> studies on cellular association of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>29b</b> in C6 glioma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Since compounds <b>21a</b> and <b>24a</b> had moderate to high affinity for σ<sub>2</sub> receptors, the binding assays of the corresponding [<sup>99m</sup>Tc]<b>21b</b> and [<sup>99m</sup>Tc]<b>24b</b> were performed in C6 glioma cells. The results are provided in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Figure S3</a>. The cellular association of [<sup>99m</sup>Tc]<b>21b</b> and [<sup>99m</sup>Tc]<b>24b</b> was 4.88% and 5.12%, respectively, but treatment with 10<sup>–6</sup> M of haloperidol only led to minimal reduction of the cellular association, suggesting high nonspecific binding of [<sup>99m</sup>Tc]<b>21b</b> and [<sup>99m</sup>Tc]<b>24b</b> in C6 glioma cells.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>In Vivo</i> Evaluation of the <sup>99m</sup>Tc-Labeled Complexes</h3><div id="sec2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Biodistribution and Blocking Studies in Male ICR Mice</h4><div class="NLM_p">To investigate the kinetics of the radiotracers, we performed biodistribution and blocking studies of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, [<sup>99m</sup>Tc]<b>25b</b>, and [<sup>99m</sup>Tc]<b>29b</b> in ICR mice. The results are summarized in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, and <a class="ref internalNav" href="#notes-2" aria-label="Table S7 and Figure S4">Table S7 and Figure S4</a>. Both [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>23b</b> exhibited high initial brain uptake with 2.57 ± 0.31% inject dose (ID)/g and 2.38 ± 0.31% ID/g at 2 min, respectively, and fast washout with 0.17 ± 0.04% ID/g and 0.09 ± 0.01% ID/g, respectively, at 240 min. However, [<sup>99m</sup>Tc]<b>25b</b> exhibited lower brain uptake (1.05 ± 0.06% ID/g) and relatively slow washout with 0.32 ± 0.04% ID/g at 240 min. [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>25b</b> exhibited fast clearance from blood and muscle. Low accumulation in the blood of the above radiotracers was observed with 0.31 ± 0.04% ID/g, 0.44 ± 0.15% ID/g, and 0.30 ± 0.05% ID/g at 240 min, respectively. Low accumulation in the muscle was also observed with 0.24 ± 0.11% ID/g, 0.21 ± 0.07% ID/g, and 0.49 ± 0.05% ID/g at 240 min, respectively. In biodistribution studies of [<sup>99m</sup>Tc]<b>29b</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), much lower brain uptake was observed with 0.24 ± 0.06% ID/g at 2 min, indicating that the amide group had a negative effect on the potential of the radiotracer to cross the BBB. Low accumulation of this radiotracer in blood and muscle at 240 min was observed.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biodistribution of [<sup>99m</sup>Tc]<b>20b</b> in Male ICR Mice<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">2 min</th><th class="colsep0 rowsep0" align="center">15 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th><th class="colsep0 rowsep0" align="center">120 min</th><th class="colsep0 rowsep0" align="center">240 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">1.82 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.81 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.71 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.57 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">2.57 ± 0.31</td><td class="colsep0 rowsep0" align="left">2.70 ± 0.18</td><td class="colsep0 rowsep0" align="left">2.08 ± 0.22</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.17</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.08</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">11.81 ± 1.58</td><td class="colsep0 rowsep0" align="left">3.25 ± 0.22</td><td class="colsep0 rowsep0" align="left">2.07 ± 0.23</td><td class="colsep0 rowsep0" align="left">1.31 ± 0.21</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">4.76 ± 1.29</td><td class="colsep0 rowsep0" align="left">10.03 ± 0.61</td><td class="colsep0 rowsep0" align="left">12.51 ± 1.88</td><td class="colsep0 rowsep0" align="left">13.41 ± 0.71</td><td class="colsep0 rowsep0" align="left">16.14 ± 1.73</td><td class="colsep0 rowsep0" align="left">17.33 ± 3.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">3.43 ± 0.89</td><td class="colsep0 rowsep0" align="left">7.46 ± 0.81</td><td class="colsep0 rowsep0" align="left">7.15 ± 1.44</td><td class="colsep0 rowsep0" align="left">4.67 ± 0.38</td><td class="colsep0 rowsep0" align="left">2.76 ± 0.58</td><td class="colsep0 rowsep0" align="left">1.24 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">29.38 ± 4.97</td><td class="colsep0 rowsep0" align="left">9.61 ± 2.58</td><td class="colsep0 rowsep0" align="left">7.14 ± 2.44</td><td class="colsep0 rowsep0" align="left">3.77 ± 0.80</td><td class="colsep0 rowsep0" align="left">2.19 ± 0.69</td><td class="colsep0 rowsep0" align="left">1.47 ± 0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">14.46 ± 1.08</td><td class="colsep0 rowsep0" align="left">15.48 ± 1.92</td><td class="colsep0 rowsep0" align="left">11.78 ± 1.04</td><td class="colsep0 rowsep0" align="left">8.92 ± 1.17</td><td class="colsep0 rowsep0" align="left">6.62 ± 0.99</td><td class="colsep0 rowsep0" align="left">6.11 ± 1.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small intestine<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4.07 ± 0.70</td><td class="colsep0 rowsep0" align="left">11.05 ± 1.77</td><td class="colsep0 rowsep0" align="left">11.69 ± 3.19</td><td class="colsep0 rowsep0" align="left">14.01 ± 2.20</td><td class="colsep0 rowsep0" align="left">15.08 ± 1.87</td><td class="colsep0 rowsep0" align="left">12.94 ± 2.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.96 ± 0.09</td><td class="colsep0 rowsep0" align="left">2.42 ± 0.74</td><td class="colsep0 rowsep0" align="left">2.67 ± 0.74</td><td class="colsep0 rowsep0" align="left">1.46 ± 0.40</td><td class="colsep0 rowsep0" align="left">1.56 ± 0.77</td><td class="colsep0 rowsep0" align="left">1.23 ± 0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">2.42 ± 0.78</td><td class="colsep0 rowsep0" align="left">2.16 ± 0.22</td><td class="colsep0 rowsep0" align="left">1.74 ± 0.20</td><td class="colsep0 rowsep0" align="left">1.40 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.23</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.20 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.17 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data are expressed as a percentage of injected dose per gram, means ± SD, <i>n</i> = 5.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Percentage of injected dose per organ.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biodistribution of [<sup>99m</sup>Tc]<b>23b</b> in Male ICR Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">2 min</th><th class="colsep0 rowsep0" align="center">15 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th><th class="colsep0 rowsep0" align="center">120 min</th><th class="colsep0 rowsep0" align="center">240 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">2.11 ± 0.15</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.74 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.44 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">2.38 ± 0.31</td><td class="colsep0 rowsep0" align="left">1.79 ± 0.20</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.13</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.20 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">8.73 ± 0.81</td><td class="colsep0 rowsep0" align="left">1.93 ± 0.13</td><td class="colsep0 rowsep0" align="left">1.29 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.79 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.51 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.34 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">7.51 ± 1.11</td><td class="colsep0 rowsep0" align="left">13.91 ± 0.92</td><td class="colsep0 rowsep0" align="left">17.03 ± 1.13</td><td class="colsep0 rowsep0" align="left">20.36 ± 1.30</td><td class="colsep0 rowsep0" align="left">22.63 ± 1.38</td><td class="colsep0 rowsep0" align="left">22.82 ± 3.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">4.39 ± 1.34</td><td class="colsep0 rowsep0" align="left">5.59 ± 0.51</td><td class="colsep0 rowsep0" align="left">4.08 ± 0.48</td><td class="colsep0 rowsep0" align="left">2.64 ± 0.13</td><td class="colsep0 rowsep0" align="left">1.20 ± 0.23</td><td class="colsep0 rowsep0" align="left">0.66 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">27.20 ± 5.00</td><td class="colsep0 rowsep0" align="left">7.13 ± 1.54</td><td class="colsep0 rowsep0" align="left">4.10 ± 1.23</td><td class="colsep0 rowsep0" align="left">2.67 ± 0.80</td><td class="colsep0 rowsep0" align="left">1.76 ± 0.40</td><td class="colsep0 rowsep0" align="left">1.29 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">18.88 ± 1.30</td><td class="colsep0 rowsep0" align="left">12.45 ± 1.30</td><td class="colsep0 rowsep0" align="left">9.91 ± 0.94</td><td class="colsep0 rowsep0" align="left">10.32 ± 1.37</td><td class="colsep0 rowsep0" align="left">9.86 ± 1.09</td><td class="colsep0 rowsep0" align="left">9.22 ± 1.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small intestine<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.13 ± 1.02</td><td class="colsep0 rowsep0" align="left">8.75 ± 2.27</td><td class="colsep0 rowsep0" align="left">11.22 ± 1.74</td><td class="colsep0 rowsep0" align="left">15.53 ± 2.24</td><td class="colsep0 rowsep0" align="left">19.15 ± 2.63</td><td class="colsep0 rowsep0" align="left">15.89 ± 1.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.32 ± 0.29</td><td class="colsep0 rowsep0" align="left">2.54 ± 0.44</td><td class="colsep0 rowsep0" align="left">2.74 ± 0.24</td><td class="colsep0 rowsep0" align="left">3.27 ± 0.13</td><td class="colsep0 rowsep0" align="left">2.77 ± 0.45</td><td class="colsep0 rowsep0" align="left">1.58 ± 0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">2.67 ± 0.35</td><td class="colsep0 rowsep0" align="left">1.66 ± 0.23</td><td class="colsep0 rowsep0" align="left">1.22 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.75 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.38 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.21 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.11 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.18 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.02</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are expressed as the percentage of injected dose per gram, means ± SD, <i>n</i> = 5.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Percentage of injected dose per organ.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biodistribution of [<sup>99m</sup>Tc]<b>29b</b> in Male ICR Mice<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">2 min</th><th class="colsep0 rowsep0" align="center">15 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th><th class="colsep0 rowsep0" align="center">120 min</th><th class="colsep0 rowsep0" align="center">240 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">2.04 ± 0.29</td><td class="colsep0 rowsep0" align="left">0.74 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.53 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.34 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.24 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.21 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.16 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">11.22 ± 1.20</td><td class="colsep0 rowsep0" align="left">3.27 ± 0.20</td><td class="colsep0 rowsep0" align="left">2.27 ± 0.24</td><td class="colsep0 rowsep0" align="left">1.74 ± 0.13</td><td class="colsep0 rowsep0" align="left">1.45 ± 0.20</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">9.27 ± 1.69</td><td class="colsep0 rowsep0" align="left">18.56 ± 2.62</td><td class="colsep0 rowsep0" align="left">24.43 ± 1.60</td><td class="colsep0 rowsep0" align="left">27.13 ± 2.13</td><td class="colsep0 rowsep0" align="left">27.98 ± 2.32</td><td class="colsep0 rowsep0" align="left">28.45 ± 3.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">5.08 ± 1.42</td><td class="colsep0 rowsep0" align="left">7.32 ± 0.65</td><td class="colsep0 rowsep0" align="left">4.50 ± 0.64</td><td class="colsep0 rowsep0" align="left">1.91 ± 0.58</td><td class="colsep0 rowsep0" align="left">1.21 ± 0.18</td><td class="colsep0 rowsep0" align="left">0.78 ± 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">31.54 ± 3.28</td><td class="colsep0 rowsep0" align="left">12.11 ± 2.08</td><td class="colsep0 rowsep0" align="left">8.93 ± 1.88</td><td class="colsep0 rowsep0" align="left">7.63 ± 2.40</td><td class="colsep0 rowsep0" align="left">4.17 ± 0.42</td><td class="colsep0 rowsep0" align="left">4.03 ± 0.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">27.45 ± 4.91</td><td class="colsep0 rowsep0" align="left">17.68 ± 3.19</td><td class="colsep0 rowsep0" align="left">14.62 ± 0.61</td><td class="colsep0 rowsep0" align="left">12.14 ± 1.81</td><td class="colsep0 rowsep0" align="left">10.21 ± 0.51</td><td class="colsep0 rowsep0" align="left">8.79 ± 1.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small intestine<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.00 ± 1.31</td><td class="colsep0 rowsep0" align="left">13.15 ± 1.09</td><td class="colsep0 rowsep0" align="left">10.62 ± 2.49</td><td class="colsep0 rowsep0" align="left">11.92 ± 3.25</td><td class="colsep0 rowsep0" align="left">22.56 ± 3.75</td><td class="colsep0 rowsep0" align="left">17.64 ± 4.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.27 ± 0.32</td><td class="colsep0 rowsep0" align="left">2.59 ± 0.47</td><td class="colsep0 rowsep0" align="left">2.58 ± 1.16</td><td class="colsep0 rowsep0" align="left">2.17 ± 0.79</td><td class="colsep0 rowsep0" align="left">2.32 ± 0.92</td><td class="colsep0 rowsep0" align="left">1.46 ± 0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">4.12 ± 0.61</td><td class="colsep0 rowsep0" align="left">2.02 ± 0.16</td><td class="colsep0 rowsep0" align="left">1.44 ± 0.21</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.13</td><td class="colsep0 rowsep0" align="left">0.68 ± 0.10</td><td class="colsep0 rowsep0" align="left">0.41 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.05 ± 0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data are expressed as the percentage of injected dose per gram, means ± SD, <i>n</i> = 5.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Percentage of injected dose per organ.</p></div></div></div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of pretreatment with haloperidol (0.1 mL, 1.0 mg/kg) on organ biodistribution of [<sup>99m</sup>Tc]<b>20b</b> (A), [<sup>99m</sup>Tc]<b>23b</b> (B), or [<sup>99m</sup>Tc]<b>29b</b> (C) in male ICR mice (<i>n</i> = 5). Student’s <i>t</i> test (independent, two-tailed) was performed, and <i>p</i> < 0.05 (except for [<sup>99m</sup>Tc]<b>20b</b> in the lungs and kidney at 120 min after intravenous injection, [<sup>99m</sup>Tc]<b>23b</b> in the heart and lungs at 60 min after intravenous injection, and [<sup>99m</sup>Tc]<b>29b</b> in the spleen at 60 min after intravenous injection).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To examine the specific binding of the radiotracers to σ receptors <i>in vivo</i>, blocking studies were carried out by administration of haloperidol (1.0 mg/kg) 5 min prior to the radiotracer administration. Pretreatment with haloperidol significantly reduced the accumulation of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>29b</b> in the brain by 43%, 45%, and 36%, respectively, at 120 min after injection (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Moreover, remarkable reduction of radiotracers in the organs known to express σ receptors was observed, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>29b</b> to σ receptors <i>in vivo</i>. However, there is no significant reduction of radiotracer accumulation observed in the brain for [<sup>99m</sup>Tc]<b>25b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Figure S4</a>), suggesting the high nonspecific binding of [<sup>99m</sup>Tc]<b>25b</b><i>in vivo</i>.</div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Biodistribution and Blocking Studies of [<sup>99m</sup>Tc]<b>20b</b> in Balb/c Nude Mice Bearing C6 Glioma Xenografts</h3><div class="NLM_p">Encouraged by the optimal properties of [<sup>99m</sup>Tc]<b>20b</b><i>in vitro</i> and <i>in vivo</i>, biodistribution and blocking studies of this radiotracer were performed in Balb/c nude mice bearing C6 glioma xenografts. The results are shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a> and <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>. High accumulation of the radiotracer in the tumor was observed with 5.41 ± 0.91% ID/g at 120 min and 5.92 ± 1.30% ID/g at 240 min. At the same time, low accumulation of the radiotracer in blood and muscle were observed as well. Therefore, high tumor/blood ratios and tumor/muscle ratios were obtained with 20.6 and 16.1 at 240 min, respectively. To further examine the specific binding to σ receptors in the tumor, blocking studies with haloperidol, ferrocene precursor <b>36</b>, and siramesine as blocking agents were performed. Pretreatment of haloperidol, <b>36</b>, and siramesine led to significant reduction of tumor accumulation by 33%, 62%, and 44% at 240 min, respectively, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b> to σ receptors in the tumor. In addition, a reduction of radiotracer in the organs known to contain σ receptors such as the brain, heart, and lung were observed, which is consistent with the biodistribution results in normal mice.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biodistribution of [<sup>99m</sup>Tc]<b>20b</b> in Balb/c Nude Mice Bearing C6 Glioma Xenografts<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organ</th><th class="colsep0 rowsep0" align="center">120 min</th><th class="colsep0 rowsep0" align="center">240 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.28 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">0.68 ± 0.21</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="left">0.80 ± 0.09</td><td class="colsep0 rowsep0" align="left">0.55 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">18.44 ± 3.58</td><td class="colsep0 rowsep0" align="left">22.47 ± 2.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="left">5.48 ± 0.58</td><td class="colsep0 rowsep0" align="left">2.69 ± 0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="left">2.92 ± 0.74</td><td class="colsep0 rowsep0" align="left">2.04 ± 0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="left">6.86 ± 1.16</td><td class="colsep0 rowsep0" align="left">5.93 ± 0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">small intestine<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">15.26 ± 1.06</td><td class="colsep0 rowsep0" align="left">16.33 ± 3.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.82 ± 0.19</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="left">0.65 ± 0.11</td><td class="colsep0 rowsep0" align="left">0.37 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.08 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor</td><td class="colsep0 rowsep0" align="left">5.41 ± 0.91</td><td class="colsep0 rowsep0" align="left">5.92 ± 1.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor/blood</td><td class="colsep0 rowsep0" align="left">17.5 ± 4.0</td><td class="colsep0 rowsep0" align="left">20.6 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tumor/muscle</td><td class="colsep0 rowsep0" align="left">8.5 ± 1.6</td><td class="colsep0 rowsep0" align="left">16.1 ± 5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Data are expressed as the percentage of injected dose per gram, means ± SD, <i>n</i> = 5.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Percentage of injected dose per organ.</p></div></div></div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of pretreatment with haloperidol, <b>36</b>, and siramesine (0.1 mL, 1.0 mg/kg) on organ biodistribution of [<sup>99m</sup>Tc]<b>20b</b> in Balb/c nude mice bearing C6 glioma xenografts. Student’s <i>t</i> test (independent, two-tailed) was performed, and <i>p</i> < 0.05 (except in the kidney with <b>36</b> and in the tumor with haloperidol at 240 min after intravenous injection).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Small Animal SPECT/CT Imaging of [<sup>99m</sup>Tc]<b>20b</b></h3><div class="NLM_p">To further confirm the potential applications of [<sup>99m</sup>Tc]<b>20b</b> in tumor imaging, small animal SPECT/CT scans of the C6 glioma xenograft mouse model were performed using NanoScan SPECT/CT. Representative transverse plane SPECT/CT images at 180 min after injection of [<sup>99m</sup>Tc]<b>20b</b> (22.2 MBq, 0.15 mL) are shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, and the coronal and sagittal plane images are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Figure S5</a>. The solid tumor was clearly visualized with high tumor-to-background contrast, indicating that [<sup>99m</sup>Tc]<b>20b</b> could determine the level of σ<sub>2</sub> receptors in solid tumors <i>in vivo</i>.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative transverse plane slices of NanoScan SPECT/CT fusion images of [<sup>99m</sup>Tc]<b>20b</b> (22.2 MBq, 0.15 mL) in male Balb/c nude mouse bearing C6 glioma xenografts at 180 min after injection. Isoflurane was used for anesthesia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>In Vivo</i> Radiometabolic Stability of [<sup>99m</sup>Tc]<b>20b</b></h3><div class="NLM_p">The metabolic stability of [<sup>99m</sup>Tc]<b>20b</b> was investigated in brain and liver samples of ICR mice 15 and 30 min after the injection of the radiotracer. The HPLC chromatograms are shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. The parent radiotracer [<sup>99m</sup>Tc]<b>20b</b> was the main radioactive compound presented in the brain at both 15 and 30 min, indicating that [<sup>99m</sup>Tc]<b>20b</b> was very stable in the brain and that there was no entry of radioactive metabolites into the brain. In the liver samples, three main metabolites with retention times of 2.4 min (M1), 4.6 min (M2), and 5.4 min (M3), respectively, were observed. Furthermore, the percentage of the parent compound [<sup>99m</sup>Tc]<b>20b</b> was decreased with time (31.8% and 16.1% at 15 and 30 min, respectively). The percentage of M1 was significantly increased with 45.8% and 65.6% at 15 and 30 min, respectively.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Analytical HPLC chromatograms of radioactive compounds in mouse brain and liver samples after intravenous injection of [<sup>99m</sup>Tc]<b>20b</b> (18.5 MBq, 0.15 mL). (A) Brain and liver samples at 15 min. (B) Brain and liver samples at 30 min. (C) [<sup>99m</sup>Tc]<b>20b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of studies have demonstrated the high expression of σ<sub>2</sub> receptors in many human tumors.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> The σ<sub>2</sub> receptor has proved to be a unique biomarker of proliferative status in solid tumors.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Therefore, the development of molecular probes for imaging σ<sub>2</sub> receptors will provide useful information on the proliferative status of tumors in patients. Recently, [<sup>18</sup>F]ISO-1 was developed as a potential σ<sub>2</sub> receptor PET radiotracer for imaging the proliferative status of tumors.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> However, there is still need for a σ<sub>2</sub> receptor SPECT imaging radioligands in clinical trials. <sup>99m</sup>Tc is the most common and convenient nuclide for SPECT imaging in clinical use. Furthermore, <sup>99m</sup>Tc/<sup>188</sup>Re is considered as the ideal “matched pair” of theragnostic radionuclides. Development of the <sup>99m</sup>Tc-labeled radiotracer will provide useful information on the synthesis and therapeutic doses of the corresponding <sup>188</sup>Re-labeled radiopharmaceuticals. Therefore, <sup>99m</sup>Tc-labeled radiotracers for σ<sub>2</sub> receptors imaging not only could be used in the early diagnosis of cancer but also could provide useful information for the therapeutic tumor medicine of <sup>188</sup>Re-labeled radiopharmaceuticals. [<sup>99m</sup>Tc] [<i>N</i>-[2-((3′-<i>N</i>′-propyl-[3,3,1]aza-bicyclononan-3α-yl)(2″-methoxy-5-methyl-phenylcarbamate)(2-mercapttoethyl)amino)acetyl]-2-amino-ethanethiolato]technetium(V) oxide ([<sup>99m</sup>Tc]<b>47)</b> was the most potential σ<sub>2</sub> receptor radiotracer ever reported with moderate affinity for σ<sub>2</sub> receptors (<i>K</i><sub>i</sub> = 22 nM) and high subtype selectivity as well as visualization of tumor shape in planar gamma imaging.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, no further evaluation, such as SPECT/CT imaging, was reported since 2001. To the best of our knowledge, only the radiotracers with high tumor uptakes and high tumor-to-muscle ratios could have potential applications in the early diagnosis of tumor. Because of the much higher expression of the σ<sub>2</sub> receptors in tumors and moderate to high expression of the σ<sub>1</sub> receptors in the normal organs, development of highly subtype selective <sup>99m</sup>Tc-labeled σ<sub>2</sub> receptor radioligands with high tumor uptakes and high tumor/background ratios will have wide applications in imaging the proliferative status in solid tumors. Our aim in this article is to develop novel <sup>99m</sup>Tc-labeled radiotracers with high affinity for σ<sub>2</sub> receptors and high selectivity as well as clear visualization of solid tumors.</div><div class="NLM_p">Enlightened by our previous results of <sup>99m</sup>Tc-labeled radiotracers with the [(Cp-R)Tc(CO)<sub>3</sub>] unit,<a onclick="showRef(event, 'ref22 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref25">(22, 25)</a> we replaced the aromatic ring of ISO-1 with a [(Cp-R)M(CO)<sub>3</sub>] unit with an electron-withdrawing group and connected it to a 5,6-dimethoxyisoindoline or 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline scaffold via different carbon length linkers. The designed complexes were in accordance with the σ<sub>2</sub> receptor ligand pharmacophore model proposed by Glennon with an amine binding site flanked by two hydrophobic regions.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It is encouraging that complexes <b>20a</b>, <b>23a</b>, <b>29a</b>, and <b>30a</b> have high affinity and subtype selectivity for σ<sub>2</sub> receptors. Among these ligands, compound <b>20a</b> had low nanomolar affinity and higher subtype selectivity than ISO-1. Moreover, it showed high selectivity toward VAChT (2374-fold), dopamine D<sub>2L</sub> receptors, NMDA receptors, opiate receptors, DAT, NET, and SERT.</div><div class="NLM_p">To detect the specific binding of the radiotracers to σ<sub>2</sub> receptors, we selected DU145 human prostate tumor cells (<i>B</i><sub>max</sub> values of σ<sub>1</sub> and σ<sub>2</sub> receptors were 1800 and 1930 fmol/mg protein, respectively)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and C6 rat glioma cells (<i>B</i><sub>max</sub> values of σ<sub>1</sub> and σ<sub>2</sub> receptors were 42 and 5507 fmol/mg protein, respectively).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In the <i>in vitro</i> binding assays in tumor cells, [<sup>99m</sup>Tc]<b>20b</b> exhibited much higher cellular association and comparable specific binding to σ<sub>2</sub> receptors in DU145 cells than [<sup>99m</sup>Tc]<b>23b</b>, which is in good agreement with the higher affinity of the former compound. Coincubation with ISO-1 led to significant reduction of cellular association in a dose-dependent manner, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b> to σ<sub>2</sub> receptors. [<sup>99m</sup>Tc]<b>29b</b> exhibited comparable cellular association and higher specific binding to σ receptors in DU145 cells than [<sup>99m</sup>Tc]<b>30b</b>. Thus, it seemed that the 5,6-dimethoxyisoindoline moiety is a better σ<sub>2</sub> preferring group than the 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety. In C6 glioma cells, [<sup>99m</sup>Tc]<b>20b</b> displayed much higher cellular association and higher specific binding to σ receptors than [<sup>99m</sup>Tc]<b>29b</b>, indicating that [<sup>99m</sup>Tc]<b>20b</b> is the most potent radioligand in this series and warrants further evaluation.</div><div class="NLM_p">To investigate the kinetics and examine the specific binding of the radiotracers <i>in vivo</i>, biodistribution studies of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>29b</b> were performed in male ICR mice. [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>23b</b> displayed high initial brain uptake with 2.57 and 2.38% ID/g at 2 min after injection, respectively. [<sup>99m</sup>Tc]<b>29b</b> exhibited low brain uptake with 0.24% ID/g at 2 min after injection, indicating that the amide and carbonyl group showed different influences on the potential of the radiotracer to cross the BBB. Interestingly, all the radiotracers mentioned above exhibited fast clearance from the muscle and blood, which is very important for tumor imaging agents. Pretreatment with haloperidol significantly reduced the accumulation in the brain, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, and [<sup>99m</sup>Tc]<b>29b</b> to σ receptors <i>in vivo</i>.</div><div class="NLM_p last">Finally, we selected the most potent radioligand [<sup>99m</sup>Tc]<b>20b</b> and evaluated its potential applications in tumor imaging. In biodistribution studies in Balb/c nude mice bearing C6 glioma xenografts, [<sup>99m</sup>Tc]<b>20b</b> showed much higher tumor uptake (5.41–5.92% ID/g) than [<sup>99m</sup>Tc]<b>47</b> (1.11–2.11% ID/g, 66 murine breast tumor)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and [<sup>18</sup>F]ISO-1 (0.64–3.67% ID/g, EMT-6 mouse mammary tumor).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> [<sup>99m</sup>Tc]<b>20b</b> also exhibited fast clearance from the surrounding tissues. Thus, the tumor-to-muscle ratios (8.5–16.1) are higher than those of [<sup>99m</sup>Tc]<b>47</b> (0.57–4.95) (16 vs 4.95 at 4 h).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Moreover, the tumor-to-blood ratios (17.5–20.6) are significantly higher than those of [<sup>99m</sup>Tc]<b>47</b> (0.56–2.21)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and [<sup>18</sup>F]ISO-1 (1.47–2.19).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Pretreatment with haloperidol, <b>36</b>, and siramesine resulted in a remarkable reduction of radiotracer accumulation in the tumors, indicating the specific binding of [<sup>99m</sup>Tc]<b>20b</b> to σ receptors in C6 glioma tumors <i>in vivo</i>. Consistent with the high tumor uptakes and high tumor-to-muscle ratios in biodistribution studies, the animal SPECT/CT imaging of [<sup>99m</sup>Tc]<b>20b</b> demonstrated a high uptake and clear visualization of C6 glioma xenografts in nude mice at 180 min. These data suggest the potential use of [<sup>99m</sup>Tc]<b>20b</b> for SPECT imaging studies of brain tumors in patients.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">By applying an integrated strategy, we have designed, prepared, and evaluated a series of cyclopentadienyl tricarbonyl <sup>99m</sup>Tc/Re complexes containing 5,6-dimethoxyisoindoline or 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety. Compared with ISO-1, the rhenium complex of the corresponding radiotracer <b>20a</b> possessed higher affinity and subtype selectivity for σ<sub>2</sub> receptors. The corresponding radiotracer [<sup>99m</sup>Tc]<b>20b</b> showed high uptakes and specific binding to σ receptors in DU145 prostate cells and C6 glioma cells. Moreover, [<sup>99m</sup>Tc]<b>20b</b> exhibited high tumor uptake and high tumor/blood and tumor/muscle ratios in nude mice bearing C6 glioma xenografts. Furthermore, this radiotracer demonstrated specific binding to σ receptors in the tumor. In particular, animal SPECT/CT imaging studies with [<sup>99m</sup>Tc]<b>20b</b> demonstrated a high uptake and clear visualization of C6 glioma xenografts in nude mice. These findings demonstrated that the further evaluation of [<sup>99m</sup>Tc]<b>20b</b> as a potential σ<sub>2</sub> receptor probe for imaging the proliferative status in brain tumors is worth doing.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents used in the synthesis were commercial products and were used without further purification unless otherwise indicated. <sup>99m</sup>Tc-pertechnetate was eluted from a commercial <sup>99</sup>Mo–<sup>99m</sup>Tc generator obtained from Beijing Atomic High-tech Co. The <sup>1</sup>H NMR spectra were recorded on Bruker Avance III NMR (400 MHz) spectrometers in CDCl<sub>3</sub> solutions at room temperature with TMS as an internal standard. Chemical shifts (δ) were reported in ppm values relative to the internal TMS. Coupling constants (<i>J</i>) were reported in Hertz (Hz). Multiplicity is defined by s (singlet), d (doublet), t (triplet), and m (multiplet). The <sup>13</sup>C NMR spectra were recorded on Bruker Avance III NMR (100 MHz) spectrometers. Mass spectra were acquired by Quattro micro API ESI/MS (Waters, USA). High-resolution mass spectrometry (HRMS) was performed on a LCT Premier XE ESI-TOF mass spectrometry instrument (Waters, USA). X-ray crystallography data were collected on a Bruker Smart APEX II diffractometer (Bruker Co., Germany). The melting point (Mp) of solid compounds was tested on a WRX-4 micro melting point apparatus (Shanghai yice instrument Co., LTD, China) and was uncorrected. Reactions were monitored by TLC (TLC Silica gel 60 F254, Merck). Flash column chromatography was conducted using silica gel (45–75 μm) from Qingdao Haiyang Chemical Co., Ltd. The compounds were visualized by illumination with a short wavelength UV lamp (λ = 254 nm). High performance liquid chromatography (HPLC) separations and analyses were performed on a Waters 600 system (Waters, corporation, USA) equipped with a Waters 2489 UV–VIS detector and a Raytest Gabi NaI (Tl) scintillation detector (Raytest, Germany) and on a Shimadzu SCL-20AVP system (Shimadzu Corporation, Japan) equipped with a Bioscan Flow Count 3200 NaI/PMT γ-radiation scintillation detector. Samples were analyzed and separated on an Agela Venusil MP C18 column (250 mm × 4.6 mm, 5 μm) using acetonitrile with 0.1% trifluoroacetic acid (TFA) and water with 0.1% TFA as the mobile phase at a flow rate of 1 mL/min. All of the final compounds were analyzed by HPLC with a purity of more than 95% (HPLC profiles are shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Male ICR mice (4–5 weeks, 22–25 g) were purchased from Vital River Laboratory Animal Technology Co. Ltd. All procedures related to animal experiments were performed in compliance with relevant laws and institutional guidelines. All protocols requiring the use of mice were approved by the animal care committee of Beijing Normal University.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(5,6-Dimethoxyisoindolin-2-yl)acetonitrile (<b>5</b>)</h4><div class="NLM_p last">Compound <b>3</b> (254.0 mg, 1.42 mmol) and 5 mL of triethylamine were dissolved in 10 mL of CH<sub>2</sub>Cl<sub>2</sub>, followed by the addition of 2-bromoacetonitrile (200.0 mg, 1.67 mmol). The reaction mixture was stirred at room temperature for 24 h. The mixture was then washed with H<sub>2</sub>O and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by silica gel chromatography (dichloromethane/methanol = 100:1) to afford <b>5</b> (219.4 mg, 72%) as a white solid. Mp: 125.5–125.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.76 (s, 2H), 4.07 (s, 4H), 3.87 (s, 6H), 3.81 (s, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 219.2).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-(5,6-Dimethoxyisoindolin-2-yl)propanenitrile (<b>6</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>5</b> was applied to compound <b>3</b> (251.2 mg, 1.40 mmol) and 3-bromopropanenitrile (223.7 mg, 1.67 mmol) to afford <b>6</b> (215.5 mg, 67%) as a light brown solid. Mp: 137.1–137.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 4.03 (s, 4H), 3.86 (s, 6H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H), 2.65 (t, <i>J</i> = 6.4 Hz, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 233.2).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(5,6-Dimethoxyisoindolin-2-yl)butanenitrile (<b>7</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>5</b> was applied to <b>3</b> (254.5 mg, 1.42 mmol) and 4-bromobutanenitrile (247.2 mg, 1.67 mmol) to afford <b>7</b> (254.9 mg, 73%) as a light brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 4.04 (s, 4H), 3.87 (s, 6H), 2.97 (t, <i>J</i> = 6.7 Hz, 2H), 2.55 (t, <i>J</i> = 7.1 Hz, 2H), 2.02 (t, <i>J</i> = 6.7 Hz, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 247.2).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(5,6-Dimethoxyisoindolin-2-yl)ethanamine (<b>11</b>)</h4><div class="NLM_p last">A solution of LiAlH<sub>4</sub> (145.7 mg, 3.83 mmol) in 10 mL of anhydrous diethyl ether was cooled at 0 °C (ice bath), followed by the addition of a solution of <b>5</b> (210.0 mg, 0.96 mmol) in 5 mL of anhydrous THF. Then, the reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with ice–H<sub>2</sub>O and extracted with ethyl acetate. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by silica gel chromatography (dichloromethane/methanol/triethylamine = 20:1:1) to give <b>11</b> (97.2 mg, 46%) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 3.91 (s, 4H), 3.86 (s, 6H), 2.90–2.87 (m, 2H), 2.84–2.81 (m, 2H), 2.04 (br s, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 223.2).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-(5,6-Dimethoxyisoindolin-2-yl)propan-1-amine (<b>12</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>11</b> was applied to LiAlH<sub>4</sub> (130.5 mg, 3.44 mmol) and compound <b>6</b> (200.0 mg, 0.86 mmol) to afford <b>12</b> (73.0 mg, 36%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 4.07 (s, 4H), 3.83 (s, 6H), 3.15 (q, 2H, <i>J</i> = 7.3 Hz), 1.74–1.67 (m, 2H), 1.47–1.32 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 237.2).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-(5,6-Dimethoxyisoindolin-2-yl)butan-1-amine (<b>13</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>11</b> was applied to LiAlH<sub>4</sub> (129.0 mg, 3.40 mmol) and compound <b>7</b> (210.0 mg, 0.85 mmol) to afford <b>13</b> (92.4 mg, 50%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.73 (s, 2H), 4.81 (br s, 2H), 3.93 (s, 4H), 3.85 (s, 6H), 2.84–2.81 (m, 2H), 2.76 (m, 2H), 1.76–1.66 (m, 4H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 251.2).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(5.6-Dimethoxyisoindolin-2-yl)-propylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>20a</b>)</h4><div class="NLM_p last">Compound <b>3</b> (23.0 mg, 0.13 mmol) was added to a solution of <b>17</b> (57.7 mg, 0.12 mmol) and KI (20.0 mg, 0.12 mmol) in 5 mL of toluene and 3 mL of triethylamine. The mixture was refluxed at 115 °C for 5 h. After cooling to room temperature, the solvent was evaporated in vacuum. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether/triethylamine = 1:3:1) to afford <b>20a</b> (8.6 mg, 10%) as a dark oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.74 (s, 2H), 5.98 (t, <i>J</i> = 2.2 Hz, 2H), 5.37 (t, <i>J</i> = 2.2 Hz, 2H), 3.88 (s, 4H), 3.85 (s, 6H), 2.78–2.71 (m, 4H), 2.00–1.93 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 194.85, 191.91, 148.53, 131.52, 105.99, 96.61, 87.69, 85.11, 59.04, 56.19, 54.98, 36.36, 23.51. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>23</sub>NO<sub>6</sub><sup>185</sup>Re 582.1055; found 582.1045.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-(5.6-Dimethoxyisoindolin-2-yl)-butylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>21a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>18</b> (70 mg, 0.14 mmol) and <b>3</b> (51.9 mg, 0.29 mmol) to afford <b>21a</b> as a dark oil (12.8 mg, 10%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.74 (s, 2H), 5.99 (t, <i>J</i> = 2.3 Hz, 2H), 5.36 (t, <i>J</i> = 2.3 Hz, 2H), 3.94 (s, 4H), 3.85 (s, 6H), 2.79 (t, <i>J</i> = 7.2 Hz, 2H), 2.66 (t, <i>J</i> = 7.0 Hz, 2H), 1.84–1.77 (m, 2H), 1.70–1.62 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 194.74, 191.90, 148.66, 130.90, 105.95, 96.24, 87.82, 85.13, 59.10, 56.19, 55.93, 38.41, 29.70, 27.69, 22.00. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>25</sub>NO<sub>6</sub><sup>185</sup>Re 596.1212; found 596.1219.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-(5.6-Dimethoxyisoindolin-2-yl)-pentylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>22a</b>)</h4><div class="NLM_p last">Compound <b>3</b> (31.9 mg, 0.18 mmol) was added to a solution of <b>19</b> (60.0 mg, 0.12 mmol), KI (32.1 mg, 0.19 mmol), and K<sub>2</sub>CO<sub>3</sub> (25.0 mg, 0.18 mmol) in 10 mL of anhydrous acetonitrile. The mixture was stirred at 90 °C for 5 h. After cooling to room temperature, the mixture was poured with cold water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether/triethylamine = 1:3:1) to afford <b>22a</b> (29.8 mg, 41%) as a dark oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.74 (s, 2H), 5.99 (t, <i>J</i> = 2.2 Hz, 2H), 5.39 (t, <i>J</i> = 2.2 Hz, 2H), 3.89 (s, 4H), 3.86 (s, 6H), 2.72 (t, <i>J</i> = 7.4 Hz, 2H), 2.62 (t, <i>J</i> = 7.3 Hz, 2H), 1.78–1.71 (m, 2H), 1.66–1.58 (m, 2H), 1.48–1.42 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 195.20, 191.88, 148.35, 131.71, 105.88, 96.51, 87.90, 85.18, 59.26, 56.13, 55.93, 38.78, 28.72, 26.93, 24.31. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd. for C<sub>24</sub>H<sub>27</sub>NO<sub>6</sub><sup>185</sup>Re 610.1368; found 610.1362.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-propylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>23a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>17</b> (53.5 mg, 0.11 mmol) and <b>4</b> (32.0 mg, 0.16 mmol) to afford <b>23a</b> as a yellow oil (19.7 mg, 30%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.58 (s, 1H), 6.51 (s, 1H), 5.96 (t, <i>J</i> = 2.2 Hz, 2H), 5.34 (t, <i>J</i> = 2.2 Hz, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.56 (s, 2H), 2.81–2.78 (m, 2H), 2.74–2.67 (m, 4H), 2.57 (t, <i>J</i> = 6.8 Hz, 2H), 2.03–1.96 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 194.65, 191.90, 147.99, 147.58, 125.04, 111.31, 109.40, 96.15, 87.84, 85.25, 55.97, 55.95, 54.70, 50.23, 36.29, 29.71, 20.97. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd. for C<sub>23</sub>H<sub>25</sub>NO<sub>6</sub><sup>185</sup>Re 596.1212; found 596.1215.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-butylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>24a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>18</b> (60 mg, 0.12 mmol) and <b>4</b> (50.1 mg, 0.26 mmol) to afford <b>24a</b> as a yellow oil (22 mg, 36%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.59 (s, 1H), 6.52 (s, 1H), 6.00 (t, <i>J</i> = 2.3 Hz, 2H), 5.33 (t, <i>J</i> = 2.3 Hz, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.58 (s, 2H), 2.83 (t, <i>J</i> = 5.2 Hz, 2H), 2.74 (t, <i>J</i> = 5.4 Hz, 2H), 2.65 (t, <i>J</i> = 7.0 Hz, 2H), 2.56 (t, <i>J</i> = 7.0 Hz, 2H), 1.82–1.74 (m, 2H), 1.73–1.63 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 195.10, 191.91, 147.59, 147.28, 126.65, 126.21, 111.46, 109.62, 96.18, 87.94, 85.08, 57.48, 55.96, 55.75, 50.91, 38.58, 29.71, 28.64, 26.29, 22.44. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd. for C<sub>24</sub>H<sub>27</sub>NO<sub>6</sub><sup>185</sup>Re 610.1368; found 610.1366.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-pentylcarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>25a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>22a</b> was applied to <b>19</b> (78.5 mg, 0.15 mmol) and <b>4</b> (45.2 mg, 0.23 mmol) to afford <b>25a</b> as a colorless oil (48.6 mg, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.59 (s, 1H), 6.52 (s, 1H), 5.98 (t, <i>J</i> = 2.2 Hz, 2H), 5.38 (t, <i>J</i> = 2.2 Hz, 2H), 3.84 (s, 3H), 3.83 (s, 3H), 3.55 (s, 2H), 2.82 (t, <i>J</i> = 5.7 Hz, 2H), 2.70 (t, <i>J</i> = 5.8 Hz, 2H), 2.61 (t, <i>J</i> = 7.3 Hz, 2H), 2.51 (t, <i>J</i> = 7.5 Hz, 2H), 1.77–1.69 (m, 2H), 1.68–1.59 (m, 2H), 1.45–1.37 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 195.20, 191.88, 147.47, 147.17, 126.73, 126.25, 111.36, 109.50, 96.15, 87.89, 85.18, 58.14, 55.92, 55.91, 55.86, 51.10, 38.79, 28.72, 27.10, 27.04, 24.32. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd. for C<sub>25</sub>H<sub>29</sub>NO<sub>6</sub><sup>185</sup>Re 624.1525; found 624.1519.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(5,6-Dimethoxyisoindolin-2-yl)-ethylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>27a</b>)</h4><div class="NLM_p last">Under N<sub>2</sub>, the solution of compound <b>11</b> (60.0 mg, 0.27 mmol) in 1.5 mL of anhydrous DMF and 100 μL of triethylamine was added to the solution of compound <b>26</b> (98.2 mg, 0.18 mmol) in 1 mL of anhydrous DMF dropwise. The reaction mixture was stirred at room temperature for 4 h. The solvent was removed, washed with saturated sodium chloride, and extracted with ethyl acetate. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl ether/hexane/triethylamine = 10:5:1) to afford <b>27a</b> (49.9 mg, 48%) as a pale yellow solid. Mp: 165.1–167.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16 (br s, 1H), 6.76 (s, 2H), 6.04 (s, 2H), 5.34 (t, <i>J</i> = 2.2 Hz, 2H), 4.12 (s, 4H), 3.87 (s, 6H), 3.61 (q, <i>J</i> = 5.4 Hz, 2H), 3.07 (t, <i>J</i> = 5.3 Hz, 2H).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.58, 162.28, 148.64, 131.10, 105.93, 95.13, 86.03, 84.66, 58.99, 56.15, 54.36, 38.12. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 583.1008, found 583.0995.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(5,6-Dimethoxyisoindolin-2-yl)-propylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>28a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>27a</b> was applied to the compound <b>12</b> (40.0 mg, 0.17 mmol) and compound <b>26</b> (60.0 mg, 0.11 mmol) to afford <b>28a</b> (26.1 mg, 40%) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.05 (br s, 1H), 6.82 (s, 2H), 5.48 (t, <i>J</i> = 2.2 Hz, 2H), 5.10 (t, <i>J</i> = 2.2 Hz, 2H), 3.97 (s, 4H), 3.88 (s, 6H), 3.53 (q, <i>J</i> = 5.4 Hz, 2H), 3.03 (t, <i>J</i> = 5.4 Hz, 2H), 1.84–1.78 (m, 2H). HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 597.1164, found 597.1177.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-(5,6-Dimethoxyisoindolin-2-yl)-butylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>29a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>27a</b> was applied to compound <b>13</b> (40.0 mg, 0.17 mmol) and compound <b>26</b> (81.8 mg, 0.15 mmol) to afford <b>29a</b> (34.4 mg, 38%) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (br s, 1H), 6.78 (s, 2H), 5.57 (t, <i>J</i> = 2.0 Hz, 2H), 5.11 (t, <i>J</i> = 2.2 Hz, 2H), 3.98 (s, 4H), 3.87 (s, 6H), 3.41 (q, <i>J</i> = 4.9 Hz, 2H), 2.85 (t, <i>J</i> = 5.4 Hz, 2H), 1.76–1.75 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.95, 162.03, 148.79, 131.16, 106.02, 96.86, 84.99, 84.57, 59.19, 56.17, 55.96, 39.71, 27.71, 26.81. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 611.1321, found 611.1323.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-ethylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>30a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>27a</b> was applied to compound <b>14</b> (74.4 mg, 0.32 mmol) and compound <b>26</b> (85.0 mg, 0.16 mmol) to afford <b>30a</b> as a light yellow solid (70.4 mg, 74%). Mp: 133.6–134.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.62 (s, 1H), 6.53 (s, 1H), 5.96 (s, 2H), 5.33 (t, <i>J</i> = 2.2 Hz, 2H), 3.85 (d, <i>J</i> = 6.3 Hz, 6H), 3.66 (s, 2H), 3.58 (q, <i>J</i> = 5.1 Hz, 2H), 2.90 (s, 4H), 2.81 (s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.57, 162.19, 147.76, 147.41, 125.89, 125.83, 111.46, 109.54, 95.17, 85.98, 84.66, 56.09, 55.95, 55.93, 55.26, 50.64, 36.32, 28.40, 26.89. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 597.1164, found 597.1176.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-propylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>31a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>27a</b> was applied to compound <b>15</b> (70.2 mg, 0.28 mmol) and compound <b>26</b> (82.7 mg, 0.15 mmol) to afford <b>31a</b> as a light yellow solid (67.6 mg, 74%). Mp: 123.6–124.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.65 (s, 1H), 6.59 (s, 1H), 5.39 (s, 2H), 5.01 (t, <i>J</i> = 2.0 Hz, 2H), 3.86 (d, <i>J</i> = 8.0 Hz, 6H), 3.66 (s, 2H), 3.51 (q, <i>J</i> = 5.2 Hz, 2H), 2.97 (t, <i>J</i> = 5.8 Hz, 2H), 2.86 (t, <i>J</i> = 5.5 Hz, 2H), 2.79 (t, <i>J</i> = 5.2 Hz, 2H), 1.83 (t, <i>J</i> = 4.7 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.94, 161.69, 148.20, 147.62, 126.10, 125.90, 111.44, 109.89, 96.33, 84.93, 84.52, 56.08, 55.96, 55.42, 51.78, 41.31, 28.89, 23.86. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 611.1321, found 611.1323.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-butylaminocarbonylcyclopentadienyl Tricarbonyl Rhenium (<b>32a</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>27a</b> was applied to compound <b>16</b> (89.0 mg, 0.34 mmol) and compound <b>26</b> (85.9 mg, 0.16 mmol) to afford <b>32a</b> as a light yellow oil (81.9 mg, 83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (br s, 1H), 6.63 (s, 1H), 6.56 (s, 1H), 5.58 (s, 2H), 5.07 (t, <i>J</i> = 2.2 Hz, 2H), 3.85 (d, <i>J</i> = 2.4 Hz, 6H), 3.65 (s, 2H), 3.41 (q, <i>J</i> = 5.6 Hz, 2H), 2.90 (t, <i>J</i> = 5.8 Hz, 2H), 2.80 (t, <i>J</i> = 5.6 Hz, 2H), 2.63 (t, <i>J</i> = 6.0 Hz, 2H), 1.79–1.68 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 192.92, 161.83, 147.83, 147.40, 126.26, 126.15, 111.49, 109.50, 96.02, 85.46, 84.55, 57.11, 56.66, 55.92, 50.01, 39.22, 28.52, 27.37, 24.69. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>28</sub>N<sub>2</sub>O<sub>6</sub><sup>185</sup>Re 625.1477, found 625.1483.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-(5,6-Dimethoxyisoindolin-2-yl)-propylcarbonylferrocene (<b>36</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>33</b> (97.5 mg, 0.29 mmol) and <b>3</b> (75.9 mg, 0.42 mmol) to afford <b>36</b> as an orange solid (20.5 mg, 16%). Mp: 116.5–119.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 4.81 (t, <i>J</i> = 1.7 Hz, 2H), 4.49 (t, <i>J</i> = 1.7 Hz, 2H), 4.20 (s, 5H), 3.94 (s, 4H), 3.86 (s, 6H), 2.88–2.80 (m, 4H), 2.04–1.98 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 434.6).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(5,6-Dimethoxyisoindolin-2-yl)-butylcarbonylferrocene (<b>37</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>34</b> (91.3 mg, 0.26 mmol) and <b>3</b> (107.5 mg, 0.60 mmol) to afford <b>37</b> as an orange solid (25.8 mg, 19%). Mp: 105.6–107.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.74 (s, 2H), 4.81 (t, <i>J</i> = 1.9 Hz, 2H), 4.49 (t, <i>J</i> = 1.8 Hz, 2H), 4.20 (s, 5H), 3.91 (s, 4H), 3.86 (s, 6H), 2.79–2.75 (m, 4H), 1.85–1.78 (m, 2H), 1.71–1.63 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 447.9).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-(5,6-Dimethoxyisoindolin-2-yl)-pentylcarbonylferrocene (<b>38</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>22a</b> was applied to <b>35</b> (49.3 mg, 0.14 mmol) and <b>3</b> (25.1 mg, 0.14 mmol) to afford <b>38</b> as an orange solid (56.5 mg, 44%). Mp: 108.1–110.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.75 (s, 2H), 4.78 (t, <i>J</i> = 1.9 Hz, 2H), 4.49 (t, <i>J</i> = 1.9 Hz, 2H), 4.20 (s, 5H), 3.95 (s, 4H), 3.86 (s, 6H), 2.79 (s, 2H), 2.74 (t, <i>J</i> = 7.4 Hz, 2H), 1.81–1.73 (m, 2H), 1.69 (s, 2H), 1.53–1.45 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 462.2).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-propylcarbonylferrocene (<b>39</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>33</b> (85.8 mg, 0.26 mmol) and <b>4</b> (62.1 mg, 0.32 mmol) to afford <b>39</b> as an orange solid (34.3 mg, 33%). Mp: 114.1–116.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.60 (s, 1H), 6.53 (s, 1H), 4.79 (t, <i>J</i> = 1.9 Hz, 2H), 4.48 (t, <i>J</i> = 1.9 Hz, 2H), 4.19 (s, 5H), 3.84 (s, 3H), 3.83 (s, 3H), 3.61 (s, 2H), 2.83 (t, <i>J</i> = 7.1 Hz, 2H), 2.77 (s, 2H), 2.63 (s, 2H), 2.04–2.01 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 448.7).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-butylcarbonylferrocene (<b>40</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>20a</b> was applied to <b>34</b> (102.6 mg, 0.29 mmol) and <b>4</b> (116.0 mg, 0.60 mmol) to afford <b>40</b> as an orange oil (25.7 mg, 22%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.59 (s, 1H), 6.53 (s, 1H), 4.79 (t, <i>J</i> = 1.9 Hz, 2H), 4.49 (t, <i>J</i> = 1.9 Hz, 2H), 4.19 (s, 5H), 3.84 (s, 3H), 3.83 (s, 3H), 3.59 (s, 2H), 2.84 (t, <i>J</i> = 5.6 Hz, 2H), 2.78–2.73 (m, 4H), 2.57 (t, <i>J</i> = 7.4 Hz, 2H), 1.81–1.70 (m, 4H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 461.9).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-(6,7-Dimethoxy-3,4-dihydro-1<i>H</i>-isoquinolin-2-yl)-pentylcarbonylferrocene (<b>41</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>22a</b> was applied to <b>35</b> (50.3 mg, 0.14 mmol) and <b>4</b> (34.1 mg, 0.18 mmol) to afford <b>41</b> as an orange solid (152.8 mg, 78%). Mp: 118.6–120.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.59 (s, 1H), 6.53 (s, 1H), 4.78 (t, <i>J</i> = 1.9 Hz, 2H), 4.49 (t, <i>J</i> = 1.8 Hz, 2H), 4.20 (s, 5H), 3.84 (s, 3H), 3.83 (s, 3H), 2.84 (s, 2H), 2.73 (t, <i>J</i> = 7.4 Hz, 2H), 2.55 (s, 2H), 1.80–1.72 (m, 2H), 1.68 (s, 2H), 1.49–1.42 (m, 2H). ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 476.2).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(5,6-Dimethoxyisoindolin-2-yl)-butylaminocarbonylferrocene (<b>43</b>)</h4><div class="NLM_p last">Under N<sub>2</sub>, the solution of compound <b>13</b> (66.0 mg, 0.26 mmol) in 1.5 mL of anhydrous DMF and 100 μL of triethylamine was added to the solution of compound <b>42</b> (102.9 mg, 0.26 mmol) in 1 mL of anhydrous DMF dropwise. The reaction mixture was stirred at room temperature for 4 h. The solvent was removed, then washed with saturated sodium chloride, and extracted with ethyl acetate. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl ether/hexane/triethylamine = 10:5:1) to afford <b>43</b> (78.4 mg, 65%) as a yellow solid. Mp: 119.6–120.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>)δ 6.76 (s, 2H), 6.62 (br s, 1H), 4.61 (s, 2H), 4.25 (s, 2H), 4.16 (s, 5H), 4.00 (s, 4H), 3.87 (s, 6H), 3.44 (d, <i>J</i> = 5.4 Hz, 2H), 2.86 (s, 2H), 1.74–1.70 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.12, 148.68, 131.14, 130.90, 105.99, 70.13, 69.67, 68.07, 65.55, 59.20, 56.20, 55.62, 39.33, 27.72, 26.33. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>Fe [M + H]<sup>+</sup>463.1684, found 463.1686.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-ethylaminocarbonylferrocene (<b>44</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>43</b> was applied to compound <b>14</b> (38.0 mg, 0.16 mmol) and compound <b>42</b> (53.8 mg, 0.14 mmol) to afford <b>44</b> (49.8 mg, 69%) as a light yellow solid. Mp: 193.9–195.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.62 (s, 1H), 6.55 (s, 1H), 6.48 (br s, 1H), 4.66 (s, 2H), 4.30 (t, <i>J</i> = 1.8 Hz, 2H), 4.15 (s, 5H), 3.84 (d, <i>J</i> = 9.8 Hz, 6H), 3.68 (s, 2H), 3.59 (q, <i>J</i> = 5.4 Hz, 2H), 2.89–2.84 (m, 4H), 2.78 (t, <i>J</i> = 5.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.35, 147.68, 147.38, 126.12, 125.99, 111.43, 109.47, 70.24, 69.68, 68.18, 56.64, 55.96, 55.94, 55.36, 50.91, 36.19, 28.71. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>Fe [M + H]<sup>+</sup> 449.1528, found 449.1520.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-propylaminocarbonylferrocene (<b>45</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>43</b> was applied to compound <b>15</b> (100.0 mg, 0.40 mmol) and compound <b>42</b> (158.4 mg, 0.40 mmol) to afford <b>45</b> (116.6 mg, 63%) as an orange solid. Mp: 72.2–73.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.73 (br s, 1H), 6.66 (s, 1H), 6.57 (s, 1H), 4.40 (s, 2H), 4.10 (s, 2H), 4.09 (s, 5H), 3.89 (s, 3H), 3.84 (s, 3H), 3.68 (s, 2H), 3.53 (q, <i>J</i> = 5.4 Hz, 2H), 2.94 (t, <i>J</i> = 5.9 Hz, 2H), 2.86–2.84 (m, 2H), 2.77 (t, <i>J</i> = 5.6 Hz, 2H), 1.89–1.84 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.02, 147.88, 147.42, 126.36, 126.04, 111.43, 109.62, 69.99, 69.54, 67.86, 58.13, 56.04, 55.94, 55.79, 51.54, 40.32, 28.83, 25.19. ESI-MS: [M + H]<sup>+</sup> (<i>m</i>/<i>z</i> = 462.8).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-butylaminocarbonylferrocene (<b>46</b>)</h4><div class="NLM_p last">The procedure described for the synthesis of <b>43</b> was applied to compound <b>16</b> (36.7 mg, 0.14 mmol) and compound <b>42</b> (63.0 mg, 0.16 mmol) to afford <b>46</b> (45.0 mg, 68%) as an orange solid. Mp: 86.3–87.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.61 (s, 1H), 6.52 (s, 1H), 4.59 (s, 2H), 4.25 (t, <i>J</i> = 1.8 Hz, 2H), 4.17 (s, 5H), 3.84 (d, <i>J</i> = 9.8 Hz, 6H), 3.62 (s, 2H), 3.43 (q, <i>J</i> = 6.2 Hz, 2H), 2.87 (d, <i>J</i> = 5.4 Hz, 2H), 2.79 (d, <i>J</i> = 5.1 Hz, 2H), 2.61 (t, <i>J</i> = 6.1 Hz, 2H), 1.76–1.68 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.04, 147.64, 147.29, 126.46, 126.17, 111.42, 109.56, 70.17, 69.66, 68.03, 57.52, 56.03, 55.94, 50.76, 39.31, 28.60, 27.79, 24.69. HRMS (ESI-Tof), [M + H]<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>Fe 477.1841, found 477.1833.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> X-ray Crystallography</h3><div class="NLM_p last">All of the procedures for X-ray crystallography were previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Detailed procedures are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>In Vitro</i> Radioligand Competition Studies</h3><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> σ Receptor Binding Assays</h4><div class="NLM_p last">All of the procedures for the radioligand competition studies were previously described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Detailed procedures are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> VAChT Binding Assays</h4><div class="NLM_p last">The determination of the affinity for VAChT were conducted by a method in the literature.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Detailed procedures are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Dopamine D<sub>2L</sub> Receptors, NMDA Receptors, Opiate Receptors, DAT, NET, and SERT Binding Assay</h4><div class="NLM_p last">The affinities of compound <b>20a</b> for the above receptors and transporters are presented in a percentage of inhibition form. Detailed information is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Radiochemistry</h3><div class="NLM_p last"><sup>99m</sup>Tc-pertechnetate was eluted from a commercial <sup>99</sup>Mo–<sup>99m</sup>Tc generator obtained from Beijing Atomic High-tech Co. The reactions were performed according to the methods in the literature.<a onclick="showRef(event, 'ref22 ref25 ref39'); return false;" href="javascript:void(0);" class="ref ref22 ref25 ref39">(22, 25, 39)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Measurement of log <i>D</i> values</h3><div class="NLM_p last">The log <i>D</i> values of [<sup>99m</sup>Tc]<b>20b</b>–<b>25b</b> and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b> were determined by measuring the distribution of the radiotracer between 1-octanol and 0.05 M sodium phosphate buffer at pH 7.4 according to the literature.<a onclick="showRef(event, 'ref22 ref25 ref36'); return false;" href="javascript:void(0);" class="ref ref22 ref25 ref36">(22, 25, 36)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>In Vitro</i> Evaluation in DU145 Prostate Cells and C6 Glioma Cells</h3><div class="NLM_p last">The culture of cells and the <i>in vitro</i> cell uptake and blocking assays were performed as previously reported.<a onclick="showRef(event, 'ref22 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref25">(22, 25)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Biodistribution and Blocking Studies in Mice</h3><div class="NLM_p last">All animal experiments in ICR mice (<i>n</i> = 5, 4–5 weeks, 22–25 g) were performed in compliance with the national laws related to the care and experiments on laboratory animals. Biodistribution studies and blocking studies of HPLC-purified [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, [<sup>99m</sup>Tc]<b>25b</b>, and [<sup>99m</sup>Tc]<b>29b</b> (370 kBq, 0.1 mL) were carried out based on a method reported previously.<a onclick="showRef(event, 'ref22 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref25">(22, 25)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Biodistribution and Blocking Studies of [<sup>99m</sup>Tc]<b>20b</b> in Balb/c Nude Mice Bearing C6 Glioma Xenografts</h3><div class="NLM_p last">All animal experiments in Balb/c nude mice (<i>n</i> = 4) were performed in compliance with the national laws related to the care and experiments on laboratory animals. Biodistribution studies and blocking studies of [<sup>99m</sup>Tc]<b>20b</b> (370 kBq, 0.1 mL) were carried out based on a method reported previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Small Animal NanoScan SPECT/CT Imaging of [<sup>99m</sup>Tc]<b>20b</b></h3><div class="NLM_p last">The detailed procedures of small animal imaging studies of [<sup>99m</sup>Tc]<b>20b</b> (22.2 MBq, 0.15 mL) in male Balb/c nude mice bearing C6 glioma xenografts are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>In Vivo</i> Radiometabolic Stability of [<sup>99m</sup>Tc]<b>20b</b></h3><div class="NLM_p last">The <i>in vivo</i> metabolism of [<sup>99m</sup>Tc]<b>20b</b> (18.5 MBq, 0.15 mL) was studied in male ICR mice according to a previously reported method.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Detailed procedures are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01378">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01378" class="ext-link">10.1021/acs.jmedchem.5b01378</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">General information and some parts of the evaluation of the radiotracers in <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>, purity of key target compounds, the HPLC chromatograms of <b>20a</b>–<b>25a</b> and [<sup>99m</sup>Tc]<b>20b</b>–<b>25b</b>, <b>29a</b>–<b>30a</b>, and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b>, X-ray crystallographic data for compound <b>31a</b>, <i>in vitro</i> evaluation of [<sup>99m</sup>Tc]<b>21b</b> and [<sup>99m</sup>Tc]<b>24b</b> in C6 glioma tumor cell line, biodistribution and blocking studies of [<sup>99m</sup>Tc]<b>25b</b> in male ICR mice, small animal NanoScan SPECT/CT imaging of [<sup>99m</sup>Tc]<b>20b</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystal information file of compound <b>31a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf">jm5b01378_si_001.pdf (929.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_002.cif">jm5b01378_si_002.cif (17.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_003.csv">jm5b01378_si_003.csv (2.42 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01378" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47756" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47756" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongmei Jia</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ed858087848cad8f8398c3888998c38e83"><span class="__cf_email__" data-cfemail="f99194939098b99b978cd79c9d8cd79a97">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Li</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanyuan Chen</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xia Wang</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Winnie Deuther-Conrad</span> - <span class="hlFld-Affiliation affiliation">Institute
of Radiopharmaceutical Cancer Research/Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Chen</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Jia</span> - <span class="hlFld-Affiliation affiliation">Medical
and Healthy Analytical Center, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chengyan Dong</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Laboratory, Institute of Biophysics, Chinese
Academy of Sciences, Beijing 100101, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Steinbach</span> - <span class="hlFld-Affiliation affiliation">Institute
of Radiopharmaceutical Cancer Research/Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Brust</span> - <span class="hlFld-Affiliation affiliation">Institute
of Radiopharmaceutical Cancer Research/Department of Neuroradiopharmaceuticals, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boli Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Radiopharmaceuticals (Beijing Normal University), Ministry
of Education, College of Chemistry, Beijing
Normal University, Beijing 100875, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>D.L. and Y.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6430-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We give special thanks to Professor Robert H. Mach for his helpful suggestions and valuable comments on this manuscript. We are grateful to Dr. Xuebing Deng (College of Chemistry, Beijing Normal University) for his assistance with X-ray diffraction. This work was supported by the National Natural Science Foundation of China (No. 21471019).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i70" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i70"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DLT</td><td class="NLM_def"><p class="first last">double ligand transfer</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DTG</td><td class="NLM_def"><p class="first last">1,3-di-<i>o</i>-tolyl-guanidine</p></td></tr><tr><td class="NLM_term">[<sup>18</sup>F]ISO-1</td><td class="NLM_def"><p class="first last"><i>N</i>-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)butyl)-2-(2-[<sup>18</sup>F]fluoroethoxy)-5-methylbenzamide</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">ID</td><td class="NLM_def"><p class="first last">injected dose</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">VAChT</td><td class="NLM_def"><p class="first last">vesicular acetylcholine transporter</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bading, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, A. F.</span><span> </span><span class="NLM_article-title">Imaging of cell proliferation: status and prospects</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">64S</span><span class="NLM_x">–</span> <span class="NLM_lpage">80S</span><span class="refDoi"> DOI: 10.2967/jnumed.107.046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.107.046391" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=64S-80S&author=J.+R.+Badingauthor=A.+F.+Shields&title=Imaging+of+cell+proliferation%3A+status+and+prospects&doi=10.2967%2Fjnumed.107.046391"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.107.046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.107.046391%26sid%3Dliteratum%253Aachs%26aulast%3DBading%26aufirst%3DJ.%2BR.%26aulast%3DShields%26aufirst%3DA.%2BF.%26atitle%3DImaging%2520of%2520cell%2520proliferation%253A%2520status%2520and%2520prospects%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D64S%26epage%3D80S%26doi%3D10.2967%2Fjnumed.107.046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bem, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamone, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscia, C. J.</span><span> </span><span class="NLM_article-title">Overexpression of σ receptors in nonneural human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6558</span><span class="NLM_x">–</span> <span class="NLM_lpage">6562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=6558-6562&author=W.+T.+Bemauthor=G.+E.+Thomasauthor=J.+Y.+Mamoneauthor=S.+M.+Homanauthor=B.+K.+Levyauthor=F.+E.+Johnsonauthor=C.+J.+Coscia&title=Overexpression+of+%CF%83+receptors+in+nonneural+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBem%26aufirst%3DW.%2BT.%26aulast%3DThomas%26aufirst%3DG.%2BE.%26aulast%3DMamone%26aufirst%3DJ.%2BY.%26aulast%3DHoman%26aufirst%3DS.%2BM.%26aulast%3DLevy%26aufirst%3DB.%2BK.%26aulast%3DJohnson%26aufirst%3DF.%2BE.%26aulast%3DCoscia%26aufirst%3DC.%2BJ.%26atitle%3DOverexpression%2520of%2520%25CF%2583%2520receptors%2520in%2520nonneural%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D6558%26epage%3D6562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=7812973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFyjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=408-413&author=B.+J.+Vilnerauthor=C.+S.+Johnauthor=W.+D.+Bowen&title=Sigma-1+and+sigma-2+receptors+are+expressed+in+a+wide+variety+of+human+and+rodent+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines</span></div><div class="casAuthors">Vilner, Bertold J.; John, Christy S.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">408-13</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thirteen tumor-derived cell lines of human and nonhuman origin and from various tissues were examd. for the presence and d. of sigma-1 and sigma-2 receptors.  Sigma-1 receptors of a crude membrane fraction were labeled using [3H](+)-pentazocine, and sigma-2 receptors were labeled with [3H]1,3-di-o-tolylguanidine ([3H]DTG); in the presence or absence of dextrallorphan.  [3H](+)-Pentazocine-binding sites were heterogeneous.  In rodent cell lines (e.g., C6 glioma, NIE-115 neuroblastoma, and NG108-15 neuroblastoma × glioma hybrid), human T47D breast ductal carcinoma, human NCI-H727 lung carcinoid, and human A375 melanoma, [3H](+)-pentazocine bound to high- and low-affinity sites with Kd1 = 0.67-7.0 nM, Bmax 1 = 25.5-108 fmol/mg protein, Kd2 = 127-600 nM, and Bmax2 = 942-5431 fmol/mg protein.  However, [3H](+)-pentazocine bound to a single site in other cell lines.  In human U-138MG glioblastoma, SK-N-sh neuroblastoma, and LNCaP.FGC prostate, Kd=28-61nM and Bmax-1411 fmol/mg protein.  The sigma-1-like nature of [3H](+)-pentazocine-binding sites was confirmed by competition studies which revealed high affinity for haloperidol and enantioselectivity for (+)-pentazocine over (-)-pentazocine.  Interestingly, human MCF-7 breast adenocarcinoma showed little or no specific binding of [3H](+)-pentazocine, suggesting the absence of sigma-1 receptors in this cell line.  All cell lines examd. expressed a high d. of sigma-2 receptors with Kd values for [3H]DTG ranging from 20 to 101 nM and Bmax values of 491 to 7324 fmol/mg protein.  Competition studies indicated possible heterogeneity of sigma-2 receptors.  While sites labeled by [3H]DTG in all cell lines tested exhibited affinity for haloperidol and approx. 10-fold lower affinity for (-)-pentazocine compared with the rodent cell lines.  The high d. of sigma-1 and sigma-2 binding sites in these cell lines suggests important cellular functions in cancer, as well as potential diagnostic utility for tumor-imaging agents which target sigma sites.  These cell lines may be useful as model systems in which to study the functions of sigma sites in normal tissues, as well as their possible role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomx5dT2-5Hz7Vg90H21EOLACvtfcHk0lgYFYOg1xkLKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFyjtr8%253D&md5=80276a71555fdb08d76ae39b73d1cbe1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-1%2520and%2520sigma-2%2520receptors%2520are%2520expressed%2520in%2520a%2520wide%2520variety%2520of%2520human%2520and%2520rodent%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D408%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Targeting sigma receptor-binding benzamides as <i>in vivo</i> diagnostic and therapeutic agents for human prostate tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4578-4583&author=C.+S.+Johnauthor=B.+J.+Vilnerauthor=B.+C.+Geyerauthor=T.+Moodyauthor=W.+D.+Bowen&title=Targeting+sigma+receptor-binding+benzamides+as+in+vivo+diagnostic+and+therapeutic+agents+for+human+prostate+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DGeyer%26aufirst%3DB.%2BC.%26aulast%3DMoody%26aufirst%3DT.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DTargeting%2520sigma%2520receptor-binding%2520benzamides%2520as%2520in%2520vivo%2520diagnostic%2520and%2520therapeutic%2520agents%2520for%2520human%2520prostate%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4578%26epage%3D4583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczynska, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A. J. O.</span><span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">–</span> <span class="NLM_lpage">3537</span><span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van+Waardeauthor=A.+A.+Rybczynskaauthor=N.+K.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+J.+O.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0lgYFYOg1xkLKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%2BK.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Megalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span> </span><span class="NLM_article-title">Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1002/med.20218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fmed.20218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20687157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=410-427&author=V.+Megalizziauthor=M.+Le+Mercierauthor=C.+Decaestecker&title=Sigma+receptors+and+their+ligands+in+cancer+biology%3A+overview+and+new+perspectives+for+cancer+therapy&doi=10.1002%2Fmed.20218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy</span></div><div class="casAuthors">Megalizzi, Veronique; Le Mercier, Marie; Decaestecker, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">410-427</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A large no. of drugs are known to bind with high affinity to sigma receptors (sigma-Rs) and have been used in the clinic to treat mental disorders for many years.  However, recent publications highlighting sigma-R overexpression in many cancer tissues suggest potential applications for sigma-R ligands in cancer diagnosis and therapy.  The present review focuses on the involvement of sigma-Rs in cancer biol. and the potential therapeutic contributions of their pharmacol. ligands in oncol.  After summarizing the current and general knowledge regarding sigma-Rs, we detail data reported in the particular context of oncol.  We then investigate the potential and specific signal transduction pathways and mechanisms involved in the actions of sigma-R ligands in cancer biol.  These processes include modulations of (1) the plasma membrane and lipid raft components, (2) intracellular calcium levels, (3) cytoskeletal protein functions, and (4) endoplasmic reticulum stress.  Finally, we conclude by speculating on the roles of sigma-R overexpression and sigma-R ligands in cancer biol. and offer perspectives on cancer therapy. © 2010 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5t2d8y5adbVg90H21EOLACvtfcHk0lg5RTSFAtDggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyrs7w%253D&md5=5c512915d6f92cd234a7d4cf7f83630f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.20218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20218%26sid%3Dliteratum%253Aachs%26aulast%3DMegalizzi%26aufirst%3DV.%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DDecaestecker%26aufirst%3DC.%26atitle%3DSigma%2520receptors%2520and%2520their%2520ligands%2520in%2520cancer%2520biology%253A%2520overview%2520and%2520new%2520perspectives%2520for%2520cancer%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D410%26epage%3D427%26doi%3D10.1002%2Fmed.20218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Nabulsi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whirrett, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">σ<sub>2</sub> receptors as potential biomarkers of proliferation in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=156-161&author=R.+H.+Machauthor=C.+R.+Smithauthor=I.+Al-Nabulsiauthor=B.+R.+Whirrettauthor=S.+R.+Childersauthor=K.+T.+Wheeler&title=%CF%832+receptors+as+potential+biomarkers+of+proliferation+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DAl-Nabulsi%26aufirst%3DI.%26aulast%3DWhirrett%26aufirst%3DB.%2BR.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3D%25CF%25832%2520receptors%2520as%2520potential%2520biomarkers%2520of%2520proliferation%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D156%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Al-Nabulsi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keng, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6690789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1038%2Fsj.bjc.6690789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10576647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=925-933&author=I.+Al-Nabulsiauthor=R.+H.+Machauthor=L.+M.+Wangauthor=C.+A.+Wallenauthor=P.+C.+Kengauthor=K.+Stenauthor=S.+R.+Childersauthor=K.+T.+Wheeler&title=Effect+of+ploidy%2C+recruitment%2C+environmental+factors%2C+and+tamoxifen+treatment+on+the+expression+of+sigma-2+receptors+in+proliferating+and+quiescent+tumour+cells&doi=10.1038%2Fsj.bjc.6690789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells</span></div><div class="casAuthors">Al-Nabulsi, I.; Mach, R. H.; Wang, L.-M.; Wallen, C. A.; Keng, P. C.; Sten, K.; Childers, S. R.; Wheeler, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-933</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Recently, the authors demonstrated that sigma-2 receptors may have the potential to be a biomarker of tumor cell proliferation.  If sigma-2 receptors were a biomarker of tumor cell proliferation, they would be amenable to detection by non-invasive imaging procedures, thus eliminating many of the problems assocd. with the flow cytometric measures of tumor cell proliferation presently used in the clinic.  To be a good biomarker of tumor cell proliferation, the expression of sigma-2 receptors must be essentially independent of many of the biol., physiol., and/or environmental properties that are found in solid tumors.  In the investigation reported here, the mouse mammary adenocarcinoma lines, 66 (diploid) and 67 (aneuploid), 9L rat brain tumor cells, and MCF-7 human breast tumor cells were used to study the extent and kinetics of expression of sigma-2 receptors in proliferative (P) and quiescent (Q) tumor cells as a function of species, cell type, ploidy, pH, nutrient depletion, metabolic state, recruitment from the Q-cell compartment to the P-cell compartment, and treatment with tamoxifen.  In these expts., the expression of sigma-2 receptors solely reflected the proliferative status of the tumor cells.  None of the biol., physiol., or environmental properties that were investigated had a measurable effect on the expression of sigma-2 receptors in these model systems.  Consequently, these data suggest that the proliferative status of tumors and normal tissues can be non-invasively assessed using radiolabeled ligands that selectively bind sigma-2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNRjnww2EFMLVg90H21EOLACvtfcHk0lg5RTSFAtDggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFSjs74%253D&md5=6e3ef0c6df3f2ad37a35a2a23541eb84</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690789%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Nabulsi%26aufirst%3DI.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWallen%26aufirst%3DC.%2BA.%26aulast%3DKeng%26aufirst%3DP.%2BC.%26aulast%3DSten%26aufirst%3DK.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3DEffect%2520of%2520ploidy%252C%2520recruitment%252C%2520environmental%2520factors%252C%2520and%2520tamoxifen%2520treatment%2520on%2520the%2520expression%2520of%2520sigma-2%2520receptors%2520in%2520proliferating%2520and%2520quiescent%2520tumour%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D81%26spage%3D925%26epage%3D933%26doi%3D10.1038%2Fsj.bjc.6690789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keng, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Sigma-2 receptors as a biomarker of proliferation in solid tumours</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span><span class="refDoi"> DOI: 10.1054/bjoc.1999.1067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1054%2Fbjoc.1999.1067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10735510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFSktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2000&pages=1223-1232&author=K.+T.+Wheelerauthor=L.+M.+Wangauthor=C.+A.+Wallenauthor=S.+R.+Childersauthor=J.+M.+Clineauthor=P.+C.+Kengauthor=R.+H.+Mach&title=Sigma-2+receptors+as+a+biomarker+of+proliferation+in+solid+tumours&doi=10.1054%2Fbjoc.1999.1067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 receptors as a biomarker of proliferation in solid tumours</span></div><div class="casAuthors">Wheeler, K. T.; Wang, L.-M.; Wallen, C. A.; Childers, S. R.; Cline, J. M.; Keng, P. C.; Mach, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1223-1232</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Over the past several years, our group has provided considerable evidence that the expression of sigma-2 (σ2) receptors may serve as a biomarker of tumor cell proliferation.  In these in vitro studies, σ2 receptors were expressed 8-10 times more in proliferative (P) tumor cells than in quiescent (Q) tumor cells, and the extent and kinetics of their expression were independent of a no. of biol., physiol. and environmental factors often found in solid tumors.  Moreover, the expression of σ2 receptors followed both the population growth kinetics when Q-cells were recruited into the P-cell compartment and the proliferative status of human breast tumor cells treated with cytostatic concns. of tamoxifen.  However, these in vitro studies may or may not be indicative of what might occur in solid tumors.  In the present study, the σ2 receptor P:Q ratio was detd. for the cells from s.c. 66 (diploid) and 67 (aneuploid) tumors grown in female nude mice.  The σ2 receptor P:Q ratio of the 66 tumors was 10.6 compared to the σ2 receptor P:Q ratio of 9.5 measured for the 66 tissue culture model.  The σ2 receptor P:Q ratio of the 67 tumors was 4.5 compared to the σ2 receptor P:Q ratio of ≈ 8 measured for the 67 tissue culture model.  The agreement between the solid tumor and tissue culture data indicates that: (1) the expression of σ2 receptors may be a reliable biomarker of the proliferative status of solid tumors and (2) radioligands with both high affinity and high selectivity for σ2 receptors may have the potential to non-invasively assess the proliferative status of human solid tumors using imaging techniques such as positron emission tomog. or single-photon emission computerized tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0asMPgLbuLbVg90H21EOLACvtfcHk0lg5RTSFAtDggw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFSktrs%253D&md5=5a36a664fb20482b0232191ec9e91a9e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.1999.1067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.1999.1067%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWallen%26aufirst%3DC.%2BA.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DCline%26aufirst%3DJ.%2BM.%26aulast%3DKeng%26aufirst%3DP.%2BC.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSigma-2%2520receptors%2520as%2520a%2520biomarker%2520of%2520proliferation%2520in%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2000%26volume%3D82%26spage%3D1223%26epage%3D1232%26doi%3D10.1054%2Fbjoc.1999.1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumstorff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Fluorine-18-labeled benzamide analogues for imaging the σ<sub>2</sub> receptor status of solid tumors with Positron Emission Tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3194</span><span class="NLM_x">–</span> <span class="NLM_lpage">3204</span><span class="refDoi"> DOI: 10.1021/jm0614883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0614883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFGnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3194-3204&author=Z.+Tuauthor=J.+Xuauthor=L.+A.+Jonesauthor=S.+Liauthor=C.+Dumstorffauthor=S.+Vangveravongauthor=D.+L.+Chenauthor=K.+T.+Wheelerauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Fluorine-18-labeled+benzamide+analogues+for+imaging+the+%CF%832+receptor+status+of+solid+tumors+with+Positron+Emission+Tomography&doi=10.1021%2Fjm0614883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-18-Labeled Benzamide Analogs for Imaging the σ2 Receptor Status of Solid Tumors with Positron Emission Tomography</span></div><div class="casAuthors">Tu, Zhude; Xu, Jinbin; Jones, Lynne A.; Li, Shihong; Dumstorff, Craig; Vangveravong, Suwanna; Chen, Delphine L.; Wheeler, Kenneth T.; Welch, Michael J.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3194-3204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. benzamide analogs was synthesized and evaluated as candidate ligands for positron emission tomog. (PET) imaging of the sigma-2 (σ2) receptor status of solid tumors.  Four compds. having a moderate to high affinity for σ2 receptors and a moderate to low affinity for sigma-1 (σ1) receptors were radiolabeled with fluorine-18 via displacement of the corresponding mesylate precursor with [18F]fluoride.  Biodistribution studies in female Balb/c mice bearing EMT-6 tumor allografts demonstrated that all four F-18-labeled compds. had a high tumor uptake (2.5-3.7% ID/g) and acceptable tumor/normal tissue ratios at 1 and 2 h post-i.v. injection.  An anal. of the chem. and biodistribution data suggested that N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-methylbenzamide and N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-iodo-3-methoxybenzamide are acceptable compds. for imaging the σ2 receptor status of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtoxOqoNWUSbVg90H21EOLACvtfcHk0ljyiuWXBniVtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFGnsro%253D&md5=ff418877245698b688efdcdc7edf9bc3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0614883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0614883%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDumstorff%26aufirst%3DC.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DFluorine-18-labeled%2520benzamide%2520analogues%2520for%2520imaging%2520the%2520%25CF%25832%2520receptor%2520status%2520of%2520solid%2520tumors%2520with%2520Positron%2520Emission%2520Tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3194%26epage%3D3204%26doi%3D10.1021%2Fjm0614883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoghi, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aft, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussenbaum, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisel, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner-Johnson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Assessment of cellular proliferation in tumors by PET using <sup>18</sup>F-ISO-1</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.2967/jnumed.112.111948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.112.111948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=23359657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=350-357&author=F.+Dehdashtiauthor=R.+Laforestauthor=F.+Gaoauthor=K.+I.+Shoghiauthor=R.+L.+Aftauthor=B.+Nussenbaumauthor=F.+H.+Kreiselauthor=N.+L.+Bartlettauthor=A.+Cashenauthor=N.+Wagner-Johnsonauthor=R.+H.+Mach&title=Assessment+of+cellular+proliferation+in+tumors+by+PET+using+18F-ISO-1&doi=10.2967%2Fjnumed.112.111948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of cellular proliferation in tumors by PET using 18F-ISO-1</span></div><div class="casAuthors">Dehdashti, Farrokh; Laforest, Richard; Gao, Feng; Shoghi, Kooresh I.; Aft, Rebecca L.; Nussenbaum, Brian; Kreisel, Friederike H.; Bartlett, Nancy L.; Cashen, Amanda; Wagner-Johnston, Nina; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-357</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This first study in humans was designed to evaluate the safety and dosimetry of a cellular proliferative marker, N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-18F-fluoro-ethoxy)-5-methylbenzamide (18F-ISO-1), and evaluate the feasibility of imaging tumor proliferation by PET in patients with newly diagnosed malignant neoplasms.  Methods: Patients with biopsy-proven lymphoma, breast cancer, or head and neck cancer underwent 18F-ISO-1 PET.  Tumor 18F-ISO-1 uptake was assessed semiquant. by max. standardized uptake value, ratios of tumor to normal tissue and tumor to muscle, and relative distribution vol. ratio.  The PET results were correlated with tumor Ki-67 and mitotic index, from in vitro assays of the tumor tissue.  The biodistribution of 18F-ISO-1 and human dosimetry were evaluated.  Results: Thirty patients with primary breast cancer (n = 13), head and neck cancer (n = 10), and lymphoma (n = 7) were evaluated.  In the entire group, tumor max. standardized uptake value and tumor-to-muscle ratio correlated significantly with Ki-67 (*au = 0.27, P = 0.04, and *au = 0.38, P = 0.003, resp.), but no significant correlation was obsd. between Ki-67 and tumor-to-normal-tissue ratio (*au = 0.07, P = 0.56) or distribution vol. ratio (*au = 0.26, P = 0.14).  On the basis of whole-body PET data, the gallbladder is the dose-limiting organ, with an av. radiation dose of 0.091 mGy/MBq.  The whole-body and EDs were 0.012 mGy/MBq and 0.016 mSv/MBq, resp.  No adverse effects of 18F-ISO-1 were encountered.  Conclusion: The presence of a significant correlation between 18F-ISO-1 and Ki-67 makes this agent promising for evaluation of the proliferative status of solid tumors.  The relatively small absorbed doses to normal organs allow for the safe administration of up to 550 MBq, which is sufficient for PET imaging in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJzNLBiXZh7Vg90H21EOLACvtfcHk0ljyiuWXBniVtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2ksr4%253D&md5=c746f6bb256184c9e2e2dfa164be875f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.111948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.111948%26sid%3Dliteratum%253Aachs%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DAft%26aufirst%3DR.%2BL.%26aulast%3DNussenbaum%26aufirst%3DB.%26aulast%3DKreisel%26aufirst%3DF.%2BH.%26aulast%3DBartlett%26aufirst%3DN.%2BL.%26aulast%3DCashen%26aufirst%3DA.%26aulast%3DWagner-Johnson%26aufirst%3DN.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DAssessment%2520of%2520cellular%2520proliferation%2520in%2520tumors%2520by%2520PET%2520using%252018F-ISO-1%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D350%26epage%3D357%26doi%3D10.2967%2Fjnumed.112.111948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Shoghi, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashikubo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span> </span><span class="NLM_article-title">Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [<sup>18</sup>F]ISO-1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74188</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1371%2Fjournal.pone.0074188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74188&author=K.+I.+Shoghiauthor=J.+Xuauthor=Y.+Suauthor=J.+Heauthor=D.+Rowlandauthor=Y.+Yanauthor=J.+R.+Garbowauthor=Z.+Tuauthor=L.+A.+Jonesauthor=R.+Higashikuboauthor=K.+T.+Wheelerauthor=R.+A.+Lubetauthor=R.+H.+Machauthor=M.+You&title=Quantitative+receptor-based+imaging+of+tumor+proliferation+with+the+sigma-2+ligand+%5B18F%5DISO-1&doi=10.1371%2Fjournal.pone.0074188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074188%26sid%3Dliteratum%253Aachs%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DRowland%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DGarbow%26aufirst%3DJ.%2BR.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DHigashikubo%26aufirst%3DR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DYou%26aufirst%3DM.%26atitle%3DQuantitative%2520receptor-based%2520imaging%2520of%2520tumor%2520proliferation%2520with%2520the%2520sigma-2%2520ligand%2520%255B18F%255DISO-1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74188%26doi%3D10.1371%2Fjournal.pone.0074188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">Development of molecular probes for imaging sigma-2 receptors in vitro and <i>in vivo</i></span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.2174/1871524910909030230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F1871524910909030230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20021357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=230-245&author=R.+H.+Machauthor=K.+T.+Wheeler&title=Development+of+molecular+probes+for+imaging+sigma-2+receptors+in+vitro+and+in+vivo&doi=10.2174%2F1871524910909030230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo</span></div><div class="casAuthors">Mach, Robert Henry; Wheeler, Kenneth Theodore</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-245</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-2 (σ2) receptor is proving to be an important protein in the field of cancer biol.  The observations that σ2 receptors have a 10-fold higher d. in proliferating tumor cells than in quiescent tumor cells, and that σ2 receptor agonists are capable of killing tumor cells via apoptotic and non-apoptotic mechanisms, indicate that this receptor is an important mol. target for the development of radiotracers for imaging tumors using techniques such as Positron Emission Tomog. (PET) and Single Photon Emission Computed Tomog. (SPECT) and for the development of cancer chemotherapeutic agents.  In spite of recent promising results towards achieving these goals, research in this field has been hampered by the fact that the mol. identity of the protein sequence of the σ2 receptor is currently not known.  Consequently, most of what is known about this protein has been obtained using either radiolabeled or fluorescent probes for this receptor, or biochem. anal. of the effect of σ2 selective ligands on cells growing under tissue culture conditions.  This article provides a review of the development and use of σ2 receptor ligands, and how these ligands have been used with a variety of in vitro and in vivo models to gain a greater understanding of the role this receptor plays in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9Mm5Pn8dtbVg90H21EOLACvtfcHk0ljdxNgjMksFFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rJ&md5=1babf73dd3a6dcf8eb3eb8b29702360e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030230%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3DDevelopment%2520of%2520molecular%2520probes%2520for%2520imaging%2520sigma-2%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D230%26epage%3D245%26doi%3D10.2174%2F1871524910909030230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sai, K. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Development of <sup>18</sup>F-labeled PET probes for imaging cell proliferation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.2174/1568026611313080003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F1568026611313080003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=23590172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=892-908&author=K.+K.+S.+Saiauthor=L.+A.+Jonesauthor=R.+H.+Mach&title=Development+of+18F-labeled+PET+probes+for+imaging+cell+proliferation&doi=10.2174%2F1568026611313080003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 18F-labeled PET probes for imaging cell proliferation</span></div><div class="casAuthors">Sai, Kiran Kumar Solingapuram; Jones, Lynne A.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">892-908</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, two different methods have been developed to image cell proliferation with the functional imaging technique, Positron emission Tomog. (PET), proliferation rate and proliferative status.  Proliferation rate is a measure of the tumor doubling time and uses radiolabeled analogs of the DNA precursor thymidine.  This approach measures the activity of the enzyme thymidine kinase 1 (TK1) and provides a pulse label of the S phase fraction of a tumor.  Proliferative status provides a measure of the ratio of proliferating (P) and quiescent (Q) cells in a tumor.  This imaging approach for measuring proliferative status involves measuring the sigma-2 (σ2) receptor status of a tumor, the only protein which has been validated for making this measurement in vivo with PET.  This article provides an overview of the biol. information obtained from these different imaging strategies, and the development of radiotracers for imaging proliferation rate and proliferative status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnMGN4tIYxMLVg90H21EOLACvtfcHk0ljdxNgjMksFFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslKhtL0%253D&md5=6d4f1a36b663ec4b9d3de6f9591e9e56</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026611313080003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611313080003%26sid%3Dliteratum%253Aachs%26aulast%3DSai%26aufirst%3DK.%2BK.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%252018F-labeled%2520PET%2520probes%2520for%2520imaging%2520cell%2520proliferation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D892%26epage%3D908%26doi%3D10.2174%2F1568026611313080003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The σ<sub>2</sub> receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+%CF%832+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The σ2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer</span></div><div class="casAuthors">Mach, Robert H.; Zeng, Chenbo; Hawkins, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7137-7160</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The σ2 receptor is an important target for the development of mol. probes in oncol. because of its 10-fold higher d. in proliferating tumor cells compared with that in quiescent tumor cells and because of the observation that σ2 receptor agonists are able to kill tumor cells via apoptotic and nonapoptotic mechanisms.  Although recent evidence indicates that the σ2 receptor binding site is localized within the progesterone receptor membrane component 1 (PGRMC1), most information regarding this protein has been obtained using either radiolabeled or fluorescent receptor-based probes and from biochem. anal. of the effect of σ2 selective ligands on cells grown in culture.  This article reviews the development of σ2 receptor ligands and presents an overview of how they have been used in vitro and in vivo to increase the authors' understanding of the role of the σ2 receptor in cancer and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWf1ZnaveYT7Vg90H21EOLACvtfcHk0ljdxNgjMksFFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWmtr0%253D&md5=55831988f692d39d423e8cfe7f18240f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520%25CF%25832%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bailey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willowson, K. P.</span><span> </span><span class="NLM_article-title">An evidence-based review of quantitative SPECT imaging and potential clinical applications</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.2967/jnumed.112.111476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.112.111476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=83-98&author=D.+L.+Baileyauthor=K.+P.+Willowson&title=An+evidence-based+review+of+quantitative+SPECT+imaging+and+potential+clinical+applications&doi=10.2967%2Fjnumed.112.111476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.111476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.111476%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%2BL.%26aulast%3DWillowson%26aufirst%3DK.%2BP.%26atitle%3DAn%2520evidence-based%2520review%2520of%2520quantitative%2520SPECT%2520imaging%2520and%2520potential%2520clinical%2520applications%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D83%26epage%3D98%26doi%3D10.2967%2Fjnumed.112.111476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled σ-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1021/bc9700087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9700087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2jsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=304-309&author=C.+S.+Johnauthor=B.+B.+Limauthor=B.+C.+Geyerauthor=B.+J.+Vilnerauthor=W.+D.+Bowen&title=99mTc-labeled+%CF%83-receptor-binding+complex%3A+synthesis%2C+characterization%2C+and+specific+binding+to+human+ductal+breast+carcinoma+%28T47D%29+cells&doi=10.1021%2Fbc9700087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeled σ-Receptor-Binding Complex: Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells</span></div><div class="casAuthors">John, Christy S.; Lim, Benjamin B.; Geyer, Brian C.; Vilner, Bertold J.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-309</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">σ-Receptors have recently been shown to be expressed in a variety of human tumor cells.  In an attempt to prep. 99mTc chelates that would bind to σ-receptors and be useful for imaging σ-receptor-pos. tumors, we have synthesized and characterized a bisaminothiol (BAT) chelate appended with a σ-receptor pharmacophore.  The synthesis of target ligand VII was accomplished in three steps starting from bicyclic imidazolidino[1,2-d]dithiazapine.  The labeling of the BAT ligand with 99mTc was carried out in high yields (>80%) using stannous tartrate as a reducing agent, resulting in the target σ [99mTc]BAT-EN6, III.  Similarly, 99gTc chelate with ligand VII was prepd. from ammonium pertechnetate by redn. with stannous tartrate.  99mTc-radiolabeled chelate was purified by reversed phase HPLC, and cell binding with human breast ductal carcinoma (T47D) was performed.  A high degree of specific binding (90-97%) was obtained when σ-receptor ligands such as halogenated phenylethylenediamines were used to det. nonspecific binding.  A modest affinity dose-dependent inhibition of binding was found with BD1008, I, and 4-IPEMP, II (IC50 = 47 ± 2 and 59 ± 5 nM, resp.), known σ-ligands.  No specific binding was found with [99mTc]BAT, VIII [without appended σ-pharmacophore (N-alkyl-substituted ethylenediamine)], showing that biol. activity resulted from the pendent pharmacophore.  99gTc complex was found to be a potent inhibitor (Ki = 42.7 ± 8.5 nM) of [3H]DTG binding in guinea pig brain membranes.  Scatchard anal. of [99mTc]BAT-EN6 (spiked with [99gTc]BAT-EN6) binding in T47D breast cancer cells showed a saturable binding, with a Kd of 43.5 ± 14.7 nM and a Bmax of 3121 ± 130 fmol/(mg of protein).  A biodistribution study of [99mTc]BAT-EN6 chelates in Sprague Dawley rats showed hepatic clearance, as expected.  A blocking study at 4 h postinjection using 2 μmol of BD1008 with [99mTc]BAT-EN6 showed a significant decrease of radiopharmaceutical in liver (15.32 vs 22.31% ID/organ) and kidney (1.01 vs 2.21% ID/organ), organs known to possess high concns. of σ-receptors.  These results imply that [99mTc]BAT-EN6 binds with high affinity to σ-receptors expressed in human breast tumor cells, and it may be useful for imaging breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2hn0M-wX8pbVg90H21EOLACvtfcHk0lhD-j89guu2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2jsbg%253D&md5=8ecf2143cc8fc3159f2c156579e681cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbc9700087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700087%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DB.%2BB.%26aulast%3DGeyer%26aufirst%3DB.%2BC.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3D99mTc-labeled%2520%25CF%2583-receptor-binding%2520complex%253A%2520synthesis%252C%2520characterization%252C%2520and%2520specific%2520binding%2520to%2520human%2520ductal%2520breast%2520carcinoma%2520%2528T47D%2529%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D304%26epage%3D309%26doi%3D10.1021%2Fbc9700087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plössl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumpradit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1016/S0969-8051(01)00234-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2FS0969-8051%2801%2900234-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=11518647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=657-666&author=S.+R.+Choiauthor=B.+Yangauthor=K.+Pl%C3%B6sslauthor=S.+Chumpraditauthor=S.+P.+Weyauthor=P.+D.+Actonauthor=K.+Wheelerauthor=R.+H.+Machauthor=H.+F.+Kung&title=Development+of+a+Tc-99m+labeled+sigma-2+receptor-specific+ligand+as+a+potential+breast+tumor+imaging+agent&doi=10.1016%2FS0969-8051%2801%2900234-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent</span></div><div class="casAuthors">Choi, S.-R.; Yang, B.; Plossl, K.; Chumpradit, S.; Wey, S.-P.; Acton, P. D.; Wheeler, K.; Mach, R. H.; Kung, H. F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A novel in vivo imaging agent, 99mTc labeled [(N-[2-((3'-N'-propyl-[3,3,1]aza-bicyclononan-3α-yl)(2''-methoxy-5-methyl-phenylcarbamate)(2-mercaptoethyl)amino)acetyl]-2-aminoethanethiolato] technetium(V) oxide), [99mTc]2, displaying specific binding towards sigma-2 receptors was prepd. and characterized.  In vitro binding assays showed that the rhenium surrogate of [99mTc]2, Re-2, displayed excellent binding affinity and selectivity towards sigma-2 receptors (Ki = 2,723 and 22 nM for sigma-1 and sigma-2 receptor, resp.).  Prepn. of [99mTc]2 was achieved by heating the S-protected starting material, 1, in the presence of acid, reducing agent (stannous glucoheptonate) and sodium [99mTc]pertechnetate.  The lipophilic racemic mixt. was successfully prepd. in 10 to 50% yield and the radiochem. purity was >98%.  Sepn. of the isomers, peak A and peak B, was successfully achieved by using a chiralpak AD column eluted with an isocratic solvent (n-hexane/isopropanol; 3:1; vol./vol.).  The peak A and peak B appear to co-elute with the isomers of the surrogate, Re-2, under the same HPLC condition.  Biodistribution studies in tumor bearing mice (mouse mammary adenocarcinoma, cell line 66, which is known to over-express sigma-2 receptors) showed that the racemic [99mTc]2 localized in the tumor.  Uptake in the tumor was 2.11, 1.30 and 1.11 %dose/g at 1, 4 and 8 h post iv injection, resp., suggesting good uptake and retention in the tumor cells.  The tumor uptake was significantly, but incompletely, blocked (about 25-30% blockage) by co-injection of "cold" (+)pentazocine or haloperidol (1 mg/Kg).  A majority of the radioactivity localized in the tumor tissue was extractable (>60%), and the HPLC anal. showed that it is the original compd., racemic [99mTc]2 (>98% pure).  The distribution of the purified peak A and peak B was detd. in the same tumor bearing mice at 4 h post iv injection.  The tumor uptake was similar for both isomers, but the blood and peripheral tissue content for the isomer in peak B was higher than that for the isomer in peak A.  It is evident that the isomer in peak A displayed significantly better tumor/blood and tumor/muscle ratios.  The higher rate of in vivo metab. was also confirmed by the higher thyroid uptake values for the isomer in peak B as compared to peak A. In summary, a 99mTc-labeled sigma receptor imaging agent, [99mTc]2, has demonstrated the feasibility of using a 99mTc-labeled agent for imaging sigma receptor expression in tumor cells.  This is the first time a subtype-selective 99mTc-labeled agent for imaging sigma receptor sites is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHIb44oMK6IrVg90H21EOLACvtfcHk0lhD-j89guu2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksr4%253D&md5=5f8b2cf8285b360a724832843d69741a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900234-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900234-7%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DPl%25C3%25B6ssl%26aufirst%3DK.%26aulast%3DChumpradit%26aufirst%3DS.%26aulast%3DWey%26aufirst%3DS.%2BP.%26aulast%3DActon%26aufirst%3DP.%2BD.%26aulast%3DWheeler%26aufirst%3DK.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DDevelopment%2520of%2520a%2520Tc-99m%2520labeled%2520sigma-2%2520receptor-specific%2520ligand%2520as%2520a%2520potential%2520breast%2520tumor%2520imaging%2520agent%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D657%26epage%3D666%26doi%3D10.1016%2FS0969-8051%2801%2900234-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Friebe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drews, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. G.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Oxotechnetium(V) complexes of amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3140</span><span class="refDoi"> DOI: 10.1021/jm0005407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0005407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3132-3140&author=M.+Friebeauthor=A.+Mahmoodauthor=C.+Bolzatiauthor=A.+Drewsauthor=B.+Johannsenauthor=M.+Eisenhutauthor=D.+Kraemerauthor=A.+Davisonauthor=A.+G.+Jones&title=%5B99mTc%5DOxotechnetium%28V%29+complexes+of+amine-amide-dithiol+chelates+with+dialkylaminoalkyl+substituents+as+potential+diagnostic+probes+for+malignant+melanoma&doi=10.1021%2Fjm0005407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0005407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0005407%26sid%3Dliteratum%253Aachs%26aulast%3DFriebe%26aufirst%3DM.%26aulast%3DMahmood%26aufirst%3DA.%26aulast%3DBolzati%26aufirst%3DC.%26aulast%3DDrews%26aufirst%3DA.%26aulast%3DJohannsen%26aufirst%3DB.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DKraemer%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DA.%2BG.%26atitle%3D%255B99mTc%255DOxotechnetium%2528V%2529%2520complexes%2520of%2520amine-amide-dithiol%2520chelates%2520with%2520dialkylaminoalkyl%2520substituents%2520as%2520potential%2520diagnostic%2520probes%2520for%2520malignant%2520melanoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3132%26epage%3D3140%26doi%3D10.1021%2Fjm0005407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Novel <sup>99m</sup>Tc labeled σ receptor ligand as a potential tumor imaging agent</span> <span class="citation_source-journal">Sci. China, Ser. B: Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span><span class="refDoi"> DOI: 10.1007/s11426-006-0169-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1007%2Fs11426-006-0169-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=169-176&author=C.+Fanauthor=H.+Jiaauthor=W.+Deuther-Conradauthor=P.+Brustauthor=J.+Steinbachauthor=B.+Liu&title=Novel+99mTc+labeled+%CF%83+receptor+ligand+as+a+potential+tumor+imaging+agent&doi=10.1007%2Fs11426-006-0169-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 99mTc labeled σ receptor ligand as a potential tumor imaging agent</span></div><div class="casAuthors">Fan, Caiyun; Jia, Hongmei; Deuther-Conrad, Winnie; Brust, Peter; Steinbach, Joerg; Liu, Boli</div><div class="citationInfo"><span class="NLM_cas:title">Science in China, Series B: Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">SCBCFQ</span>;
        ISSN:<span class="NLM_cas:issn">1006-9291</span>.
    
            (<span class="NLM_cas:orgname">Science in China Press</span>)
        </div><div class="casAbstract">A novel 99mTc labeled complex, [N-[2-((2-oxo-2-(4-(3-phenylpropyl)piperazin-1-yl)ethyl) (2-mercaptoethyl)amino)acetyl]-2-aminoethanethiolato]Technetium(V) oxide (PPPE-MAMA'-99mTcO) ([99mTc]-2) has been designed and prepd. based on the integrated approach.  The corresponding rhenium complex (PPPE-MAMA'-ReO)(Re-2) has been prepd. and characterized.  In vitro competition binding assays show moderate affinity of Re-2 towards σ1 and σ2 receptors with K i values of 8.67±0.07 and 5.71±1.88 μmol, resp.  Planar images obtained at 0.5 h, 4 h, 20 h after i.v. injection indicate the accumulation of [99mTc]-2 in MCF-7 human breast tumor bearing mice at 20 h.  Furthermore, the accumulation of [ 99m Tc]-2 has been inhibited at 20 h after co-injection of [99mTc]-2 plus haloperidol (1 mg/kg).  Biodistribution studies of [99mTc]-2 display an in vivo tumor uptake of 0.14% ± 0.01% ID/g at 24 h post i.v. injection with a tumor/muscle ratio of 6.02±0.87.  The above results suggest that [99mTc]-2, derived from a previously published lead compd., retains certain tumor uptake and affinity for σ receptors.  [99mTc]-2 may be used as a basis for further structural modifications to develop tumor imaging agents with high affinity for σ receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg1EqaHzl6tLVg90H21EOLACvtfcHk0lhD-j89guu2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVKjt7s%253D&md5=e252aa8dd5ea0518f2e55359516f7605</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11426-006-0169-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-006-0169-z%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DNovel%252099mTc%2520labeled%2520%25CF%2583%2520receptor%2520ligand%2520as%2520a%2520potential%2520tumor%2520imaging%2520agent%26jtitle%3DSci.%2520China%252C%2520Ser.%2520B%253A%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D169%26epage%3D176%26doi%3D10.1007%2Fs11426-006-0169-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of <sup>99m</sup>TcN-4-(cyclohexylpiperazin-1-yl)dithioformate as a potential sigma receptor imaging agent</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span><span class="refDoi"> DOI: 10.1002/jlcr.1438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fjlcr.1438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1cXit1Sns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1200-1205&author=J.+Luauthor=D.+Kongauthor=H.+Jiaauthor=W.+Deuther-Conradauthor=P.+Brustauthor=X.+Wang&title=Preparation+and+biological+evaluation+of+99mTcN-4-%28cyclohexylpiperazin-1-yl%29dithioformate+as+a+potential+sigma+receptor+imaging+agent&doi=10.1002%2Fjlcr.1438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and biological evaluation of 99mTcN-4-(cyclohexylpiperazin-1-yl)dithioformate as a potential sigma receptor imaging agent</span></div><div class="casAuthors">Lu, Jie; Kong, Dejing; Jia, Hongmei; Deuther-Conrad, Winnie; Brust, Peter; Wang, Xuebin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1200-1205</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The goal of this study is to develop a novel 99mTc-labeled σ receptor imaging agent.  Potassium 4-(cyclohexylpiperazin-1-yl)dithioformate and the corresponding rhenium complex, ReN-2, were synthesized and characterized.  ReN-2 possessed moderate affinity toward σ1 (Ki = 1.94±0.60 μmol/L) and σ2 (Ki = 2.83±1.39 μmol/L) receptors.  The radiolabeled complex 99mTcN-2 was prepd. in high yield (> 95%) through the [99mTcN]2+int precursor and characterized by HPLC.  99mTcN-2 was found to be a lipophilic and neutral complex with good stability.  The biodistribution in tumor-bearing mice showed that 99mTcN-2 had good tumor uptake (2.12±0.01 %ID/g at 2 h p.i.) and moderate brain uptake (0.27±0.05 %ID/g at 2 h p.i.).  After blocking with haloperidol, the uptakes by tumor and brain were lower than control.  The results indicated that the complex has specific binding to the σ receptors in vivo.  Further structural modifications of this complex are needed to obtain 99mTc-based σ receptor imaging agents with high affinity and subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0FDI3mbmU7Vg90H21EOLACvtfcHk0liu3GLCT2M8qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXit1Sns7k%253D&md5=31ce2cc4a283dc67cbce96705477aacb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1438%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%252099mTcN-4-%2528cyclohexylpiperazin-1-yl%2529dithioformate%2520as%2520a%2520potential%2520sigma%2520receptor%2520imaging%2520agent%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2007%26volume%3D50%26spage%3D1200%26epage%3D1205%26doi%3D10.1002%2Fjlcr.1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel <sup>99m</sup>Tc cyclopentadienyl tricarbonyl complex ([(Cp-R)<sup>99m</sup>Tc(CO)<sub>3</sub>]) for sigma-2 receptor tumor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6352</span><span class="NLM_x">–</span> <span class="NLM_lpage">6357</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmcl.2012.08.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6352-6357&author=X.+Chenauthor=M.+C.+Cuiauthor=W.+Deuther-Conradauthor=Y.+F.+Tuauthor=T.+Maauthor=Y.+Xieauthor=B.+Jiaauthor=Y.+Liauthor=F.+Xieauthor=X.+Wangauthor=J.+Steinbachauthor=P.+Brustauthor=B.+L.+Liuauthor=H.+M.+Jia&title=Synthesis+and+biological+evaluation+of+a+novel+99mTc+cyclopentadienyl+tricarbonyl+complex+%28%5B%28Cp-R%2999mTc%28CO%293%5D%29+for+sigma-2+receptor+tumor+imaging&doi=10.1016%2Fj.bmcl.2012.08.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.083%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DY.%2BF.%26aulast%3DMa%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26aulast%3DJia%26aufirst%3DH.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%252099mTc%2520cyclopentadienyl%2520tricarbonyl%2520complex%2520%2528%255B%2528Cp-R%252999mTc%2528CO%25293%255D%2529%2520for%2520sigma-2%2520receptor%2520tumor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6352%26epage%3D6357%26doi%3D10.1016%2Fj.bmcl.2012.08.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Novel indole-based sigma-2 receptor ligands: synthesis, structure-affinity relationship and antiproliferative activity</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1039/C5MD00079C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1039%2FC5MD00079C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslGgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1093-1103&author=F.+Xieauthor=T.+Kniessauthor=C.+Neuberauthor=W.+Deuther-Conradauthor=C.+Mamatauthor=B.+P.+Liebermanauthor=B.+Liuauthor=R.+H.+Machauthor=P.+Brustauthor=J.+Steinbachauthor=J.+Pietzschauthor=H.+Jia&title=Novel+indole-based+sigma-2+receptor+ligands%3A+synthesis%2C+structure-affinity+relationship+and+antiproliferative+activity&doi=10.1039%2FC5MD00079C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Novel indole-based sigma-2 receptor ligands: synthesis, structure-affinity relationship and antiproliferative activity</span></div><div class="casAuthors">Xie, Fang; Kniess, Torsten; Neuber, Christin; Deuther-Conrad, Winnie; Mamat, Constantin; Lieberman, Brian P.; Liu, Boli; Mach, Robert H.; Brust, Peter; Steinbach, Jorg; Pietzsch, Jens; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1093-1103</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis and biol. evaluation of a series of indole-based σ2 receptor ligands I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl, 4-phenylpiperidinyl-4-carbonitrile, etc.] derived from siramesine was reported.  In vitro competition binding assays showed that these analogs possessed high to moderate affinity and selectivity for σ2 receptors.  Structure-affinity relationship analyses of these indole-based σ2 receptor ligands were performed.  In the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl] displayed significant and comparable antiproliferative activity in DU145, MCF7 and C6 cells to siramesine.  In cell cycle analyses, compds. I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl] and siramesine were found to induce a G1 phase cell cycle arrest in DU145 cells using flow cytometry.  The combination of 5,6-dimethoxyisoindoline scaffold and N-(4-fluorophenyl)indole moiety was identified as a new σ2 receptor ligand deserving further investigation as an antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtDXWI6Q_fILVg90H21EOLACvtfcHk0lhbTpn6lzJfhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslGgtbk%253D&md5=766f04340f2e6ec6f64c7dcd3790334b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2FC5MD00079C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00079C%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DF.%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DNeuber%26aufirst%3DC.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DMamat%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DB.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DPietzsch%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DNovel%2520indole-based%2520sigma-2%2520receptor%2520ligands%253A%2520synthesis%252C%2520structure-affinity%2520relationship%2520and%2520antiproliferative%2520activity%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1093%26epage%3D1103%26doi%3D10.1039%2FC5MD00079C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, S. Z.</span><span> </span><span class="NLM_article-title">Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ<sub>1</sub> and σ<sub>2</sub> receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1852</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmc.2011.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1852-1859&author=K.+H.+Fanauthor=J.+R.+Leverauthor=S.+Z.+Lever&title=Effect+of+structural+modification+in+the+amine+portion+of+substituted+aminobutyl-benzamides+as+ligands+for+binding+%CF%831+and+%CF%832+receptors&doi=10.1016%2Fj.bmc.2011.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DLever%26aufirst%3DJ.%2BR.%26aulast%3DLever%26aufirst%3DS.%2BZ.%26atitle%3DEffect%2520of%2520structural%2520modification%2520in%2520the%2520amine%2520portion%2520of%2520substituted%2520aminobutyl-benzamides%2520as%2520ligands%2520for%2520binding%2520%25CF%25831%2520and%2520%25CF%25832%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1852%26epage%3D1859%26doi%3D10.1016%2Fj.bmc.2011.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Novel cyclopentadienyl tricarbonyl <sup>99m</sup>Tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7113</span><span class="NLM_x">–</span> <span class="NLM_lpage">7125</span><span class="refDoi"> DOI: 10.1021/jm5009488</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5009488" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1egs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7113-7125&author=X.+Wangauthor=D.+Liauthor=W.+Deuther-Conradauthor=J.+Luauthor=Y.+Xieauthor=B.+Jiaauthor=M.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Novel+cyclopentadienyl+tricarbonyl+99mTc+complexes+containing+1-piperonylpiperazine+moiety%3A+potential+imaging+probes+for+sigma-1+receptors&doi=10.1021%2Fjm5009488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclopentadienyl Tricarbonyl 99mTc Complexes Containing 1-Piperonylpiperazine Moiety: Potential Imaging Probes for Sigma-1 Receptors</span></div><div class="casAuthors">Wang, Xia; Li, Dan; Deuther-Conrad, Winnie; Lu, Jie; Xie, Ying; Jia, Bing; Cui, Mengchao; Steinbach, Jorg; Brust, Peter; Liu, Boli; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7113-7125</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the design, synthesis, and evaluation of a series of novel cyclopentadienyl tricarbonyl 99mTc complexes as potent σ1 receptor radioligands.  Rhenium compds. 3-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)propylcarbonylcyclopentadienyl tricarbonyl rhenium (10a) and 4-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)butylcarbonylcyclopentadienyl tricarbonyl rhenium (10b) possessed high in vitro affinity for σ1 receptors and moderate to high selectivity for σ2 receptors and the vesicular acetylcholine transporter.  Biodistribution studies in mice demonstrated high initial brain uptake for corresponding 99mTc derivs. [99mTc]23 and [99mTc]24 of 2.94 and 2.13% injected dose (ID)/g, resp., at 2 min postinjection.  Pretreatment of haloperidol significantly reduced the radiotracer accumulation of [99mTc]23 or [99mTc]24 in the brain.  Studies of the cellular uptake of [99mTc]23 in C6 and DU145 tumor cells demonstrated a redn. of accumulation by incubation with haloperidol, 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine (SA4503), or 1,3-di-o-tolyl-guanidine (DTG).  Furthermore, blocking studies in C6 glioma-bearing mice confirmed the specific binding of [99mTc]23 to σ1 receptors in the tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmqY0f1Jf77Vg90H21EOLACvtfcHk0lhbTpn6lzJfhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1egs7jJ&md5=47ad2ee73f8711b9f26e27119d1d0a93</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm5009488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5009488%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DNovel%2520cyclopentadienyl%2520tricarbonyl%252099mTc%2520complexes%2520containing%25201-piperonylpiperazine%2520moiety%253A%2520potential%2520imaging%2520probes%2520for%2520sigma-1%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7113%26epage%3D7125%26doi%3D10.1021%2Fjm5009488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Shumway, S. D.; Toniatti, C.; Roberts, B. S.; Martin, M. M.</span><span> </span><span class="NLM_article-title">Compositions and Methods for Treating Cancer</span>. WO2013039854A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+D.+Shumway&author=C.+Toniatti&author=B.+S.+Roberts&author=M.+M.+Martin&title=Compositions+and+Methods+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShumway%26aufirst%3DS.%2BD.%26atitle%3DCompositions%2520and%2520Methods%2520for%2520Treating%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Conformationally-flexible benzamide analogues as dopamine D<sub>3</sub> and σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmcl.2003.09.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=195-202&author=R.+H.+Machauthor=Y.+Huangauthor=R.+A.+Freemanauthor=L.+Wuauthor=S.+Vangveravongauthor=R.+R.+Luedtke&title=Conformationally-flexible+benzamide+analogues+as+dopamine+D3+and+%CF%832+receptor+ligands&doi=10.1016%2Fj.bmcl.2003.09.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.083%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DConformationally-flexible%2520benzamide%2520analogues%2520as%2520dopamine%2520D3%2520and%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D195%26epage%3D202%26doi%3D10.1016%2Fj.bmcl.2003.09.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Peindy N’Dongo, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Can, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmutz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spingler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberto, R.</span><span> </span><span class="NLM_article-title">Aqueous syntheses of [(Cp-R)M(CO)<sub>3</sub>] type complexes (Cp = cyclopentadienyl, M = Mn, <sup>99m</sup>Tc, Re) with bioactive functionalities</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">694</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1016/j.jorganchem.2008.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.jorganchem.2008.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVKqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=694&publication_year=2009&pages=981-987&author=H.+W.+Peindy+N%E2%80%99Dongoauthor=Y.+Liuauthor=D.+Canauthor=P.+Schmutzauthor=B.+Spinglerauthor=R.+Alberto&title=Aqueous+syntheses+of+%5B%28Cp-R%29M%28CO%293%5D+type+complexes+%28Cp+%3D+cyclopentadienyl%2C+M+%3D+Mn%2C+99mTc%2C+Re%29+with+bioactive+functionalities&doi=10.1016%2Fj.jorganchem.2008.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous syntheses of [(Cp-R)M(CO)3] type complexes (Cp = cyclopentadienyl, M = Mn, 99mTc, Re) with bioactive functionalities</span></div><div class="casAuthors">Peindy N'Dongo, H. W.; Liu, Y.; Can, D.; Schmutz, P.; Spingler, B.; Alberto, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">694</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">981-987</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The reactions of [99mTc(H2O)3(CO)3]+ (1) with Diels-Alder products of cyclopentadiene such as "Thiele's acid" (HCp-COOH)2 (2) and derivs. thereof in which the corresponding [(Cp-COOH)99mTc(CO)3] (3) complex did form in water is described.  Authors propose a metal mediated Diels-Alder reaction mechanism.  To show that this reaction was not limited to carboxylate groups, authors synthesized conjugates of 2 (HCp-CONHR)2 (4a-c) (4a, R = benzylamine; 4b, R = Nα-Boc-L-2,3-diaminopropionic acid and 4c, R = glycine).  The corresponding 99mTc complexes [(4a)99mTc(CO)3] 6a, [(4b)99mTc(CO)3] 6b and [(4c)99mTc(CO)3] 6c have been prepd. along the same route as for Thiele's acid in aq. media demonstrating the general applicability of this synthetic strategy.  The authenticity of the 99mTc complexes on the no carrier added level have been confirmed by chromatog. comparison with the structurally characterized manganese or rhenium complexes.  Studies of the reaction of 1 with Thiele's acid bound to a solid phase resin demonstrated the formation of [(Cp-COOH)99mTc(CO)3] 3 in a heterogeneous reaction.  This is the first evidence for the formation of no carrier added 99mTc radiopharmaceuticals contg. cyclopentadienyl ligands via solid phase syntheses.  Macroscopically, the manganese analog 5a and the rhenium complexes 5b-c have been prepd. and characterized by IR, NMR, ESI-MS and x-ray crystallog. for 5a (monoclinic, P21/c, a = 9.8696(2) Å, b = 25.8533(4) Å, c = 11.8414(2) Å, β = 98.7322(17)°) in order to unambiguously assign the authenticity of the corresponding 99mTc complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_oMhzppigbVg90H21EOLACvtfcHk0lgseSVe487N3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVKqsLk%253D&md5=32f0d8a48e6351ddb5e5aa3e68667833</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2008.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2008.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DPeindy%2BN%25E2%2580%2599Dongo%26aufirst%3DH.%2BW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCan%26aufirst%3DD.%26aulast%3DSchmutz%26aufirst%3DP.%26aulast%3DSpingler%26aufirst%3DB.%26aulast%3DAlberto%26aufirst%3DR.%26atitle%3DAqueous%2520syntheses%2520of%2520%255B%2528Cp-R%2529M%2528CO%25293%255D%2520type%2520complexes%2520%2528Cp%2520%253D%2520cyclopentadienyl%252C%2520M%2520%253D%2520Mn%252C%252099mTc%252C%2520Re%2529%2520with%2520bioactive%2520functionalities%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2009%26volume%3D694%26spage%3D981%26epage%3D987%26doi%3D10.1016%2Fj.jorganchem.2008.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of novel [(Cp-R)M(CO)<sub>3</sub>] (M = Re, <sup>99m</sup>Tc) complexes as potent sigma-2 receptor ligands</span> <span class="citation_source-journal">J. Labelled. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">S383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=S383&author=D.+Liauthor=X.+Wangauthor=W.+Deuther-Conradauthor=X.+Chenauthor=M.+C.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Synthesis+and+preliminary+evaluation+of+novel+%5B%28Cp-R%29M%28CO%293%5D+%28M+%3D+Re%2C+99mTc%29+complexes+as+potent+sigma-2+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%2520novel%2520%255B%2528Cp-R%2529M%2528CO%25293%255D%2520%2528M%2520%253D%2520Re%252C%252099mTc%2529%2520complexes%2520as%2520potent%2520sigma-2%2520receptor%2520ligands%26jtitle%3DJ.%2520Labelled.%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3DS383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">A novel cyclopentadienyl tricarbonyl <sup>99m</sup>Tc complex containing 5,6-dimethoxyisoindoline motif – synthesis and evaluation of a radiotracer for imaging of sigma-2 receptors in cancer</span> <span class="citation_source-journal">J. Labelled. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">S98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=S98&author=Y.+Chenauthor=W.+Deuther-Conradauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=A+novel+cyclopentadienyl+tricarbonyl+99mTc+complex+containing+5%2C6-dimethoxyisoindoline+motif+%E2%80%93+synthesis+and+evaluation+of+a+radiotracer+for+imaging+of+sigma-2+receptors+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DA%2520novel%2520cyclopentadienyl%2520tricarbonyl%252099mTc%2520complex%2520containing%25205%252C6-dimethoxyisoindoline%2520motif%2520%25E2%2580%2593%2520synthesis%2520and%2520evaluation%2520of%2520a%2520radiotracer%2520for%2520imaging%2520of%2520sigma-2%2520receptors%2520in%2520cancer%26jtitle%3DJ.%2520Labelled.%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3DS98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1998</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span><span class="refDoi"> DOI: 10.1021/jm00011a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2MXls1yqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1998-2008&author=J.+Perregaardauthor=E.+K.+Moltzenauthor=E.+Meierauthor=C.+Sanchez&title=Sigma+ligands+with+subnanomolar+affinity+and+preference+for+the+sigma+2+binding+site.+1.+3-%28omega-aminoalkyl%29-1H-indoles&doi=10.1021%2Fjm00011a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">σ Ligands with Subnanomolar Affinity and Preference for the σ2 Binding Site. 1. 3-(ω-Aminoalkyl)-1H-indoles</span></div><div class="casAuthors">Perregaard, Jens; Moltzen, Ejner K.; Meier, Eddi; Sanchez, Connie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1998-2008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 4-(1H-indol-3-yl)-1-butyl-substituted 4-phenylpiperidines, 4-phenyl-1,2,3,6-tetrahydropyridines, and 4-phenylpiperazines was synthesized.  The Ph group was optionally substituted with 4-fluoro or 2-methoxy substituents.  High affinity for both σ1 and σ2 binding sites was achieved with these compds.  Addnl., these compds. had relatively high affinity for serotonin 5-HT1A and 5-HT2A, dopamine D2, and adrenergic α1 receptors.  Introduction of a 4-fluorophenyl substituent at the indole nitrogen atom rendered very selective σ2 ligands with subnanomolar affinity for the σ2 binding site.  The prototype of such a compd. was I.  This compd. had the following binding affinities: IC50 (σ1) = 16 nM, IC50 (σ2) = 0.27 nM, IC50 (5-HT1A) = 22 000 nM, IC50 (5-HT2A) = 270 nM, IC50 (D2) = 4200 nM, IC50 (α1) = 220 nM.  Spiro-joining of the Ph and the piperidine rings into a spiro[isobenzofuran-1(3H),4'-piperidine] ring system resulted in even more selective compds.  Variations of the 1-substituent at the indole and of the chain length of the alkylene spacer group were studied.  The optimal compd. was the spiro analog of I.  This compd. (II) had the binding affinities: IC50 (σ1) = 17 nM, IC50 (σ2) = 0.12 nM, IC50 (5-HT1A) = 21 000 nM, IC50 (5-HT2A) = 2000 nM, IC50 (D2) = 800 nM, IC50 (α1) = 330 nM.  However, the most selective σ2 vs. σ1 ligand was the tropane deriv. (III).  This compd. had the following binding affinities: IC50 (σ1) = 1200 nM, IC50 (σ2) = 2.5 nM.  Potent anxiolytic activity in the black/white box exploration test in rats was found with the two most prominent σ2 ligands Lu 29-253 and Lu 28-179.  Good penetration into the CNS was documented both after s.c. and peroral administration of Lu 28-179 by ex vivo binding studies.  Long duration of action was demonstrated both in ex vivo binding (T1/2 ∼ 20 h) and in the black/white box exploration test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJL4h7Q5nXbVg90H21EOLACvtfcHk0lgseSVe487N3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1yqt7w%253D&md5=c7856739a0cfdd0615e1a6428d759445</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a019%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DSigma%2520ligands%2520with%2520subnanomolar%2520affinity%2520and%2520preference%2520for%2520the%2520sigma%25202%2520binding%2520site.%25201.%25203-%2528omega-aminoalkyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Fjm00011a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferorelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzariti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span> </span><span class="NLM_article-title">Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2026</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span><span class="refDoi"> DOI: 10.1002/cmdc.201300291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fcmdc.201300291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=24106081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOlt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2026-2035&author=M.+Nisoauthor=C.+Abateauthor=M.+Continoauthor=S.+Ferorelliauthor=A.+Azzaritiauthor=R.+Perroneauthor=N.+A.+Colabufoauthor=F.+Berardi&title=Sigma-2+receptor+agonists+as+possible+antitumor+agents+in+resistant+tumors%3A+hints+for+collateral+sensitivity&doi=10.1002%2Fcmdc.201300291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity</span></div><div class="casAuthors">Niso, Mauro; Abate, Carmen; Contino, Marialessandra; Ferorelli, Savina; Azzariti, Amalia; Perrone, Roberto; Colabufo, Nicola Antonio; Berardi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2026-2035</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of contributing to the development of novel antitumor agents, high-affinity σ2 receptor agonists were developed, with 6,7-dimethoxy-2-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]butyl]-1,2,3,4-tetrahydroisoquinoline (15) and 9-[4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)butyl]-9H-carbazole (25) showing exceptional selectivity for the σ2 subtype.  Most of the compds. displayed notable antiproliferative activity in human MCF7 breast adenocarcinoma cells, with similar activity in the corresponding doxorubicin-resistant MCF7adr cell line.  Surprisingly, a few compds., including 25, displayed enhanced activity in MCF7adr cells over parent cells, recalling the phenomenon of collateral sensitivity, which is under study for the treatment of drug-resistant tumors.  All of the compds. showed interaction with P-glycoprotein (P-gp), and 15 and 25, with the greatest activity, were able to revert P-gp-mediated resistance and reestablish the antitumor effect of doxorubicin in MCF7adr cells.  The authors therefore identified a series of σ2 receptor agonists endowed with intriguing antitumor properties; these compds. deserve further investigation for the development of alternate strategies against multidrug-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGrW9r580YjbVg90H21EOLACvtfcHk0lg2CzjNz_xEWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOlt7vE&md5=cd4926ffa90d3fd1c2761bfe2cbe777c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300291%26sid%3Dliteratum%253Aachs%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26atitle%3DSigma-2%2520receptor%2520agonists%2520as%2520possible%2520antitumor%2520agents%2520in%2520resistant%2520tumors%253A%2520hints%2520for%2520collateral%2520sensitivity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D2026%26epage%3D2035%26doi%3D10.1002%2Fcmdc.201300291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.-M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <sup>18</sup>F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmc.2012.10.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=215-222&author=X.+Wangauthor=Y.+Liauthor=W.+Deuther-Conradauthor=F.+Xieauthor=X.+Chenauthor=M.-C.+Cuiauthor=X.-J.+Zhangauthor=J.-M.+Zhangauthor=J.+Steinbachauthor=P.+Brustauthor=B.-L.+Liuauthor=H.-M.+Jia&title=Synthesis+and+biological+evaluation+of+18F+labeled+fluoro-oligo-ethoxylated+4-benzylpiperazine+derivatives+for+sigma-1+receptor+imaging&doi=10.1016%2Fj.bmc.2012.10.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.-C.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DZhang%26aufirst%3DJ.-M.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.-L.%26aulast%3DJia%26aufirst%3DH.-M.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%252018F%2520labeled%2520fluoro-oligo-ethoxylated%25204-benzylpiperazine%2520derivatives%2520for%2520sigma-1%2520receptor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D215%26epage%3D222%26doi%3D10.1016%2Fj.bmc.2012.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-75&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography&doi=10.1016%2Fj.mibio.2003.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2ea6lQSwRbnqZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D75%26doi%3D10.1016%2Fj.mibio.2003.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J. M.</span><span> </span><span class="NLM_article-title">Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.2174/156802610793176792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F156802610793176792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20583995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1499-1526&author=Y.+Huangauthor=M.-Q.+Zhengauthor=J.+M.+Gerdes&title=Development+of+effective+PET+and+SPECT+imaging+agents+for+the+serotonin+transporter%3A+has+a+twenty-year+journey+reached+its+destination%3F&doi=10.2174%2F156802610793176792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?</span></div><div class="casAuthors">Huang, Yiyun; Zheng, Ming-Qiang; Gerdes, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1499-1526</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin transporter (SERT) has been implicated in a variety of neuropsychiatric disorders including depression, schizophrenia, substance abuse, alcoholism, and Alzheimer's disease.  Radiotracer-based in vivo imaging techniques such as Positron Emission Tomog. (PET) and Single-Photon Emission Computed Tomog. (SPECT) are important tools to investigate the functions of SERT in the living brain under normal conditions and its dysfunction in diseases.  The authors review the development and validation of effective PET and SPECT radiotracers in the last twenty years.  First, the requirements for an effective imaging tracer, and factors influencing a tracer's in vivo imaging performance are discussed.  PET and SPECT radiotracers for SERT are then categorized and reviewed according to their chem. scaffolds: (1) SSRIs and related compds.; (2) tropane-based ligands; (3) isoquinolines; and (4) substituted diarylsulfides.  Crit. evaluation and comments are provided for promising radiotracers, if any, emerging from each chem. scaffold.  Based on exptl. data gathered from radiotracer development for SERT, an examn. of the relationship between an imaging tracer's in vitro physicochem. and pharmacol. properties and its in vivo performance parameters is provided.  Finally, tracers available for imaging applications in humans are assessed and compared in terms of tissue binding kinetics, non-specific binding, and specific binding signals in vivo.  From these assessments, the authors conclude that, after twenty years of development efforts, a no. of effective PET and SPECT radiotracers have now been validated and are available for imaging SERT in humans.  The applications of these efficacious SERT imaging agents will further advance the understanding of this important transporter in psychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1VPLvWl1u5rVg90H21EOLACvtfcHk0li4ZLJLWqR6wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3N&md5=716e3dfa369f94018b86c89af6a57cfa</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F156802610793176792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610793176792%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DM.-Q.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26atitle%3DDevelopment%2520of%2520effective%2520PET%2520and%2520SPECT%2520imaging%2520agents%2520for%2520the%2520serotonin%2520transporter%253A%2520has%2520a%2520twenty-year%2520journey%2520reached%2520its%2520destination%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1499%26epage%3D1526%26doi%3D10.2174%2F156802610793176792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel <sup>18</sup>F-labeled spirocyclic piperidine derivatives as σ<sub>1</sub> receptor ligands for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3478</span><span class="NLM_x">–</span> <span class="NLM_lpage">3491</span><span class="refDoi"> DOI: 10.1021/jm301734g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301734g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3478-3491&author=Y.+Liauthor=X.+Wangauthor=J.+Zhangauthor=W.+Deuther-Conradauthor=F.+Xieauthor=X.+Zhangauthor=J.+Liuauthor=J.+Qiaoauthor=M.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Synthesis+and+evaluation+of+novel+18F-labeled+spirocyclic+piperidine+derivatives+as+%CF%831+receptor+ligands+for+positron+emission+tomography+imaging&doi=10.1021%2Fjm301734g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel 18F-Labeled Spirocyclic Piperidine Derivatives as σ1 Receptor Ligands for Positron Emission Tomography Imaging</span></div><div class="casAuthors">Li, Yan; Wang, Xia; Zhang, Jinming; Deuther-Conrad, Winnie; Xie, Fang; Zhang, Xiaojun; Liu, Jian; Qiao, Jinping; Cui, Mengchao; Steinbach, Jorg; Brust, Peter; Liu, Boli; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3478-3491</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of spirocyclic piperidine derivs. were designed and synthesized as σ1 receptor ligands.  In vitro competition binding assays showed that 1'-[4-(2-fluoroethoxy)benzyl]-3H-spiro[2-benzofuran-1,4'-piperidine] [I (R = F)] possessed high σ1 receptor affinity (Ki = 0.79 nM) and excellent σ1/σ2 subtype selectivity (350-fold) as well as high σ1/VAChT selectivity (799-fold).  The radiolabeled compd. I (R = 18F) was synthesized by substitution of the tosylate precursor I (R = OTs) with [18F]fluoride, with an isolated radiochem. yield of 35-60%, a radiochem. purity of >99%, and a specific activity of 30-55 GBq/μmol.  Biodistribution studies in imprinting control region mice indicated that I (R = 18F) displayed excellent initial brain uptake and slow washout.  Ex vivo autoradiog. in Sprague-Dawley rats demonstrated high accumulation of the radiotracer in brain areas known to express high levels of σ1 receptors.  Micro positron emission tomog. imaging and blocking studies confirmed the specific binding of I (R = 18F) to σ1 receptors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXEMXGF6bF7Vg90H21EOLACvtfcHk0li4ZLJLWqR6wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gt74%253D&md5=ca2ccb146e2722e4ae0d98513b7b53c0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm301734g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301734g%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DQiao%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%252018F-labeled%2520spirocyclic%2520piperidine%2520derivatives%2520as%2520%25CF%25831%2520receptor%2520ligands%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3478%26epage%3D3491%26doi%3D10.1021%2Fjm301734g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding characteristics of σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Rev. Bras. Cienc. Farm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1590/S1516-93322005000100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1590%2FS1516-93322005000100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1-12&author=R.+A.+Glennon&title=Binding+characteristics+of+%CF%832+receptor+ligands&doi=10.1590%2FS1516-93322005000100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Binding characteristics of σ2 receptor ligands</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Revista Brasileira de Ciencias Farmaceuticas</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">RBCFFM</span>;
        ISSN:<span class="NLM_cas:issn">1516-9332</span>.
    
            (<span class="NLM_cas:orgname">Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, once considered a type of opioid receptor are now recognized as representing a unique receptive entity and at least two different types of σ receptors have been identified σ1 and σ2 receptors.  Evidence suggests that these receptors might be targeted and exploited for the development of agents potentially useful for the treatment of several central disorders.  This review primarily describes some of our efforts to understand those structural features that contribute to σ2 receptor binding, and some recent work by other investigators is also included.  Despite an inability to formulate a unified pharmacophore model for α2 binding due to the diversity of structure-types that bind at the receptor, and to the conformational flexibility of these ligands, significant progress has been made to ward the development od some very high affinity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQAG2gQdALrVg90H21EOLACvtfcHk0li4ZLJLWqR6wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D&md5=863bf7ddc28bafbe45a21d852d85954f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1590%2FS1516-93322005000100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS1516-93322005000100002%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520characteristics%2520of%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DRev.%2520Bras.%2520Cienc.%2520Farm.%26date%3D2005%26volume%3D41%26spage%3D1%26epage%3D12%26doi%3D10.1590%2FS1516-93322005000100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sorger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheunemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vercouille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roghani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliebs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span> </span><span class="NLM_article-title">A new <sup>18</sup>F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.nucmedbio.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=18312828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=185-195&author=D.+Sorgerauthor=M.+Scheunemannauthor=U.+Grossmannauthor=S.+Fischerauthor=J.+Vercouilleauthor=A.+Hillerauthor=B.+Wenzelauthor=A.+Roghaniauthor=R.+Schliebsauthor=P.+Brustauthor=O.+Sabriauthor=J.+Steinbach&title=A+new+18F-labeled+fluoroacetylmorpholino+derivative+of+vesamicol+for+neuroimaging+of+the+vesicular+acetylcholine+transporter&doi=10.1016%2Fj.nucmedbio.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter</span></div><div class="casAuthors">Sorger, Dietlind; Scheunemann, Matthias; Grossmann, Udo; Fischer, Steffen; Vercouille, Johnny; Hiller, Achim; Wenzel, Barbara; Roghani, Ali; Schliebs, Reinhard; Brust, Peter; Sabri, Osama; Steinbach, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-195</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">With the aim of producing selective radiotracers for in vivo imaging of the vesicular acetylcholine transporter (VAChT) using positron mission tomog. (PET), here, we report synthesis and anal. of a new class of conformationally constrained vesamicol analogs with moderate lipophilicity.  The sequential ring opening on trans-1,4-cyclohexadiene dioxide enabled an approach to synthesize 6-arylpiperidino-octahydrobenzo[1,4]oxazine-7-ols [morpholino vesamicols].  The radiosynthesis of the [18F]fluoroacetyl-substituted deriv. ([18F]FAMV) was achieved starting from a corresponding bromo precursor [2-Bromo-1-[7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazin-4-yl]-ethanone] and using a modified com. computer-controlled module system with a radiochem. yield of 27 ± 4%, a high radiochem. purity (99%) and a specific activity of 35 GBq/μmol.  In competitive binding assays using a PC12 cell line overexpressing VAChT and [3H]-(-) vesamicol, 2-fluoro-1-[7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazin-4-yl]-ethanone (FAMV) demonstrated a high selectivity for binding to VAChT (Ki: 39.9 ± 5.9 nM) when compared to its binding to sigma1/2 receptors (Ki > 1500 nM).  The compd. showed a moderate lipophilicity (logD(pH7) = 1.9) and a plasma protein binding of 49%.  The brain uptake of [18F]FAMV was about 0.1% injected dose per g at 5 min after injection and decreased continuously with time.  Notably, an increasing accumulation of radioactivity in the lateral brain ventricles was obsd.  After 1 h, the accumulation of [18F]FAMV, expressed as ratio to the cerebellum, was 4.5 for the striatum, 2.0 for the cortical and 1.5 for the hippocampal regions, measured on brain slices using ex vivo autoradiog.  At the present time, 75% of [18F]FAMV in the plasma was shown to be metabolized to various hydrophilic compds., as detected by high-performance liq. chromatog.  The degrdn. of [18F]FAMV was also detected in brain exts. as early as 15 min post injection (p.i.) and increased to 50% at 1 h postinjection.  In conclusion, although the chem. properties of [18F]FAMV and the selectivity of binding to VAChT appear to be promising indicators of a useful PET tracer for imaging VAChT, a low brain extn., in combination with only moderate specific accumulation in cholinergic brain regions and an insufficient in vivo stability prevents the application of this compd. for neuroimaging in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY3NDgGQ_kbLVg90H21EOLACvtfcHk0li4ZLJLWqR6wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2huro%253D&md5=44127cdc164bfe771602eb27bbba1d20</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DSorger%26aufirst%3DD.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DGrossmann%26aufirst%3DU.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DVercouille%26aufirst%3DJ.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DRoghani%26aufirst%3DA.%26aulast%3DSchliebs%26aufirst%3DR.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSabri%26aufirst%3DO.%26aulast%3DSteinbach%26aufirst%3DJ.%26atitle%3DA%2520new%252018F-labeled%2520fluoroacetylmorpholino%2520derivative%2520of%2520vesamicol%2520for%2520neuroimaging%2520of%2520the%2520vesicular%2520acetylcholine%2520transporter%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D185%26epage%3D195%26doi%3D10.1016%2Fj.nucmedbio.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Saidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillai, M. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unnikrishnan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzouz, Z.</span><span> </span><span class="NLM_article-title">Cyclopentadienyl technetium (<sup>99m</sup>Tc) tricarbonyl piperidine conjugates: biodistribution and imaging studies</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1002/jlcr.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fjlcr.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1Sjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=603-618&author=M.+Saidiauthor=K.+Kothariauthor=M.+R.+A.+Pillaiauthor=A.+Hassanauthor=H.+D.+Sarmaauthor=P.+R.+Chaudhariauthor=T.+P.+Unnikrishnanauthor=A.+Kordeauthor=Z.+Azzouz&title=Cyclopentadienyl+technetium+%2899mTc%29+tricarbonyl+piperidine+conjugates%3A+biodistribution+and+imaging+studies&doi=10.1002%2Fjlcr.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies</span></div><div class="casAuthors">Saidi, Mouldi; Kothari, K.; Pillai, M. R. A.; Hassan, Amri; Sarma, H. D.; Chaudhari, P. R.; Unnikrishnan, T. P.; Korde, A.; Azzouz, Zohra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-618</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Synthesis of organometallic complexes of 99mTc using the precursor ligands N-methylpiperidino-4[(bispentahaptocyclopentadienyl)iron] carboxylate and N-(isopropyl)-piperidino-4[(bispentahaptocyclopentadienyl)iron]carboxylate is described.  The labeling method involved reaction of the ligands with 99mTcO4- in the presence of Mn(CO)5Br in DMF at 150° for 1 h in an oil bath.  The purifn. of the complexes was carried out by preparative TLC using ether/n-Bu Me amine (95:5) solvent system.  The purified complexes were characterized by HPLC using acetonitrile:water (80:20) solvent system in a PRP-1 column in which both the complexes were eluted as single peaks.  Biodistribution studies carried out in rats showed 2.4 ± 0.14 and 1.1 ± 0.42% of the injected activity in the brain tissue 5 min p.i. for cytectrene I and II, resp.  The brain to blood activity ratio was > 15:1 for both the complexes at 5 min p.i.  Scintigraphic studies in rabbits showed significant uptake of the activity in the brain with fast clearance from blood.  The complexes warrant further investigation as agents for brain imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGgAnqDg5SmrVg90H21EOLACvtfcHk0lhX9OrpbvFYhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1Sjt7g%253D&md5=670c9c22adab89bb2a45bb3a275de891</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.491%26sid%3Dliteratum%253Aachs%26aulast%3DSaidi%26aufirst%3DM.%26aulast%3DKothari%26aufirst%3DK.%26aulast%3DPillai%26aufirst%3DM.%2BR.%2BA.%26aulast%3DHassan%26aufirst%3DA.%26aulast%3DSarma%26aufirst%3DH.%2BD.%26aulast%3DChaudhari%26aufirst%3DP.%2BR.%26aulast%3DUnnikrishnan%26aufirst%3DT.%2BP.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DAzzouz%26aufirst%3DZ.%26atitle%3DCyclopentadienyl%2520technetium%2520%252899mTc%2529%2520tricarbonyl%2520piperidine%2520conjugates%253A%2520biodistribution%2520and%2520imaging%2520studies%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2001%26volume%3D44%26spage%3D603%26epage%3D618%26doi%3D10.1002%2Fjlcr.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Raphael Lengacher, Joshua Csucker, Daniel Hernández-Valdés, Bernhard Spingler, Henrik Braband, <span class="NLM_string-name hlFld-ContribAuthor">Roger Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">Expanding the Cyclopentadienyl Framework: 99mTc/Re Complexes with Orthogonal Functions for Bioconjugation. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 1393-1398. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00468" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00468%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DExpanding%252Bthe%252BCyclopentadienyl%252BFramework%25253A%252B99mTc%25252FRe%252BComplexes%252Bwith%252BOrthogonal%252BFunctions%252Bfor%252BBioconjugation%26aulast%3DLengacher%26aufirst%3DRaphael%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20082020%26date%3D15092020%26date%3D30092020%26volume%3D32%26issue%3D7%26spage%3D1393%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongzhi  Yang</span>, <span class="hlFld-ContribAuthor ">Anthony  Comeau</span>, <span class="hlFld-ContribAuthor ">Wayne D.  Bowen</span>, <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>, <span class="hlFld-ContribAuthor ">Brian D.  Ross</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, and <span class="hlFld-ContribAuthor ">Marcian E.  Van Dort</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Investigation of a [18F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (3)
                                     , 770-780. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b01020" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b01020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b01020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b01020%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DDesign%252Band%252BInvestigation%252Bof%252Ba%252B%25255B18F%25255D-Labeled%252BBenzamide%252BDerivative%252Bas%252Ba%252BHigh%252BAffinity%252BDual%252BSigma%252BReceptor%252BSubtype%252BRadioligand%252Bfor%252BProstate%252BTumor%252BImaging%26aulast%3DYang%26aufirst%3DDongzhi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2017%26date%3D10112016%26date%3D30012017%26date%3D13012017%26date%3D14022017%26date%3D06032017%26date%3D30012017%26volume%3D14%26issue%3D3%26spage%3D770%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zahra  Shaghaghi</span>, <span class="hlFld-ContribAuthor ">Maryam  Alvandi</span>, <span class="hlFld-ContribAuthor ">Zahra  Ghanbarimasir</span>, <span class="hlFld-ContribAuthor ">Soghra  Farzipour</span>, <span class="hlFld-ContribAuthor ">Saeed  Emami</span>. </span><span class="cited-content_cbyCitation_article-title">Current development of sigma-2 receptor radioligands as potential tumor imaging agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>115 </em>, 105163. <a href="https://doi.org/10.1016/j.bioorg.2021.105163" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105163%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCurrent%252Bdevelopment%252Bof%252Bsigma-2%252Breceptor%252Bradioligands%252Bas%252Bpotential%252Btumor%252Bimaging%252Bagents%26aulast%3DShaghaghi%26aufirst%3DZahra%26date%3D2021%26volume%3D115%26spage%3D105163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael  Lengacher</span>, <span class="hlFld-ContribAuthor ">Roger  Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">Bioorganometallics: 99mTc cytectrenes, syntheses and applications in nuclear medicine. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>437 </em>, 213869. <a href="https://doi.org/10.1016/j.ccr.2021.213869" title="DOI URL">https://doi.org/10.1016/j.ccr.2021.213869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2021.213869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2021.213869%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DBioorganometallics%25253A%252B99mTc%252Bcytectrenes%25252C%252Bsyntheses%252Band%252Bapplications%252Bin%252Bnuclear%252Bmedicine%26aulast%3DLengacher%26aufirst%3DRaphael%26date%3D2021%26volume%3D437%26spage%3D213869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faheem</span>, <span class="hlFld-ContribAuthor ">Banoth  Karan Kumar</span>, <span class="hlFld-ContribAuthor ">Kondapalli  Venkata Gowri Chandra Sekhar</span>, <span class="hlFld-ContribAuthor ">Subhash  Chander</span>, <span class="hlFld-ContribAuthor ">Selvaraj  Kunjiappan</span>, <span class="hlFld-ContribAuthor ">Sankaranarayanan  Murugesan</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>5 </em>, 1-30. <a href="https://doi.org/10.1080/17460441.2021.1916464" title="DOI URL">https://doi.org/10.1080/17460441.2021.1916464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1916464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1916464%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3D1%25252C2%25252C3%25252C4-Tetrahydroisoquinoline%252B%252528THIQ%252529%252Bas%252Bprivileged%252Bscaffold%252Bfor%252Banticancer%252Bde%252Bnovo%252Bdrug%252Bdesign%26aulast%3DFaheem%26date%3D2021%26date%3D2021%26volume%3D5%26spage%3D1%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun‐Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Kun‐Hang  Jia</span>, <span class="hlFld-ContribAuthor ">Hao  Sun</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Jian  Luo</span>, <span class="hlFld-ContribAuthor ">Li‐Fang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3‐Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 524-536. <a href="https://doi.org/10.1002/cmdc.202000461" title="DOI URL">https://doi.org/10.1002/cmdc.202000461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000461%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252B%2525CF%2525832%252BReceptor%252BLigands%252BBased%252Bon%252Ba%252B3%2525E2%252580%252590Alkoxyisoxazole%252BScaffold%25253A%252BPotential%252BAntitumor%252BEffects%252Bagainst%252BOsteosarcoma%26aulast%3DShi%26aufirst%3DJun%25E2%2580%2590Jie%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D524%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Guochen  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Carbon Bonds of Heavier Group 7 and 8 Metals (Tc, Re, Ru, Os): Mononuclear Tc/Re/Ru/Os Complexes With Metal-Carbon Bonds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-08-102688-5.00049-0" title="DOI URL">https://doi.org/10.1016/B978-0-08-102688-5.00049-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102688-5.00049-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102688-5.00049-0%26sid%3Dliteratum%253Aachs%26atitle%3DMetal-Carbon%252BBonds%252Bof%252BHeavier%252BGroup%252B7%252Band%252B8%252BMetals%252B%252528Tc%25252C%252BRe%25252C%252BRu%25252C%252BOs%252529%25253A%252BMononuclear%252BTc%25252FRe%25252FRu%25252FOs%252BComplexes%252BWith%252BMetal-Carbon%252BBonds%26aulast%3DWei%26aufirst%3DWei%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">Organometallic Chemistry of Drugs Based on Technetium and Rhenium. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820206-7.00029-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-820206-7.00029-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820206-7.00029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820206-7.00029-9%26sid%3Dliteratum%253Aachs%26atitle%3DOrganometallic%252BChemistry%252Bof%252BDrugs%252BBased%252Bon%252BTechnetium%252Band%252BRhenium%26aulast%3DAlberto%26aufirst%3DRoger%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gopalakrishnan  Balakrishnan</span>, <span class="hlFld-ContribAuthor ">Thangamuthu  Rajendran</span>, <span class="hlFld-ContribAuthor ">Krishnan Senthil  Murugan</span>, <span class="hlFld-ContribAuthor ">Muniyandi  Ganesan</span>, <span class="hlFld-ContribAuthor ">Veluchamy Kamaraj  Sivasubramanian</span>, <span class="hlFld-ContribAuthor ">Seenivasan  Rajagopal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, photophysics and the binding studies of rhenium(I) diimine surfactant complexes with serum albumins: A spectroscopic and docking study approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Luminescence</span><span> <strong>2019,</strong> <em>205 </em>, 51-60. <a href="https://doi.org/10.1016/j.jlumin.2018.08.078" title="DOI URL">https://doi.org/10.1016/j.jlumin.2018.08.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jlumin.2018.08.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jlumin.2018.08.078%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Luminescence%26atitle%3DSynthesis%25252C%252Bphotophysics%252Band%252Bthe%252Bbinding%252Bstudies%252Bof%252Brhenium%252528I%252529%252Bdiimine%252Bsurfactant%252Bcomplexes%252Bwith%252Bserum%252Balbumins%25253A%252BA%252Bspectroscopic%252Band%252Bdocking%252Bstudy%252Bapproach%26aulast%3DBalakrishnan%26aufirst%3DGopalakrishnan%26date%3D2019%26volume%3D205%26spage%3D51%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lydia  Ramzy</span>, <span class="hlFld-ContribAuthor ">Maha  Nasr</span>, <span class="hlFld-ContribAuthor ">Abdelkader A.  Metwally</span>, <span class="hlFld-ContribAuthor ">Gehanne A.S.  Awad</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>104 </em>, 273-292. <a href="https://doi.org/10.1016/j.ejps.2017.04.005" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DCancer%252Bnanotheranostics%25253A%252BA%252Breview%252Bof%252Bthe%252Brole%252Bof%252Bconjugated%252Bligands%252Bfor%252Boverexpressed%252Breceptors%26aulast%3DRamzy%26aufirst%3DLydia%26date%3D2017%26volume%3D104%26spage%3D273%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaouther  Zenati</span>, <span class="hlFld-ContribAuthor ">Nadia  Malek Saied</span>, <span class="hlFld-ContribAuthor ">Amine  Asmi</span>, <span class="hlFld-ContribAuthor ">Mouldi  Saidi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 99mTc labeled aryl piperazine derivatives as cerebral radiotracers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Radioanalytical and Nuclear Chemistry</span><span> <strong>2017,</strong> <em>312 </em>
                                    (1)
                                     , 67-74. <a href="https://doi.org/10.1007/s10967-017-5201-6" title="DOI URL">https://doi.org/10.1007/s10967-017-5201-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10967-017-5201-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10967-017-5201-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Radioanalytical%2520and%2520Nuclear%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B99mTc%252Blabeled%252Baryl%252Bpiperazine%252Bderivatives%252Bas%252Bcerebral%252Bradiotracers%26aulast%3DZenati%26aufirst%3DKaouther%26date%3D2017%26date%3D2017%26volume%3D312%26issue%3D1%26spage%3D67%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design concept of novel [(Cp-R)M(CO)<sub>3</sub>] (M = <sup>99m</sup>Tc, Re) complexes as potent σ<sub>2</sub> receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of the Rhenium Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 33% HBr/HOAc, rt (20 h)–65 °C (1 h), 32%; (b) tritylamine, DIEA, DMF, 60 °C, 2 h, 77%; (c) TFA, CHCl<sub>3</sub>/MeOH, 0 °C–rt, 1 h, 69%; (d) Br(CH<sub>2</sub>)<sub>m</sub>CN, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h, for <b>5</b>–<b>7</b>, 67–73%, for <b>8</b>–<b>10</b>, 59–70%; (e) LiAlH<sub>4</sub>, THF-Et<sub>2</sub>O, 0 °C–rt, 24 h, for <b>11</b>–<b>13</b>, 36–50%, for <b>14</b>–<b>16</b>, 27–40%; (f) toluene, <b>3</b> or <b>4</b>, KI, Et<sub>3</sub>N, 115 °C, 10% for <b>20a</b>, 10% for <b>21a</b>, 30% for <b>23a</b> and 36% for <b>24a</b>; (g) acetonitrile, <b>3</b> or <b>4</b>, KI, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 41% for <b>22a</b> and 51% for <b>25a</b>; (h)<b>11</b>–<b>16</b>, Et<sub>3</sub>N, anhydrous DMF, rt, 4 h, 38–48% for <b>27a</b>–<b>29a</b>, 74–83% for <b>30a</b>–<b>32a</b>.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of compound <b>31a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for the Ferrocene Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, <b>3</b> or <b>4</b>, KI, Et<sub>3</sub>N, 115 °C, 16% for <b>36</b>, 19% for <b>37</b>, 33% for <b>39</b> and 22% for <b>40</b>; (b) acetonitrile, <b>3</b> or <b>4</b>, KI, K<sub>2</sub>CO<sub>3</sub>, 90 °C, 44% for <b>38</b> and 78% for <b>41</b>; (c)<b>13</b>–<b>16</b>, Et<sub>3</sub>N, anhydrous DMF, rt, 4 h, 65% for <b>43</b>, 69% for <b>44</b>, 63% for <b>45</b>, 68% for <b>46</b>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the <sup>99m</sup>Tc-Labeled Complexes from the Ferrocene Precursors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <sup>99m</sup>TcO<sub>4</sub><sup>–</sup>, Mn(CO)<sub>5</sub>, DMF, 140 °C, 1 h, 13<b>–</b>32% for [<sup>99m</sup>Tc]<b>20b</b>, 37<b>–</b>59% for [<sup>99m</sup>Tc]<b>21b</b>, 25<b>–</b>33% for [<sup>99m</sup>Tc]<b>22b</b>, 34<b>–</b>53% for [<sup>99m</sup>Tc]<b>23b</b>, 44<b>–</b>62% for [<sup>99m</sup>Tc]<b>24b</b>, 57<b>–</b>63% for [<sup>99m</sup>Tc]<b>25b</b>; (b) <sup>99m</sup>TcO<sub>4</sub><sup>–</sup>, Mn(CO)<sub>5</sub>, DMF, 150 °C, 1 h, 36<b>–</b>67% for [<sup>99m</sup>Tc]<b>29b</b>, 48<b>–</b>60% for [<sup>99m</sup>Tc]<b>30b</b>.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <i>In vitro</i> studies on cellular association of [<sup>99m</sup>Tc]<b>20b</b>, [<sup>99m</sup>Tc]<b>23b</b>, [<sup>99m</sup>Tc]<b>29b</b>, and [<sup>99m</sup>Tc]<b>30b</b> in DU145 prostate tumor cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vitro</i> studies on cellular association of [<sup>99m</sup>Tc]<b>20b</b> and [<sup>99m</sup>Tc]<b>29b</b> in C6 glioma cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of pretreatment with haloperidol (0.1 mL, 1.0 mg/kg) on organ biodistribution of [<sup>99m</sup>Tc]<b>20b</b> (A), [<sup>99m</sup>Tc]<b>23b</b> (B), or [<sup>99m</sup>Tc]<b>29b</b> (C) in male ICR mice (<i>n</i> = 5). Student’s <i>t</i> test (independent, two-tailed) was performed, and <i>p</i> < 0.05 (except for [<sup>99m</sup>Tc]<b>20b</b> in the lungs and kidney at 120 min after intravenous injection, [<sup>99m</sup>Tc]<b>23b</b> in the heart and lungs at 60 min after intravenous injection, and [<sup>99m</sup>Tc]<b>29b</b> in the spleen at 60 min after intravenous injection).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of pretreatment with haloperidol, <b>36</b>, and siramesine (0.1 mL, 1.0 mg/kg) on organ biodistribution of [<sup>99m</sup>Tc]<b>20b</b> in Balb/c nude mice bearing C6 glioma xenografts. Student’s <i>t</i> test (independent, two-tailed) was performed, and <i>p</i> < 0.05 (except in the kidney with <b>36</b> and in the tumor with haloperidol at 240 min after intravenous injection).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative transverse plane slices of NanoScan SPECT/CT fusion images of [<sup>99m</sup>Tc]<b>20b</b> (22.2 MBq, 0.15 mL) in male Balb/c nude mouse bearing C6 glioma xenografts at 180 min after injection. Isoflurane was used for anesthesia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/medium/jm-2015-01378q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Analytical HPLC chromatograms of radioactive compounds in mouse brain and liver samples after intravenous injection of [<sup>99m</sup>Tc]<b>20b</b> (18.5 MBq, 0.15 mL). (A) Brain and liver samples at 15 min. (B) Brain and liver samples at 30 min. (C) [<sup>99m</sup>Tc]<b>20b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-3/acs.jmedchem.5b01378/20171211/images/large/jm-2015-01378q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01378&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bading, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, A. F.</span><span> </span><span class="NLM_article-title">Imaging of cell proliferation: status and prospects</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">64S</span><span class="NLM_x">–</span> <span class="NLM_lpage">80S</span><span class="refDoi"> DOI: 10.2967/jnumed.107.046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.107.046391" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=64S-80S&author=J.+R.+Badingauthor=A.+F.+Shields&title=Imaging+of+cell+proliferation%3A+status+and+prospects&doi=10.2967%2Fjnumed.107.046391"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.107.046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.107.046391%26sid%3Dliteratum%253Aachs%26aulast%3DBading%26aufirst%3DJ.%2BR.%26aulast%3DShields%26aufirst%3DA.%2BF.%26atitle%3DImaging%2520of%2520cell%2520proliferation%253A%2520status%2520and%2520prospects%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D64S%26epage%3D80S%26doi%3D10.2967%2Fjnumed.107.046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bem, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamone, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coscia, C. J.</span><span> </span><span class="NLM_article-title">Overexpression of σ receptors in nonneural human tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6558</span><span class="NLM_x">–</span> <span class="NLM_lpage">6562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=6558-6562&author=W.+T.+Bemauthor=G.+E.+Thomasauthor=J.+Y.+Mamoneauthor=S.+M.+Homanauthor=B.+K.+Levyauthor=F.+E.+Johnsonauthor=C.+J.+Coscia&title=Overexpression+of+%CF%83+receptors+in+nonneural+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBem%26aufirst%3DW.%2BT.%26aulast%3DThomas%26aufirst%3DG.%2BE.%26aulast%3DMamone%26aufirst%3DJ.%2BY.%26aulast%3DHoman%26aufirst%3DS.%2BM.%26aulast%3DLevy%26aufirst%3DB.%2BK.%26aulast%3DJohnson%26aufirst%3DF.%2BE.%26aulast%3DCoscia%26aufirst%3DC.%2BJ.%26atitle%3DOverexpression%2520of%2520%25CF%2583%2520receptors%2520in%2520nonneural%2520human%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D6558%26epage%3D6562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=7812973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFyjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=408-413&author=B.+J.+Vilnerauthor=C.+S.+Johnauthor=W.+D.+Bowen&title=Sigma-1+and+sigma-2+receptors+are+expressed+in+a+wide+variety+of+human+and+rodent+tumor+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines</span></div><div class="casAuthors">Vilner, Bertold J.; John, Christy S.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">408-13</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Thirteen tumor-derived cell lines of human and nonhuman origin and from various tissues were examd. for the presence and d. of sigma-1 and sigma-2 receptors.  Sigma-1 receptors of a crude membrane fraction were labeled using [3H](+)-pentazocine, and sigma-2 receptors were labeled with [3H]1,3-di-o-tolylguanidine ([3H]DTG); in the presence or absence of dextrallorphan.  [3H](+)-Pentazocine-binding sites were heterogeneous.  In rodent cell lines (e.g., C6 glioma, NIE-115 neuroblastoma, and NG108-15 neuroblastoma × glioma hybrid), human T47D breast ductal carcinoma, human NCI-H727 lung carcinoid, and human A375 melanoma, [3H](+)-pentazocine bound to high- and low-affinity sites with Kd1 = 0.67-7.0 nM, Bmax 1 = 25.5-108 fmol/mg protein, Kd2 = 127-600 nM, and Bmax2 = 942-5431 fmol/mg protein.  However, [3H](+)-pentazocine bound to a single site in other cell lines.  In human U-138MG glioblastoma, SK-N-sh neuroblastoma, and LNCaP.FGC prostate, Kd=28-61nM and Bmax-1411 fmol/mg protein.  The sigma-1-like nature of [3H](+)-pentazocine-binding sites was confirmed by competition studies which revealed high affinity for haloperidol and enantioselectivity for (+)-pentazocine over (-)-pentazocine.  Interestingly, human MCF-7 breast adenocarcinoma showed little or no specific binding of [3H](+)-pentazocine, suggesting the absence of sigma-1 receptors in this cell line.  All cell lines examd. expressed a high d. of sigma-2 receptors with Kd values for [3H]DTG ranging from 20 to 101 nM and Bmax values of 491 to 7324 fmol/mg protein.  Competition studies indicated possible heterogeneity of sigma-2 receptors.  While sites labeled by [3H]DTG in all cell lines tested exhibited affinity for haloperidol and approx. 10-fold lower affinity for (-)-pentazocine compared with the rodent cell lines.  The high d. of sigma-1 and sigma-2 binding sites in these cell lines suggests important cellular functions in cancer, as well as potential diagnostic utility for tumor-imaging agents which target sigma sites.  These cell lines may be useful as model systems in which to study the functions of sigma sites in normal tissues, as well as their possible role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomx5dT2-5Hz7Vg90H21EOLACvtfcHk0lg5a9SxF-CsWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFyjtr8%253D&md5=80276a71555fdb08d76ae39b73d1cbe1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DSigma-1%2520and%2520sigma-2%2520receptors%2520are%2520expressed%2520in%2520a%2520wide%2520variety%2520of%2520human%2520and%2520rodent%2520tumor%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D408%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title">Targeting sigma receptor-binding benzamides as <i>in vivo</i> diagnostic and therapeutic agents for human prostate tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4578</span><span class="NLM_x">–</span> <span class="NLM_lpage">4583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4578-4583&author=C.+S.+Johnauthor=B.+J.+Vilnerauthor=B.+C.+Geyerauthor=T.+Moodyauthor=W.+D.+Bowen&title=Targeting+sigma+receptor-binding+benzamides+as+in+vivo+diagnostic+and+therapeutic+agents+for+human+prostate+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DGeyer%26aufirst%3DB.%2BC.%26aulast%3DMoody%26aufirst%3DT.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3DTargeting%2520sigma%2520receptor-binding%2520benzamides%2520as%2520in%2520vivo%2520diagnostic%2520and%2520therapeutic%2520agents%2520for%2520human%2520prostate%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4578%26epage%3D4583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">van Waarde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczynska, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsinga, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierckx, R. A. J. O.</span><span> </span><span class="NLM_article-title">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3519</span><span class="NLM_x">–</span> <span class="NLM_lpage">3537</span><span class="refDoi"> DOI: 10.2174/138161210793563365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F138161210793563365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=21050178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3519-3537&author=A.+van+Waardeauthor=A.+A.+Rybczynskaauthor=N.+K.+Ramakrishnanauthor=K.+Ishiwataauthor=P.+H.+Elsingaauthor=R.+A.+J.+O.+Dierckx&title=Sigma+receptors+in+oncology%3A+therapeutic+and+diagnostic+applications+of+sigma+ligands&doi=10.2174%2F138161210793563365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands</span></div><div class="casAuthors">van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3519-3537</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed throughout the mammalian body.  The endogenous ligand for these sites has not been identified, but steroid hormones (particularly progesterone), sphingolipid-derived amines and N,N-dimethyltryptamine can bind with fairly high affinity.  Sigma receptors are overexpressed in rapidly proliferating cells, like cancer cells.  Particularly the sigma-2 subtype is upregulated when cells divide and down regulated when they become quiescent.  Sigma ligands, esp. sigma-2 agonists, can inhibit proliferation and induce apoptosis by a mechanism involving changes in cytosolic Ca2+, ceramide and sphingolipid levels.  Tumor cells are much more sensitive to such treatment than cells from their tissue of origin.  Sigma ligands induce apoptosis not only in drug-sensitive but also in drug-resistant cancer cells (e.g., cells with p53 mutations, or caspase dysfunction).  Moreover, sigma ligands may abrogate P-glycoprotein-mediated drug resistance and at subtoxic doses, they can potentiate the effect of conventional cytostatics.  Thus, sigma-2 agonists may be developed as antineoplastic agents for the treatment of drug-resistant tumors.  A large no. of radiolabeled sigma ligands has been prepd. for SPECT (single-photon emission computed tomog.) and PET (positron emission tomog.) imaging.  Such radiopharmaceuticals can be used for tumor detection, tumor staging, and evaluation of anti-tumor therapy.  There is still a need for the development of ligands with (1) high selectivity for the sigma-2 subtype, (2) defined action (agonist or antagonist) and (3) optimal pharmacokinetics (low affinity for P-glycoprotein, high and specific tumor uptake, and rapid washout from non-target tissues).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX-vSPpRtU37Vg90H21EOLACvtfcHk0lj15_lfrE7Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1KqsA%253D%253D&md5=e77adeaf932e2fa8eca70ec0e4e84ec6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F138161210793563365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793563365%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26aulast%3DRybczynska%26aufirst%3DA.%2BA.%26aulast%3DRamakrishnan%26aufirst%3DN.%2BK.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26atitle%3DSigma%2520receptors%2520in%2520oncology%253A%2520therapeutic%2520and%2520diagnostic%2520applications%2520of%2520sigma%2520ligands%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3519%26epage%3D3537%26doi%3D10.2174%2F138161210793563365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Megalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span> </span><span class="NLM_article-title">Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span><span class="refDoi"> DOI: 10.1002/med.20218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fmed.20218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20687157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFyrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=410-427&author=V.+Megalizziauthor=M.+Le+Mercierauthor=C.+Decaestecker&title=Sigma+receptors+and+their+ligands+in+cancer+biology%3A+overview+and+new+perspectives+for+cancer+therapy&doi=10.1002%2Fmed.20218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy</span></div><div class="casAuthors">Megalizzi, Veronique; Le Mercier, Marie; Decaestecker, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">410-427</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A large no. of drugs are known to bind with high affinity to sigma receptors (sigma-Rs) and have been used in the clinic to treat mental disorders for many years.  However, recent publications highlighting sigma-R overexpression in many cancer tissues suggest potential applications for sigma-R ligands in cancer diagnosis and therapy.  The present review focuses on the involvement of sigma-Rs in cancer biol. and the potential therapeutic contributions of their pharmacol. ligands in oncol.  After summarizing the current and general knowledge regarding sigma-Rs, we detail data reported in the particular context of oncol.  We then investigate the potential and specific signal transduction pathways and mechanisms involved in the actions of sigma-R ligands in cancer biol.  These processes include modulations of (1) the plasma membrane and lipid raft components, (2) intracellular calcium levels, (3) cytoskeletal protein functions, and (4) endoplasmic reticulum stress.  Finally, we conclude by speculating on the roles of sigma-R overexpression and sigma-R ligands in cancer biol. and offer perspectives on cancer therapy. © 2010 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5t2d8y5adbVg90H21EOLACvtfcHk0lj15_lfrE7Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFyrs7w%253D&md5=5c512915d6f92cd234a7d4cf7f83630f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fmed.20218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20218%26sid%3Dliteratum%253Aachs%26aulast%3DMegalizzi%26aufirst%3DV.%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DDecaestecker%26aufirst%3DC.%26atitle%3DSigma%2520receptors%2520and%2520their%2520ligands%2520in%2520cancer%2520biology%253A%2520overview%2520and%2520new%2520perspectives%2520for%2520cancer%2520therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2012%26volume%3D32%26spage%3D410%26epage%3D427%26doi%3D10.1002%2Fmed.20218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Nabulsi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whirrett, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">σ<sub>2</sub> receptors as potential biomarkers of proliferation in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=156-161&author=R.+H.+Machauthor=C.+R.+Smithauthor=I.+Al-Nabulsiauthor=B.+R.+Whirrettauthor=S.+R.+Childersauthor=K.+T.+Wheeler&title=%CF%832+receptors+as+potential+biomarkers+of+proliferation+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DAl-Nabulsi%26aufirst%3DI.%26aulast%3DWhirrett%26aufirst%3DB.%2BR.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3D%25CF%25832%2520receptors%2520as%2520potential%2520biomarkers%2520of%2520proliferation%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D156%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Al-Nabulsi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keng, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1038/sj.bjc.6690789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1038%2Fsj.bjc.6690789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10576647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=925-933&author=I.+Al-Nabulsiauthor=R.+H.+Machauthor=L.+M.+Wangauthor=C.+A.+Wallenauthor=P.+C.+Kengauthor=K.+Stenauthor=S.+R.+Childersauthor=K.+T.+Wheeler&title=Effect+of+ploidy%2C+recruitment%2C+environmental+factors%2C+and+tamoxifen+treatment+on+the+expression+of+sigma-2+receptors+in+proliferating+and+quiescent+tumour+cells&doi=10.1038%2Fsj.bjc.6690789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells</span></div><div class="casAuthors">Al-Nabulsi, I.; Mach, R. H.; Wang, L.-M.; Wallen, C. A.; Keng, P. C.; Sten, K.; Childers, S. R.; Wheeler, K. T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">925-933</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Recently, the authors demonstrated that sigma-2 receptors may have the potential to be a biomarker of tumor cell proliferation.  If sigma-2 receptors were a biomarker of tumor cell proliferation, they would be amenable to detection by non-invasive imaging procedures, thus eliminating many of the problems assocd. with the flow cytometric measures of tumor cell proliferation presently used in the clinic.  To be a good biomarker of tumor cell proliferation, the expression of sigma-2 receptors must be essentially independent of many of the biol., physiol., and/or environmental properties that are found in solid tumors.  In the investigation reported here, the mouse mammary adenocarcinoma lines, 66 (diploid) and 67 (aneuploid), 9L rat brain tumor cells, and MCF-7 human breast tumor cells were used to study the extent and kinetics of expression of sigma-2 receptors in proliferative (P) and quiescent (Q) tumor cells as a function of species, cell type, ploidy, pH, nutrient depletion, metabolic state, recruitment from the Q-cell compartment to the P-cell compartment, and treatment with tamoxifen.  In these expts., the expression of sigma-2 receptors solely reflected the proliferative status of the tumor cells.  None of the biol., physiol., or environmental properties that were investigated had a measurable effect on the expression of sigma-2 receptors in these model systems.  Consequently, these data suggest that the proliferative status of tumors and normal tissues can be non-invasively assessed using radiolabeled ligands that selectively bind sigma-2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNRjnww2EFMLVg90H21EOLACvtfcHk0lj15_lfrE7Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFSjs74%253D&md5=6e3ef0c6df3f2ad37a35a2a23541eb84</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690789%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Nabulsi%26aufirst%3DI.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWallen%26aufirst%3DC.%2BA.%26aulast%3DKeng%26aufirst%3DP.%2BC.%26aulast%3DSten%26aufirst%3DK.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3DEffect%2520of%2520ploidy%252C%2520recruitment%252C%2520environmental%2520factors%252C%2520and%2520tamoxifen%2520treatment%2520on%2520the%2520expression%2520of%2520sigma-2%2520receptors%2520in%2520proliferating%2520and%2520quiescent%2520tumour%2520cells%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D81%26spage%3D925%26epage%3D933%26doi%3D10.1038%2Fsj.bjc.6690789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keng, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Sigma-2 receptors as a biomarker of proliferation in solid tumours</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span><span class="refDoi"> DOI: 10.1054/bjoc.1999.1067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1054%2Fbjoc.1999.1067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10735510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisFSktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2000&pages=1223-1232&author=K.+T.+Wheelerauthor=L.+M.+Wangauthor=C.+A.+Wallenauthor=S.+R.+Childersauthor=J.+M.+Clineauthor=P.+C.+Kengauthor=R.+H.+Mach&title=Sigma-2+receptors+as+a+biomarker+of+proliferation+in+solid+tumours&doi=10.1054%2Fbjoc.1999.1067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 receptors as a biomarker of proliferation in solid tumours</span></div><div class="casAuthors">Wheeler, K. T.; Wang, L.-M.; Wallen, C. A.; Childers, S. R.; Cline, J. M.; Keng, P. C.; Mach, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1223-1232</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Over the past several years, our group has provided considerable evidence that the expression of sigma-2 (σ2) receptors may serve as a biomarker of tumor cell proliferation.  In these in vitro studies, σ2 receptors were expressed 8-10 times more in proliferative (P) tumor cells than in quiescent (Q) tumor cells, and the extent and kinetics of their expression were independent of a no. of biol., physiol. and environmental factors often found in solid tumors.  Moreover, the expression of σ2 receptors followed both the population growth kinetics when Q-cells were recruited into the P-cell compartment and the proliferative status of human breast tumor cells treated with cytostatic concns. of tamoxifen.  However, these in vitro studies may or may not be indicative of what might occur in solid tumors.  In the present study, the σ2 receptor P:Q ratio was detd. for the cells from s.c. 66 (diploid) and 67 (aneuploid) tumors grown in female nude mice.  The σ2 receptor P:Q ratio of the 66 tumors was 10.6 compared to the σ2 receptor P:Q ratio of 9.5 measured for the 66 tissue culture model.  The σ2 receptor P:Q ratio of the 67 tumors was 4.5 compared to the σ2 receptor P:Q ratio of ≈ 8 measured for the 67 tissue culture model.  The agreement between the solid tumor and tissue culture data indicates that: (1) the expression of σ2 receptors may be a reliable biomarker of the proliferative status of solid tumors and (2) radioligands with both high affinity and high selectivity for σ2 receptors may have the potential to non-invasively assess the proliferative status of human solid tumors using imaging techniques such as positron emission tomog. or single-photon emission computerized tomog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0asMPgLbuLbVg90H21EOLACvtfcHk0lieGNTQl3xadg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisFSktrs%253D&md5=5a36a664fb20482b0232191ec9e91a9e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1054%2Fbjoc.1999.1067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fbjoc.1999.1067%26sid%3Dliteratum%253Aachs%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DL.%2BM.%26aulast%3DWallen%26aufirst%3DC.%2BA.%26aulast%3DChilders%26aufirst%3DS.%2BR.%26aulast%3DCline%26aufirst%3DJ.%2BM.%26aulast%3DKeng%26aufirst%3DP.%2BC.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSigma-2%2520receptors%2520as%2520a%2520biomarker%2520of%2520proliferation%2520in%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2000%26volume%3D82%26spage%3D1223%26epage%3D1232%26doi%3D10.1054%2Fbjoc.1999.1067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumstorff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Fluorine-18-labeled benzamide analogues for imaging the σ<sub>2</sub> receptor status of solid tumors with Positron Emission Tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3194</span><span class="NLM_x">–</span> <span class="NLM_lpage">3204</span><span class="refDoi"> DOI: 10.1021/jm0614883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0614883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFGnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3194-3204&author=Z.+Tuauthor=J.+Xuauthor=L.+A.+Jonesauthor=S.+Liauthor=C.+Dumstorffauthor=S.+Vangveravongauthor=D.+L.+Chenauthor=K.+T.+Wheelerauthor=M.+J.+Welchauthor=R.+H.+Mach&title=Fluorine-18-labeled+benzamide+analogues+for+imaging+the+%CF%832+receptor+status+of+solid+tumors+with+Positron+Emission+Tomography&doi=10.1021%2Fjm0614883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-18-Labeled Benzamide Analogs for Imaging the σ2 Receptor Status of Solid Tumors with Positron Emission Tomography</span></div><div class="casAuthors">Tu, Zhude; Xu, Jinbin; Jones, Lynne A.; Li, Shihong; Dumstorff, Craig; Vangveravong, Suwanna; Chen, Delphine L.; Wheeler, Kenneth T.; Welch, Michael J.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3194-3204</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. benzamide analogs was synthesized and evaluated as candidate ligands for positron emission tomog. (PET) imaging of the sigma-2 (σ2) receptor status of solid tumors.  Four compds. having a moderate to high affinity for σ2 receptors and a moderate to low affinity for sigma-1 (σ1) receptors were radiolabeled with fluorine-18 via displacement of the corresponding mesylate precursor with [18F]fluoride.  Biodistribution studies in female Balb/c mice bearing EMT-6 tumor allografts demonstrated that all four F-18-labeled compds. had a high tumor uptake (2.5-3.7% ID/g) and acceptable tumor/normal tissue ratios at 1 and 2 h post-i.v. injection.  An anal. of the chem. and biodistribution data suggested that N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-methylbenzamide and N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-[18F]-fluoroethoxy)-5-iodo-3-methoxybenzamide are acceptable compds. for imaging the σ2 receptor status of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtoxOqoNWUSbVg90H21EOLACvtfcHk0lieGNTQl3xadg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFGnsro%253D&md5=ff418877245698b688efdcdc7edf9bc3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0614883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0614883%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDumstorff%26aufirst%3DC.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DD.%2BL.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DFluorine-18-labeled%2520benzamide%2520analogues%2520for%2520imaging%2520the%2520%25CF%25832%2520receptor%2520status%2520of%2520solid%2520tumors%2520with%2520Positron%2520Emission%2520Tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3194%26epage%3D3204%26doi%3D10.1021%2Fjm0614883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dehdashti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laforest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoghi, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aft, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussenbaum, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisel, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner-Johnson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Assessment of cellular proliferation in tumors by PET using <sup>18</sup>F-ISO-1</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span><span class="refDoi"> DOI: 10.2967/jnumed.112.111948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.112.111948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=23359657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=350-357&author=F.+Dehdashtiauthor=R.+Laforestauthor=F.+Gaoauthor=K.+I.+Shoghiauthor=R.+L.+Aftauthor=B.+Nussenbaumauthor=F.+H.+Kreiselauthor=N.+L.+Bartlettauthor=A.+Cashenauthor=N.+Wagner-Johnsonauthor=R.+H.+Mach&title=Assessment+of+cellular+proliferation+in+tumors+by+PET+using+18F-ISO-1&doi=10.2967%2Fjnumed.112.111948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of cellular proliferation in tumors by PET using 18F-ISO-1</span></div><div class="casAuthors">Dehdashti, Farrokh; Laforest, Richard; Gao, Feng; Shoghi, Kooresh I.; Aft, Rebecca L.; Nussenbaum, Brian; Kreisel, Friederike H.; Bartlett, Nancy L.; Cashen, Amanda; Wagner-Johnston, Nina; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">350-357</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This first study in humans was designed to evaluate the safety and dosimetry of a cellular proliferative marker, N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-(2-18F-fluoro-ethoxy)-5-methylbenzamide (18F-ISO-1), and evaluate the feasibility of imaging tumor proliferation by PET in patients with newly diagnosed malignant neoplasms.  Methods: Patients with biopsy-proven lymphoma, breast cancer, or head and neck cancer underwent 18F-ISO-1 PET.  Tumor 18F-ISO-1 uptake was assessed semiquant. by max. standardized uptake value, ratios of tumor to normal tissue and tumor to muscle, and relative distribution vol. ratio.  The PET results were correlated with tumor Ki-67 and mitotic index, from in vitro assays of the tumor tissue.  The biodistribution of 18F-ISO-1 and human dosimetry were evaluated.  Results: Thirty patients with primary breast cancer (n = 13), head and neck cancer (n = 10), and lymphoma (n = 7) were evaluated.  In the entire group, tumor max. standardized uptake value and tumor-to-muscle ratio correlated significantly with Ki-67 (*au = 0.27, P = 0.04, and *au = 0.38, P = 0.003, resp.), but no significant correlation was obsd. between Ki-67 and tumor-to-normal-tissue ratio (*au = 0.07, P = 0.56) or distribution vol. ratio (*au = 0.26, P = 0.14).  On the basis of whole-body PET data, the gallbladder is the dose-limiting organ, with an av. radiation dose of 0.091 mGy/MBq.  The whole-body and EDs were 0.012 mGy/MBq and 0.016 mSv/MBq, resp.  No adverse effects of 18F-ISO-1 were encountered.  Conclusion: The presence of a significant correlation between 18F-ISO-1 and Ki-67 makes this agent promising for evaluation of the proliferative status of solid tumors.  The relatively small absorbed doses to normal organs allow for the safe administration of up to 550 MBq, which is sufficient for PET imaging in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJzNLBiXZh7Vg90H21EOLACvtfcHk0lieGNTQl3xadg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2ksr4%253D&md5=c746f6bb256184c9e2e2dfa164be875f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.111948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.111948%26sid%3Dliteratum%253Aachs%26aulast%3DDehdashti%26aufirst%3DF.%26aulast%3DLaforest%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DAft%26aufirst%3DR.%2BL.%26aulast%3DNussenbaum%26aufirst%3DB.%26aulast%3DKreisel%26aufirst%3DF.%2BH.%26aulast%3DBartlett%26aufirst%3DN.%2BL.%26aulast%3DCashen%26aufirst%3DA.%26aulast%3DWagner-Johnson%26aufirst%3DN.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DAssessment%2520of%2520cellular%2520proliferation%2520in%2520tumors%2520by%2520PET%2520using%252018F-ISO-1%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D350%26epage%3D357%26doi%3D10.2967%2Fjnumed.112.111948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Shoghi, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashikubo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubet, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, M.</span><span> </span><span class="NLM_article-title">Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [<sup>18</sup>F]ISO-1</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74188</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1371%2Fjournal.pone.0074188" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74188&author=K.+I.+Shoghiauthor=J.+Xuauthor=Y.+Suauthor=J.+Heauthor=D.+Rowlandauthor=Y.+Yanauthor=J.+R.+Garbowauthor=Z.+Tuauthor=L.+A.+Jonesauthor=R.+Higashikuboauthor=K.+T.+Wheelerauthor=R.+A.+Lubetauthor=R.+H.+Machauthor=M.+You&title=Quantitative+receptor-based+imaging+of+tumor+proliferation+with+the+sigma-2+ligand+%5B18F%5DISO-1&doi=10.1371%2Fjournal.pone.0074188"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074188%26sid%3Dliteratum%253Aachs%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DRowland%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DGarbow%26aufirst%3DJ.%2BR.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DHigashikubo%26aufirst%3DR.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26aulast%3DLubet%26aufirst%3DR.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DYou%26aufirst%3DM.%26atitle%3DQuantitative%2520receptor-based%2520imaging%2520of%2520tumor%2520proliferation%2520with%2520the%2520sigma-2%2520ligand%2520%255B18F%255DISO-1%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74188%26doi%3D10.1371%2Fjournal.pone.0074188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K. T.</span><span> </span><span class="NLM_article-title">Development of molecular probes for imaging sigma-2 receptors in vitro and <i>in vivo</i></span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.2174/1871524910909030230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F1871524910909030230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20021357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=230-245&author=R.+H.+Machauthor=K.+T.+Wheeler&title=Development+of+molecular+probes+for+imaging+sigma-2+receptors+in+vitro+and+in+vivo&doi=10.2174%2F1871524910909030230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo</span></div><div class="casAuthors">Mach, Robert Henry; Wheeler, Kenneth Theodore</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">230-245</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The sigma-2 (σ2) receptor is proving to be an important protein in the field of cancer biol.  The observations that σ2 receptors have a 10-fold higher d. in proliferating tumor cells than in quiescent tumor cells, and that σ2 receptor agonists are capable of killing tumor cells via apoptotic and non-apoptotic mechanisms, indicate that this receptor is an important mol. target for the development of radiotracers for imaging tumors using techniques such as Positron Emission Tomog. (PET) and Single Photon Emission Computed Tomog. (SPECT) and for the development of cancer chemotherapeutic agents.  In spite of recent promising results towards achieving these goals, research in this field has been hampered by the fact that the mol. identity of the protein sequence of the σ2 receptor is currently not known.  Consequently, most of what is known about this protein has been obtained using either radiolabeled or fluorescent probes for this receptor, or biochem. anal. of the effect of σ2 selective ligands on cells growing under tissue culture conditions.  This article provides a review of the development and use of σ2 receptor ligands, and how these ligands have been used with a variety of in vitro and in vivo models to gain a greater understanding of the role this receptor plays in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9Mm5Pn8dtbVg90H21EOLACvtfcHk0lg-AaGve2z_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWnt7rJ&md5=1babf73dd3a6dcf8eb3eb8b29702360e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F1871524910909030230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524910909030230%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DWheeler%26aufirst%3DK.%2BT.%26atitle%3DDevelopment%2520of%2520molecular%2520probes%2520for%2520imaging%2520sigma-2%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D230%26epage%3D245%26doi%3D10.2174%2F1871524910909030230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sai, K. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Development of <sup>18</sup>F-labeled PET probes for imaging cell proliferation</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">908</span><span class="refDoi"> DOI: 10.2174/1568026611313080003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F1568026611313080003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=23590172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=892-908&author=K.+K.+S.+Saiauthor=L.+A.+Jonesauthor=R.+H.+Mach&title=Development+of+18F-labeled+PET+probes+for+imaging+cell+proliferation&doi=10.2174%2F1568026611313080003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 18F-labeled PET probes for imaging cell proliferation</span></div><div class="casAuthors">Sai, Kiran Kumar Solingapuram; Jones, Lynne A.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">892-908</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, two different methods have been developed to image cell proliferation with the functional imaging technique, Positron emission Tomog. (PET), proliferation rate and proliferative status.  Proliferation rate is a measure of the tumor doubling time and uses radiolabeled analogs of the DNA precursor thymidine.  This approach measures the activity of the enzyme thymidine kinase 1 (TK1) and provides a pulse label of the S phase fraction of a tumor.  Proliferative status provides a measure of the ratio of proliferating (P) and quiescent (Q) cells in a tumor.  This imaging approach for measuring proliferative status involves measuring the sigma-2 (σ2) receptor status of a tumor, the only protein which has been validated for making this measurement in vivo with PET.  This article provides an overview of the biol. information obtained from these different imaging strategies, and the development of radiotracers for imaging proliferation rate and proliferative status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnMGN4tIYxMLVg90H21EOLACvtfcHk0lg-AaGve2z_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslKhtL0%253D&md5=6d4f1a36b663ec4b9d3de6f9591e9e56</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1568026611313080003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611313080003%26sid%3Dliteratum%253Aachs%26aulast%3DSai%26aufirst%3DK.%2BK.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DDevelopment%2520of%252018F-labeled%2520PET%2520probes%2520for%2520imaging%2520cell%2520proliferation%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D892%26epage%3D908%26doi%3D10.2174%2F1568026611313080003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, W. G.</span><span> </span><span class="NLM_article-title">The σ<sub>2</sub> receptor: a novel protein for the imaging and treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7137</span><span class="NLM_x">–</span> <span class="NLM_lpage">7160</span><span class="refDoi"> DOI: 10.1021/jm301545c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301545c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7137-7160&author=R.+H.+Machauthor=C.+Zengauthor=W.+G.+Hawkins&title=The+%CF%832+receptor%3A+a+novel+protein+for+the+imaging+and+treatment+of+cancer&doi=10.1021%2Fjm301545c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The σ2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer</span></div><div class="casAuthors">Mach, Robert H.; Zeng, Chenbo; Hawkins, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7137-7160</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The σ2 receptor is an important target for the development of mol. probes in oncol. because of its 10-fold higher d. in proliferating tumor cells compared with that in quiescent tumor cells and because of the observation that σ2 receptor agonists are able to kill tumor cells via apoptotic and nonapoptotic mechanisms.  Although recent evidence indicates that the σ2 receptor binding site is localized within the progesterone receptor membrane component 1 (PGRMC1), most information regarding this protein has been obtained using either radiolabeled or fluorescent receptor-based probes and from biochem. anal. of the effect of σ2 selective ligands on cells grown in culture.  This article reviews the development of σ2 receptor ligands and presents an overview of how they have been used in vitro and in vivo to increase the authors' understanding of the role of the σ2 receptor in cancer and proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWf1ZnaveYT7Vg90H21EOLACvtfcHk0lg-AaGve2z_Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWmtr0%253D&md5=55831988f692d39d423e8cfe7f18240f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301545c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301545c%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DZeng%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DW.%2BG.%26atitle%3DThe%2520%25CF%25832%2520receptor%253A%2520a%2520novel%2520protein%2520for%2520the%2520imaging%2520and%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7137%26epage%3D7160%26doi%3D10.1021%2Fjm301545c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bailey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willowson, K. P.</span><span> </span><span class="NLM_article-title">An evidence-based review of quantitative SPECT imaging and potential clinical applications</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.2967/jnumed.112.111476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2967%2Fjnumed.112.111476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=83-98&author=D.+L.+Baileyauthor=K.+P.+Willowson&title=An+evidence-based+review+of+quantitative+SPECT+imaging+and+potential+clinical+applications&doi=10.2967%2Fjnumed.112.111476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.111476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.111476%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DD.%2BL.%26aulast%3DWillowson%26aufirst%3DK.%2BP.%26atitle%3DAn%2520evidence-based%2520review%2520of%2520quantitative%2520SPECT%2520imaging%2520and%2520potential%2520clinical%2520applications%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D83%26epage%3D98%26doi%3D10.2967%2Fjnumed.112.111476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">John, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labeled σ-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1021/bc9700087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9700087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2sXivF2jsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=304-309&author=C.+S.+Johnauthor=B.+B.+Limauthor=B.+C.+Geyerauthor=B.+J.+Vilnerauthor=W.+D.+Bowen&title=99mTc-labeled+%CF%83-receptor-binding+complex%3A+synthesis%2C+characterization%2C+and+specific+binding+to+human+ductal+breast+carcinoma+%28T47D%29+cells&doi=10.1021%2Fbc9700087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeled σ-Receptor-Binding Complex: Synthesis, Characterization, and Specific Binding to Human Ductal Breast Carcinoma (T47D) Cells</span></div><div class="casAuthors">John, Christy S.; Lim, Benjamin B.; Geyer, Brian C.; Vilner, Bertold J.; Bowen, Wayne D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-309</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">σ-Receptors have recently been shown to be expressed in a variety of human tumor cells.  In an attempt to prep. 99mTc chelates that would bind to σ-receptors and be useful for imaging σ-receptor-pos. tumors, we have synthesized and characterized a bisaminothiol (BAT) chelate appended with a σ-receptor pharmacophore.  The synthesis of target ligand VII was accomplished in three steps starting from bicyclic imidazolidino[1,2-d]dithiazapine.  The labeling of the BAT ligand with 99mTc was carried out in high yields (>80%) using stannous tartrate as a reducing agent, resulting in the target σ [99mTc]BAT-EN6, III.  Similarly, 99gTc chelate with ligand VII was prepd. from ammonium pertechnetate by redn. with stannous tartrate.  99mTc-radiolabeled chelate was purified by reversed phase HPLC, and cell binding with human breast ductal carcinoma (T47D) was performed.  A high degree of specific binding (90-97%) was obtained when σ-receptor ligands such as halogenated phenylethylenediamines were used to det. nonspecific binding.  A modest affinity dose-dependent inhibition of binding was found with BD1008, I, and 4-IPEMP, II (IC50 = 47 ± 2 and 59 ± 5 nM, resp.), known σ-ligands.  No specific binding was found with [99mTc]BAT, VIII [without appended σ-pharmacophore (N-alkyl-substituted ethylenediamine)], showing that biol. activity resulted from the pendent pharmacophore.  99gTc complex was found to be a potent inhibitor (Ki = 42.7 ± 8.5 nM) of [3H]DTG binding in guinea pig brain membranes.  Scatchard anal. of [99mTc]BAT-EN6 (spiked with [99gTc]BAT-EN6) binding in T47D breast cancer cells showed a saturable binding, with a Kd of 43.5 ± 14.7 nM and a Bmax of 3121 ± 130 fmol/(mg of protein).  A biodistribution study of [99mTc]BAT-EN6 chelates in Sprague Dawley rats showed hepatic clearance, as expected.  A blocking study at 4 h postinjection using 2 μmol of BD1008 with [99mTc]BAT-EN6 showed a significant decrease of radiopharmaceutical in liver (15.32 vs 22.31% ID/organ) and kidney (1.01 vs 2.21% ID/organ), organs known to possess high concns. of σ-receptors.  These results imply that [99mTc]BAT-EN6 binds with high affinity to σ-receptors expressed in human breast tumor cells, and it may be useful for imaging breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2hn0M-wX8pbVg90H21EOLACvtfcHk0lilrS40U2sTCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivF2jsbg%253D&md5=8ecf2143cc8fc3159f2c156579e681cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fbc9700087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9700087%26sid%3Dliteratum%253Aachs%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DLim%26aufirst%3DB.%2BB.%26aulast%3DGeyer%26aufirst%3DB.%2BC.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26atitle%3D99mTc-labeled%2520%25CF%2583-receptor-binding%2520complex%253A%2520synthesis%252C%2520characterization%252C%2520and%2520specific%2520binding%2520to%2520human%2520ductal%2520breast%2520carcinoma%2520%2528T47D%2529%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D1997%26volume%3D8%26spage%3D304%26epage%3D309%26doi%3D10.1021%2Fbc9700087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plössl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chumpradit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wey, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1016/S0969-8051(01)00234-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2FS0969-8051%2801%2900234-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=11518647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=657-666&author=S.+R.+Choiauthor=B.+Yangauthor=K.+Pl%C3%B6sslauthor=S.+Chumpraditauthor=S.+P.+Weyauthor=P.+D.+Actonauthor=K.+Wheelerauthor=R.+H.+Machauthor=H.+F.+Kung&title=Development+of+a+Tc-99m+labeled+sigma-2+receptor-specific+ligand+as+a+potential+breast+tumor+imaging+agent&doi=10.1016%2FS0969-8051%2801%2900234-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent</span></div><div class="casAuthors">Choi, S.-R.; Yang, B.; Plossl, K.; Chumpradit, S.; Wey, S.-P.; Acton, P. D.; Wheeler, K.; Mach, R. H.; Kung, H. F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">657-666</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A novel in vivo imaging agent, 99mTc labeled [(N-[2-((3'-N'-propyl-[3,3,1]aza-bicyclononan-3α-yl)(2''-methoxy-5-methyl-phenylcarbamate)(2-mercaptoethyl)amino)acetyl]-2-aminoethanethiolato] technetium(V) oxide), [99mTc]2, displaying specific binding towards sigma-2 receptors was prepd. and characterized.  In vitro binding assays showed that the rhenium surrogate of [99mTc]2, Re-2, displayed excellent binding affinity and selectivity towards sigma-2 receptors (Ki = 2,723 and 22 nM for sigma-1 and sigma-2 receptor, resp.).  Prepn. of [99mTc]2 was achieved by heating the S-protected starting material, 1, in the presence of acid, reducing agent (stannous glucoheptonate) and sodium [99mTc]pertechnetate.  The lipophilic racemic mixt. was successfully prepd. in 10 to 50% yield and the radiochem. purity was >98%.  Sepn. of the isomers, peak A and peak B, was successfully achieved by using a chiralpak AD column eluted with an isocratic solvent (n-hexane/isopropanol; 3:1; vol./vol.).  The peak A and peak B appear to co-elute with the isomers of the surrogate, Re-2, under the same HPLC condition.  Biodistribution studies in tumor bearing mice (mouse mammary adenocarcinoma, cell line 66, which is known to over-express sigma-2 receptors) showed that the racemic [99mTc]2 localized in the tumor.  Uptake in the tumor was 2.11, 1.30 and 1.11 %dose/g at 1, 4 and 8 h post iv injection, resp., suggesting good uptake and retention in the tumor cells.  The tumor uptake was significantly, but incompletely, blocked (about 25-30% blockage) by co-injection of "cold" (+)pentazocine or haloperidol (1 mg/Kg).  A majority of the radioactivity localized in the tumor tissue was extractable (>60%), and the HPLC anal. showed that it is the original compd., racemic [99mTc]2 (>98% pure).  The distribution of the purified peak A and peak B was detd. in the same tumor bearing mice at 4 h post iv injection.  The tumor uptake was similar for both isomers, but the blood and peripheral tissue content for the isomer in peak B was higher than that for the isomer in peak A.  It is evident that the isomer in peak A displayed significantly better tumor/blood and tumor/muscle ratios.  The higher rate of in vivo metab. was also confirmed by the higher thyroid uptake values for the isomer in peak B as compared to peak A. In summary, a 99mTc-labeled sigma receptor imaging agent, [99mTc]2, has demonstrated the feasibility of using a 99mTc-labeled agent for imaging sigma receptor expression in tumor cells.  This is the first time a subtype-selective 99mTc-labeled agent for imaging sigma receptor sites is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHIb44oMK6IrVg90H21EOLACvtfcHk0lilrS40U2sTCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtV2ksr4%253D&md5=5f8b2cf8285b360a724832843d69741a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900234-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900234-7%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DPl%25C3%25B6ssl%26aufirst%3DK.%26aulast%3DChumpradit%26aufirst%3DS.%26aulast%3DWey%26aufirst%3DS.%2BP.%26aulast%3DActon%26aufirst%3DP.%2BD.%26aulast%3DWheeler%26aufirst%3DK.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DDevelopment%2520of%2520a%2520Tc-99m%2520labeled%2520sigma-2%2520receptor-specific%2520ligand%2520as%2520a%2520potential%2520breast%2520tumor%2520imaging%2520agent%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D657%26epage%3D666%26doi%3D10.1016%2FS0969-8051%2801%2900234-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Friebe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drews, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraemer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. G.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc]Oxotechnetium(V) complexes of amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3140</span><span class="refDoi"> DOI: 10.1021/jm0005407</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0005407" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3132-3140&author=M.+Friebeauthor=A.+Mahmoodauthor=C.+Bolzatiauthor=A.+Drewsauthor=B.+Johannsenauthor=M.+Eisenhutauthor=D.+Kraemerauthor=A.+Davisonauthor=A.+G.+Jones&title=%5B99mTc%5DOxotechnetium%28V%29+complexes+of+amine-amide-dithiol+chelates+with+dialkylaminoalkyl+substituents+as+potential+diagnostic+probes+for+malignant+melanoma&doi=10.1021%2Fjm0005407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0005407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0005407%26sid%3Dliteratum%253Aachs%26aulast%3DFriebe%26aufirst%3DM.%26aulast%3DMahmood%26aufirst%3DA.%26aulast%3DBolzati%26aufirst%3DC.%26aulast%3DDrews%26aufirst%3DA.%26aulast%3DJohannsen%26aufirst%3DB.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DKraemer%26aufirst%3DD.%26aulast%3DDavison%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DA.%2BG.%26atitle%3D%255B99mTc%255DOxotechnetium%2528V%2529%2520complexes%2520of%2520amine-amide-dithiol%2520chelates%2520with%2520dialkylaminoalkyl%2520substituents%2520as%2520potential%2520diagnostic%2520probes%2520for%2520malignant%2520melanoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3132%26epage%3D3140%26doi%3D10.1021%2Fjm0005407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Novel <sup>99m</sup>Tc labeled σ receptor ligand as a potential tumor imaging agent</span> <span class="citation_source-journal">Sci. China, Ser. B: Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span><span class="refDoi"> DOI: 10.1007/s11426-006-0169-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1007%2Fs11426-006-0169-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVKjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=169-176&author=C.+Fanauthor=H.+Jiaauthor=W.+Deuther-Conradauthor=P.+Brustauthor=J.+Steinbachauthor=B.+Liu&title=Novel+99mTc+labeled+%CF%83+receptor+ligand+as+a+potential+tumor+imaging+agent&doi=10.1007%2Fs11426-006-0169-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 99mTc labeled σ receptor ligand as a potential tumor imaging agent</span></div><div class="casAuthors">Fan, Caiyun; Jia, Hongmei; Deuther-Conrad, Winnie; Brust, Peter; Steinbach, Joerg; Liu, Boli</div><div class="citationInfo"><span class="NLM_cas:title">Science in China, Series B: Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-176</span>CODEN:
                <span class="NLM_cas:coden">SCBCFQ</span>;
        ISSN:<span class="NLM_cas:issn">1006-9291</span>.
    
            (<span class="NLM_cas:orgname">Science in China Press</span>)
        </div><div class="casAbstract">A novel 99mTc labeled complex, [N-[2-((2-oxo-2-(4-(3-phenylpropyl)piperazin-1-yl)ethyl) (2-mercaptoethyl)amino)acetyl]-2-aminoethanethiolato]Technetium(V) oxide (PPPE-MAMA'-99mTcO) ([99mTc]-2) has been designed and prepd. based on the integrated approach.  The corresponding rhenium complex (PPPE-MAMA'-ReO)(Re-2) has been prepd. and characterized.  In vitro competition binding assays show moderate affinity of Re-2 towards σ1 and σ2 receptors with K i values of 8.67±0.07 and 5.71±1.88 μmol, resp.  Planar images obtained at 0.5 h, 4 h, 20 h after i.v. injection indicate the accumulation of [99mTc]-2 in MCF-7 human breast tumor bearing mice at 20 h.  Furthermore, the accumulation of [ 99m Tc]-2 has been inhibited at 20 h after co-injection of [99mTc]-2 plus haloperidol (1 mg/kg).  Biodistribution studies of [99mTc]-2 display an in vivo tumor uptake of 0.14% ± 0.01% ID/g at 24 h post i.v. injection with a tumor/muscle ratio of 6.02±0.87.  The above results suggest that [99mTc]-2, derived from a previously published lead compd., retains certain tumor uptake and affinity for σ receptors.  [99mTc]-2 may be used as a basis for further structural modifications to develop tumor imaging agents with high affinity for σ receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg1EqaHzl6tLVg90H21EOLACvtfcHk0ljRPZrWIAR7Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVKjt7s%253D&md5=e252aa8dd5ea0518f2e55359516f7605</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11426-006-0169-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11426-006-0169-z%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DNovel%252099mTc%2520labeled%2520%25CF%2583%2520receptor%2520ligand%2520as%2520a%2520potential%2520tumor%2520imaging%2520agent%26jtitle%3DSci.%2520China%252C%2520Ser.%2520B%253A%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D169%26epage%3D176%26doi%3D10.1007%2Fs11426-006-0169-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Preparation and biological evaluation of <sup>99m</sup>TcN-4-(cyclohexylpiperazin-1-yl)dithioformate as a potential sigma receptor imaging agent</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1200</span><span class="NLM_x">–</span> <span class="NLM_lpage">1205</span><span class="refDoi"> DOI: 10.1002/jlcr.1438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fjlcr.1438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1cXit1Sns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1200-1205&author=J.+Luauthor=D.+Kongauthor=H.+Jiaauthor=W.+Deuther-Conradauthor=P.+Brustauthor=X.+Wang&title=Preparation+and+biological+evaluation+of+99mTcN-4-%28cyclohexylpiperazin-1-yl%29dithioformate+as+a+potential+sigma+receptor+imaging+agent&doi=10.1002%2Fjlcr.1438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and biological evaluation of 99mTcN-4-(cyclohexylpiperazin-1-yl)dithioformate as a potential sigma receptor imaging agent</span></div><div class="casAuthors">Lu, Jie; Kong, Dejing; Jia, Hongmei; Deuther-Conrad, Winnie; Brust, Peter; Wang, Xuebin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1200-1205</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The goal of this study is to develop a novel 99mTc-labeled σ receptor imaging agent.  Potassium 4-(cyclohexylpiperazin-1-yl)dithioformate and the corresponding rhenium complex, ReN-2, were synthesized and characterized.  ReN-2 possessed moderate affinity toward σ1 (Ki = 1.94±0.60 μmol/L) and σ2 (Ki = 2.83±1.39 μmol/L) receptors.  The radiolabeled complex 99mTcN-2 was prepd. in high yield (> 95%) through the [99mTcN]2+int precursor and characterized by HPLC.  99mTcN-2 was found to be a lipophilic and neutral complex with good stability.  The biodistribution in tumor-bearing mice showed that 99mTcN-2 had good tumor uptake (2.12±0.01 %ID/g at 2 h p.i.) and moderate brain uptake (0.27±0.05 %ID/g at 2 h p.i.).  After blocking with haloperidol, the uptakes by tumor and brain were lower than control.  The results indicated that the complex has specific binding to the σ receptors in vivo.  Further structural modifications of this complex are needed to obtain 99mTc-based σ receptor imaging agents with high affinity and subtype selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0FDI3mbmU7Vg90H21EOLACvtfcHk0ljRPZrWIAR7Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXit1Sns7k%253D&md5=31ce2cc4a283dc67cbce96705477aacb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1438%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DJia%26aufirst%3DH.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPreparation%2520and%2520biological%2520evaluation%2520of%252099mTcN-4-%2528cyclohexylpiperazin-1-yl%2529dithioformate%2520as%2520a%2520potential%2520sigma%2520receptor%2520imaging%2520agent%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2007%26volume%3D50%26spage%3D1200%26epage%3D1205%26doi%3D10.1002%2Fjlcr.1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H. M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of a novel <sup>99m</sup>Tc cyclopentadienyl tricarbonyl complex ([(Cp-R)<sup>99m</sup>Tc(CO)<sub>3</sub>]) for sigma-2 receptor tumor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6352</span><span class="NLM_x">–</span> <span class="NLM_lpage">6357</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.08.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmcl.2012.08.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6352-6357&author=X.+Chenauthor=M.+C.+Cuiauthor=W.+Deuther-Conradauthor=Y.+F.+Tuauthor=T.+Maauthor=Y.+Xieauthor=B.+Jiaauthor=Y.+Liauthor=F.+Xieauthor=X.+Wangauthor=J.+Steinbachauthor=P.+Brustauthor=B.+L.+Liuauthor=H.+M.+Jia&title=Synthesis+and+biological+evaluation+of+a+novel+99mTc+cyclopentadienyl+tricarbonyl+complex+%28%5B%28Cp-R%2999mTc%28CO%293%5D%29+for+sigma-2+receptor+tumor+imaging&doi=10.1016%2Fj.bmcl.2012.08.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.08.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.08.083%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTu%26aufirst%3DY.%2BF.%26aulast%3DMa%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%2BL.%26aulast%3DJia%26aufirst%3DH.%2BM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%252099mTc%2520cyclopentadienyl%2520tricarbonyl%2520complex%2520%2528%255B%2528Cp-R%252999mTc%2528CO%25293%255D%2529%2520for%2520sigma-2%2520receptor%2520tumor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6352%26epage%3D6357%26doi%3D10.1016%2Fj.bmcl.2012.08.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuber, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Novel indole-based sigma-2 receptor ligands: synthesis, structure-affinity relationship and antiproliferative activity</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1103</span><span class="refDoi"> DOI: 10.1039/C5MD00079C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1039%2FC5MD00079C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslGgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1093-1103&author=F.+Xieauthor=T.+Kniessauthor=C.+Neuberauthor=W.+Deuther-Conradauthor=C.+Mamatauthor=B.+P.+Liebermanauthor=B.+Liuauthor=R.+H.+Machauthor=P.+Brustauthor=J.+Steinbachauthor=J.+Pietzschauthor=H.+Jia&title=Novel+indole-based+sigma-2+receptor+ligands%3A+synthesis%2C+structure-affinity+relationship+and+antiproliferative+activity&doi=10.1039%2FC5MD00079C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Novel indole-based sigma-2 receptor ligands: synthesis, structure-affinity relationship and antiproliferative activity</span></div><div class="casAuthors">Xie, Fang; Kniess, Torsten; Neuber, Christin; Deuther-Conrad, Winnie; Mamat, Constantin; Lieberman, Brian P.; Liu, Boli; Mach, Robert H.; Brust, Peter; Steinbach, Jorg; Pietzsch, Jens; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1093-1103</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis and biol. evaluation of a series of indole-based σ2 receptor ligands I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl, 4-phenylpiperidinyl-4-carbonitrile, etc.] derived from siramesine was reported.  In vitro competition binding assays showed that these analogs possessed high to moderate affinity and selectivity for σ2 receptors.  Structure-affinity relationship analyses of these indole-based σ2 receptor ligands were performed.  In the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl] displayed significant and comparable antiproliferative activity in DU145, MCF7 and C6 cells to siramesine.  In cell cycle analyses, compds. I [R = 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolinyl, 5,6-dimethoxyisoindolinyl] and siramesine were found to induce a G1 phase cell cycle arrest in DU145 cells using flow cytometry.  The combination of 5,6-dimethoxyisoindoline scaffold and N-(4-fluorophenyl)indole moiety was identified as a new σ2 receptor ligand deserving further investigation as an antitumor agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtDXWI6Q_fILVg90H21EOLACvtfcHk0lidu5ga8P2ybA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslGgtbk%253D&md5=766f04340f2e6ec6f64c7dcd3790334b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2FC5MD00079C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00079C%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DF.%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DNeuber%26aufirst%3DC.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DMamat%26aufirst%3DC.%26aulast%3DLieberman%26aufirst%3DB.%2BP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DPietzsch%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DNovel%2520indole-based%2520sigma-2%2520receptor%2520ligands%253A%2520synthesis%252C%2520structure-affinity%2520relationship%2520and%2520antiproliferative%2520activity%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1093%26epage%3D1103%26doi%3D10.1039%2FC5MD00079C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, S. Z.</span><span> </span><span class="NLM_article-title">Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ<sub>1</sub> and σ<sub>2</sub> receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1852</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmc.2011.02.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1852-1859&author=K.+H.+Fanauthor=J.+R.+Leverauthor=S.+Z.+Lever&title=Effect+of+structural+modification+in+the+amine+portion+of+substituted+aminobutyl-benzamides+as+ligands+for+binding+%CF%831+and+%CF%832+receptors&doi=10.1016%2Fj.bmc.2011.02.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DLever%26aufirst%3DJ.%2BR.%26aulast%3DLever%26aufirst%3DS.%2BZ.%26atitle%3DEffect%2520of%2520structural%2520modification%2520in%2520the%2520amine%2520portion%2520of%2520substituted%2520aminobutyl-benzamides%2520as%2520ligands%2520for%2520binding%2520%25CF%25831%2520and%2520%25CF%25832%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1852%26epage%3D1859%26doi%3D10.1016%2Fj.bmc.2011.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Novel cyclopentadienyl tricarbonyl <sup>99m</sup>Tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7113</span><span class="NLM_x">–</span> <span class="NLM_lpage">7125</span><span class="refDoi"> DOI: 10.1021/jm5009488</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5009488" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1egs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7113-7125&author=X.+Wangauthor=D.+Liauthor=W.+Deuther-Conradauthor=J.+Luauthor=Y.+Xieauthor=B.+Jiaauthor=M.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Novel+cyclopentadienyl+tricarbonyl+99mTc+complexes+containing+1-piperonylpiperazine+moiety%3A+potential+imaging+probes+for+sigma-1+receptors&doi=10.1021%2Fjm5009488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Cyclopentadienyl Tricarbonyl 99mTc Complexes Containing 1-Piperonylpiperazine Moiety: Potential Imaging Probes for Sigma-1 Receptors</span></div><div class="casAuthors">Wang, Xia; Li, Dan; Deuther-Conrad, Winnie; Lu, Jie; Xie, Ying; Jia, Bing; Cui, Mengchao; Steinbach, Jorg; Brust, Peter; Liu, Boli; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7113-7125</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the design, synthesis, and evaluation of a series of novel cyclopentadienyl tricarbonyl 99mTc complexes as potent σ1 receptor radioligands.  Rhenium compds. 3-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)propylcarbonylcyclopentadienyl tricarbonyl rhenium (10a) and 4-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)butylcarbonylcyclopentadienyl tricarbonyl rhenium (10b) possessed high in vitro affinity for σ1 receptors and moderate to high selectivity for σ2 receptors and the vesicular acetylcholine transporter.  Biodistribution studies in mice demonstrated high initial brain uptake for corresponding 99mTc derivs. [99mTc]23 and [99mTc]24 of 2.94 and 2.13% injected dose (ID)/g, resp., at 2 min postinjection.  Pretreatment of haloperidol significantly reduced the radiotracer accumulation of [99mTc]23 or [99mTc]24 in the brain.  Studies of the cellular uptake of [99mTc]23 in C6 and DU145 tumor cells demonstrated a redn. of accumulation by incubation with haloperidol, 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine (SA4503), or 1,3-di-o-tolyl-guanidine (DTG).  Furthermore, blocking studies in C6 glioma-bearing mice confirmed the specific binding of [99mTc]23 to σ1 receptors in the tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcmqY0f1Jf77Vg90H21EOLACvtfcHk0lidu5ga8P2ybA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1egs7jJ&md5=47ad2ee73f8711b9f26e27119d1d0a93</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm5009488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5009488%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DNovel%2520cyclopentadienyl%2520tricarbonyl%252099mTc%2520complexes%2520containing%25201-piperonylpiperazine%2520moiety%253A%2520potential%2520imaging%2520probes%2520for%2520sigma-1%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7113%26epage%3D7125%26doi%3D10.1021%2Fjm5009488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Shumway, S. D.; Toniatti, C.; Roberts, B. S.; Martin, M. M.</span><span> </span><span class="NLM_article-title">Compositions and Methods for Treating Cancer</span>. WO2013039854A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+D.+Shumway&author=C.+Toniatti&author=B.+S.+Roberts&author=M.+M.+Martin&title=Compositions+and+Methods+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShumway%26aufirst%3DS.%2BD.%26atitle%3DCompositions%2520and%2520Methods%2520for%2520Treating%2520Cancer%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span> </span><span class="NLM_article-title">Conformationally-flexible benzamide analogues as dopamine D<sub>3</sub> and σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmcl.2003.09.083" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=195-202&author=R.+H.+Machauthor=Y.+Huangauthor=R.+A.+Freemanauthor=L.+Wuauthor=S.+Vangveravongauthor=R.+R.+Luedtke&title=Conformationally-flexible+benzamide+analogues+as+dopamine+D3+and+%CF%832+receptor+ligands&doi=10.1016%2Fj.bmcl.2003.09.083"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.083%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFreeman%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26atitle%3DConformationally-flexible%2520benzamide%2520analogues%2520as%2520dopamine%2520D3%2520and%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D195%26epage%3D202%26doi%3D10.1016%2Fj.bmcl.2003.09.083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Peindy N’Dongo, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Can, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmutz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spingler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberto, R.</span><span> </span><span class="NLM_article-title">Aqueous syntheses of [(Cp-R)M(CO)<sub>3</sub>] type complexes (Cp = cyclopentadienyl, M = Mn, <sup>99m</sup>Tc, Re) with bioactive functionalities</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">694</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1016/j.jorganchem.2008.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.jorganchem.2008.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVKqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=694&publication_year=2009&pages=981-987&author=H.+W.+Peindy+N%E2%80%99Dongoauthor=Y.+Liuauthor=D.+Canauthor=P.+Schmutzauthor=B.+Spinglerauthor=R.+Alberto&title=Aqueous+syntheses+of+%5B%28Cp-R%29M%28CO%293%5D+type+complexes+%28Cp+%3D+cyclopentadienyl%2C+M+%3D+Mn%2C+99mTc%2C+Re%29+with+bioactive+functionalities&doi=10.1016%2Fj.jorganchem.2008.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aqueous syntheses of [(Cp-R)M(CO)3] type complexes (Cp = cyclopentadienyl, M = Mn, 99mTc, Re) with bioactive functionalities</span></div><div class="casAuthors">Peindy N'Dongo, H. W.; Liu, Y.; Can, D.; Schmutz, P.; Spingler, B.; Alberto, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">694</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">981-987</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The reactions of [99mTc(H2O)3(CO)3]+ (1) with Diels-Alder products of cyclopentadiene such as "Thiele's acid" (HCp-COOH)2 (2) and derivs. thereof in which the corresponding [(Cp-COOH)99mTc(CO)3] (3) complex did form in water is described.  Authors propose a metal mediated Diels-Alder reaction mechanism.  To show that this reaction was not limited to carboxylate groups, authors synthesized conjugates of 2 (HCp-CONHR)2 (4a-c) (4a, R = benzylamine; 4b, R = Nα-Boc-L-2,3-diaminopropionic acid and 4c, R = glycine).  The corresponding 99mTc complexes [(4a)99mTc(CO)3] 6a, [(4b)99mTc(CO)3] 6b and [(4c)99mTc(CO)3] 6c have been prepd. along the same route as for Thiele's acid in aq. media demonstrating the general applicability of this synthetic strategy.  The authenticity of the 99mTc complexes on the no carrier added level have been confirmed by chromatog. comparison with the structurally characterized manganese or rhenium complexes.  Studies of the reaction of 1 with Thiele's acid bound to a solid phase resin demonstrated the formation of [(Cp-COOH)99mTc(CO)3] 3 in a heterogeneous reaction.  This is the first evidence for the formation of no carrier added 99mTc radiopharmaceuticals contg. cyclopentadienyl ligands via solid phase syntheses.  Macroscopically, the manganese analog 5a and the rhenium complexes 5b-c have been prepd. and characterized by IR, NMR, ESI-MS and x-ray crystallog. for 5a (monoclinic, P21/c, a = 9.8696(2) Å, b = 25.8533(4) Å, c = 11.8414(2) Å, β = 98.7322(17)°) in order to unambiguously assign the authenticity of the corresponding 99mTc complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC_oMhzppigbVg90H21EOLACvtfcHk0lijlOOepiDavg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVKqsLk%253D&md5=32f0d8a48e6351ddb5e5aa3e68667833</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2008.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2008.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DPeindy%2BN%25E2%2580%2599Dongo%26aufirst%3DH.%2BW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCan%26aufirst%3DD.%26aulast%3DSchmutz%26aufirst%3DP.%26aulast%3DSpingler%26aufirst%3DB.%26aulast%3DAlberto%26aufirst%3DR.%26atitle%3DAqueous%2520syntheses%2520of%2520%255B%2528Cp-R%2529M%2528CO%25293%255D%2520type%2520complexes%2520%2528Cp%2520%253D%2520cyclopentadienyl%252C%2520M%2520%253D%2520Mn%252C%252099mTc%252C%2520Re%2529%2520with%2520bioactive%2520functionalities%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2009%26volume%3D694%26spage%3D981%26epage%3D987%26doi%3D10.1016%2Fj.jorganchem.2008.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of novel [(Cp-R)M(CO)<sub>3</sub>] (M = Re, <sup>99m</sup>Tc) complexes as potent sigma-2 receptor ligands</span> <span class="citation_source-journal">J. Labelled. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">S383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=S383&author=D.+Liauthor=X.+Wangauthor=W.+Deuther-Conradauthor=X.+Chenauthor=M.+C.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Synthesis+and+preliminary+evaluation+of+novel+%5B%28Cp-R%29M%28CO%293%5D+%28M+%3D+Re%2C+99mTc%29+complexes+as+potent+sigma-2+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.%2BC.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%2520novel%2520%255B%2528Cp-R%2529M%2528CO%25293%255D%2520%2528M%2520%253D%2520Re%252C%252099mTc%2529%2520complexes%2520as%2520potent%2520sigma-2%2520receptor%2520ligands%26jtitle%3DJ.%2520Labelled.%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3DS383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">A novel cyclopentadienyl tricarbonyl <sup>99m</sup>Tc complex containing 5,6-dimethoxyisoindoline motif – synthesis and evaluation of a radiotracer for imaging of sigma-2 receptors in cancer</span> <span class="citation_source-journal">J. Labelled. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">S98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=S98&author=Y.+Chenauthor=W.+Deuther-Conradauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=A+novel+cyclopentadienyl+tricarbonyl+99mTc+complex+containing+5%2C6-dimethoxyisoindoline+motif+%E2%80%93+synthesis+and+evaluation+of+a+radiotracer+for+imaging+of+sigma-2+receptors+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DA%2520novel%2520cyclopentadienyl%2520tricarbonyl%252099mTc%2520complex%2520containing%25205%252C6-dimethoxyisoindoline%2520motif%2520%25E2%2580%2593%2520synthesis%2520and%2520evaluation%2520of%2520a%2520radiotracer%2520for%2520imaging%2520of%2520sigma-2%2520receptors%2520in%2520cancer%26jtitle%3DJ.%2520Labelled.%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3DS98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Perregaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1998</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span><span class="refDoi"> DOI: 10.1021/jm00011a019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00011a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADyaK2MXls1yqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1998-2008&author=J.+Perregaardauthor=E.+K.+Moltzenauthor=E.+Meierauthor=C.+Sanchez&title=Sigma+ligands+with+subnanomolar+affinity+and+preference+for+the+sigma+2+binding+site.+1.+3-%28omega-aminoalkyl%29-1H-indoles&doi=10.1021%2Fjm00011a019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">σ Ligands with Subnanomolar Affinity and Preference for the σ2 Binding Site. 1. 3-(ω-Aminoalkyl)-1H-indoles</span></div><div class="casAuthors">Perregaard, Jens; Moltzen, Ejner K.; Meier, Eddi; Sanchez, Connie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1998-2008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 4-(1H-indol-3-yl)-1-butyl-substituted 4-phenylpiperidines, 4-phenyl-1,2,3,6-tetrahydropyridines, and 4-phenylpiperazines was synthesized.  The Ph group was optionally substituted with 4-fluoro or 2-methoxy substituents.  High affinity for both σ1 and σ2 binding sites was achieved with these compds.  Addnl., these compds. had relatively high affinity for serotonin 5-HT1A and 5-HT2A, dopamine D2, and adrenergic α1 receptors.  Introduction of a 4-fluorophenyl substituent at the indole nitrogen atom rendered very selective σ2 ligands with subnanomolar affinity for the σ2 binding site.  The prototype of such a compd. was I.  This compd. had the following binding affinities: IC50 (σ1) = 16 nM, IC50 (σ2) = 0.27 nM, IC50 (5-HT1A) = 22 000 nM, IC50 (5-HT2A) = 270 nM, IC50 (D2) = 4200 nM, IC50 (α1) = 220 nM.  Spiro-joining of the Ph and the piperidine rings into a spiro[isobenzofuran-1(3H),4'-piperidine] ring system resulted in even more selective compds.  Variations of the 1-substituent at the indole and of the chain length of the alkylene spacer group were studied.  The optimal compd. was the spiro analog of I.  This compd. (II) had the binding affinities: IC50 (σ1) = 17 nM, IC50 (σ2) = 0.12 nM, IC50 (5-HT1A) = 21 000 nM, IC50 (5-HT2A) = 2000 nM, IC50 (D2) = 800 nM, IC50 (α1) = 330 nM.  However, the most selective σ2 vs. σ1 ligand was the tropane deriv. (III).  This compd. had the following binding affinities: IC50 (σ1) = 1200 nM, IC50 (σ2) = 2.5 nM.  Potent anxiolytic activity in the black/white box exploration test in rats was found with the two most prominent σ2 ligands Lu 29-253 and Lu 28-179.  Good penetration into the CNS was documented both after s.c. and peroral administration of Lu 28-179 by ex vivo binding studies.  Long duration of action was demonstrated both in ex vivo binding (T1/2 ∼ 20 h) and in the black/white box exploration test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraJL4h7Q5nXbVg90H21EOLACvtfcHk0lijlOOepiDavg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXls1yqt7w%253D&md5=c7856739a0cfdd0615e1a6428d759445</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00011a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00011a019%26sid%3Dliteratum%253Aachs%26aulast%3DPerregaard%26aufirst%3DJ.%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DSigma%2520ligands%2520with%2520subnanomolar%2520affinity%2520and%2520preference%2520for%2520the%2520sigma%25202%2520binding%2520site.%25201.%25203-%2528omega-aminoalkyl%2529-1H-indoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1998%26epage%3D2008%26doi%3D10.1021%2Fjm00011a019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abate, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferorelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzariti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span> </span><span class="NLM_article-title">Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2026</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span><span class="refDoi"> DOI: 10.1002/cmdc.201300291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fcmdc.201300291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=24106081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOlt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2026-2035&author=M.+Nisoauthor=C.+Abateauthor=M.+Continoauthor=S.+Ferorelliauthor=A.+Azzaritiauthor=R.+Perroneauthor=N.+A.+Colabufoauthor=F.+Berardi&title=Sigma-2+receptor+agonists+as+possible+antitumor+agents+in+resistant+tumors%3A+hints+for+collateral+sensitivity&doi=10.1002%2Fcmdc.201300291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sigma-2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity</span></div><div class="casAuthors">Niso, Mauro; Abate, Carmen; Contino, Marialessandra; Ferorelli, Savina; Azzariti, Amalia; Perrone, Roberto; Colabufo, Nicola Antonio; Berardi, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2026-2035</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With the aim of contributing to the development of novel antitumor agents, high-affinity σ2 receptor agonists were developed, with 6,7-dimethoxy-2-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]butyl]-1,2,3,4-tetrahydroisoquinoline (15) and 9-[4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)butyl]-9H-carbazole (25) showing exceptional selectivity for the σ2 subtype.  Most of the compds. displayed notable antiproliferative activity in human MCF7 breast adenocarcinoma cells, with similar activity in the corresponding doxorubicin-resistant MCF7adr cell line.  Surprisingly, a few compds., including 25, displayed enhanced activity in MCF7adr cells over parent cells, recalling the phenomenon of collateral sensitivity, which is under study for the treatment of drug-resistant tumors.  All of the compds. showed interaction with P-glycoprotein (P-gp), and 15 and 25, with the greatest activity, were able to revert P-gp-mediated resistance and reestablish the antitumor effect of doxorubicin in MCF7adr cells.  The authors therefore identified a series of σ2 receptor agonists endowed with intriguing antitumor properties; these compds. deserve further investigation for the development of alternate strategies against multidrug-resistant cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGrW9r580YjbVg90H21EOLACvtfcHk0ljzzQK2Uxf7Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOlt7vE&md5=cd4926ffa90d3fd1c2761bfe2cbe777c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300291%26sid%3Dliteratum%253Aachs%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DAbate%26aufirst%3DC.%26aulast%3DContino%26aufirst%3DM.%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DBerardi%26aufirst%3DF.%26atitle%3DSigma-2%2520receptor%2520agonists%2520as%2520possible%2520antitumor%2520agents%2520in%2520resistant%2520tumors%253A%2520hints%2520for%2520collateral%2520sensitivity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D2026%26epage%3D2035%26doi%3D10.1002%2Fcmdc.201300291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.-M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <sup>18</sup>F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span><span class="refDoi"> DOI: 10.1016/j.bmc.2012.10.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.bmc.2012.10.038" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=215-222&author=X.+Wangauthor=Y.+Liauthor=W.+Deuther-Conradauthor=F.+Xieauthor=X.+Chenauthor=M.-C.+Cuiauthor=X.-J.+Zhangauthor=J.-M.+Zhangauthor=J.+Steinbachauthor=P.+Brustauthor=B.-L.+Liuauthor=H.-M.+Jia&title=Synthesis+and+biological+evaluation+of+18F+labeled+fluoro-oligo-ethoxylated+4-benzylpiperazine+derivatives+for+sigma-1+receptor+imaging&doi=10.1016%2Fj.bmc.2012.10.038"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DM.-C.%26aulast%3DZhang%26aufirst%3DX.-J.%26aulast%3DZhang%26aufirst%3DJ.-M.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.-L.%26aulast%3DJia%26aufirst%3DH.-M.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%252018F%2520labeled%2520fluoro-oligo-ethoxylated%25204-benzylpiperazine%2520derivatives%2520for%2520sigma-1%2520receptor%2520imaging%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D215%26epage%3D222%26doi%3D10.1016%2Fj.bmc.2012.10.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.mibio.2003.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-75&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography&doi=10.1016%2Fj.mibio.2003.09.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eaGgKh97kAIVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D75%26doi%3D10.1016%2Fj.mibio.2003.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, M.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerdes, J. M.</span><span> </span><span class="NLM_article-title">Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.2174/156802610793176792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.2174%2F156802610793176792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=20583995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1499-1526&author=Y.+Huangauthor=M.-Q.+Zhengauthor=J.+M.+Gerdes&title=Development+of+effective+PET+and+SPECT+imaging+agents+for+the+serotonin+transporter%3A+has+a+twenty-year+journey+reached+its+destination%3F&doi=10.2174%2F156802610793176792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?</span></div><div class="casAuthors">Huang, Yiyun; Zheng, Ming-Qiang; Gerdes, John M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1499-1526</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin transporter (SERT) has been implicated in a variety of neuropsychiatric disorders including depression, schizophrenia, substance abuse, alcoholism, and Alzheimer's disease.  Radiotracer-based in vivo imaging techniques such as Positron Emission Tomog. (PET) and Single-Photon Emission Computed Tomog. (SPECT) are important tools to investigate the functions of SERT in the living brain under normal conditions and its dysfunction in diseases.  The authors review the development and validation of effective PET and SPECT radiotracers in the last twenty years.  First, the requirements for an effective imaging tracer, and factors influencing a tracer's in vivo imaging performance are discussed.  PET and SPECT radiotracers for SERT are then categorized and reviewed according to their chem. scaffolds: (1) SSRIs and related compds.; (2) tropane-based ligands; (3) isoquinolines; and (4) substituted diarylsulfides.  Crit. evaluation and comments are provided for promising radiotracers, if any, emerging from each chem. scaffold.  Based on exptl. data gathered from radiotracer development for SERT, an examn. of the relationship between an imaging tracer's in vitro physicochem. and pharmacol. properties and its in vivo performance parameters is provided.  Finally, tracers available for imaging applications in humans are assessed and compared in terms of tissue binding kinetics, non-specific binding, and specific binding signals in vivo.  From these assessments, the authors conclude that, after twenty years of development efforts, a no. of effective PET and SPECT radiotracers have now been validated and are available for imaging SERT in humans.  The applications of these efficacious SERT imaging agents will further advance the understanding of this important transporter in psychiatric and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1VPLvWl1u5rVg90H21EOLACvtfcHk0lj-Ty8U-3VnvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ahtr3N&md5=716e3dfa369f94018b86c89af6a57cfa</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F156802610793176792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610793176792%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DM.-Q.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26atitle%3DDevelopment%2520of%2520effective%2520PET%2520and%2520SPECT%2520imaging%2520agents%2520for%2520the%2520serotonin%2520transporter%253A%2520has%2520a%2520twenty-year%2520journey%2520reached%2520its%2520destination%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1499%26epage%3D1526%26doi%3D10.2174%2F156802610793176792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuther-Conrad, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, H.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel <sup>18</sup>F-labeled spirocyclic piperidine derivatives as σ<sub>1</sub> receptor ligands for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3478</span><span class="NLM_x">–</span> <span class="NLM_lpage">3491</span><span class="refDoi"> DOI: 10.1021/jm301734g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301734g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsV2gt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3478-3491&author=Y.+Liauthor=X.+Wangauthor=J.+Zhangauthor=W.+Deuther-Conradauthor=F.+Xieauthor=X.+Zhangauthor=J.+Liuauthor=J.+Qiaoauthor=M.+Cuiauthor=J.+Steinbachauthor=P.+Brustauthor=B.+Liuauthor=H.+Jia&title=Synthesis+and+evaluation+of+novel+18F-labeled+spirocyclic+piperidine+derivatives+as+%CF%831+receptor+ligands+for+positron+emission+tomography+imaging&doi=10.1021%2Fjm301734g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novel 18F-Labeled Spirocyclic Piperidine Derivatives as σ1 Receptor Ligands for Positron Emission Tomography Imaging</span></div><div class="casAuthors">Li, Yan; Wang, Xia; Zhang, Jinming; Deuther-Conrad, Winnie; Xie, Fang; Zhang, Xiaojun; Liu, Jian; Qiao, Jinping; Cui, Mengchao; Steinbach, Jorg; Brust, Peter; Liu, Boli; Jia, Hongmei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3478-3491</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of spirocyclic piperidine derivs. were designed and synthesized as σ1 receptor ligands.  In vitro competition binding assays showed that 1'-[4-(2-fluoroethoxy)benzyl]-3H-spiro[2-benzofuran-1,4'-piperidine] [I (R = F)] possessed high σ1 receptor affinity (Ki = 0.79 nM) and excellent σ1/σ2 subtype selectivity (350-fold) as well as high σ1/VAChT selectivity (799-fold).  The radiolabeled compd. I (R = 18F) was synthesized by substitution of the tosylate precursor I (R = OTs) with [18F]fluoride, with an isolated radiochem. yield of 35-60%, a radiochem. purity of >99%, and a specific activity of 30-55 GBq/μmol.  Biodistribution studies in imprinting control region mice indicated that I (R = 18F) displayed excellent initial brain uptake and slow washout.  Ex vivo autoradiog. in Sprague-Dawley rats demonstrated high accumulation of the radiotracer in brain areas known to express high levels of σ1 receptors.  Micro positron emission tomog. imaging and blocking studies confirmed the specific binding of I (R = 18F) to σ1 receptors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXEMXGF6bF7Vg90H21EOLACvtfcHk0lj-Ty8U-3VnvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsV2gt74%253D&md5=ca2ccb146e2722e4ae0d98513b7b53c0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm301734g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301734g%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DQiao%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%252018F-labeled%2520spirocyclic%2520piperidine%2520derivatives%2520as%2520%25CF%25831%2520receptor%2520ligands%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3478%26epage%3D3491%26doi%3D10.1021%2Fjm301734g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding characteristics of σ<sub>2</sub> receptor ligands</span> <span class="citation_source-journal">Rev. Bras. Cienc. Farm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1590/S1516-93322005000100002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1590%2FS1516-93322005000100002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1-12&author=R.+A.+Glennon&title=Binding+characteristics+of+%CF%832+receptor+ligands&doi=10.1590%2FS1516-93322005000100002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Binding characteristics of σ2 receptor ligands</span></div><div class="casAuthors">Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Revista Brasileira de Ciencias Farmaceuticas</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">RBCFFM</span>;
        ISSN:<span class="NLM_cas:issn">1516-9332</span>.
    
            (<span class="NLM_cas:orgname">Universidade de Sao Paulo, Faculdade de Ciencias Farmaceuticas</span>)
        </div><div class="casAbstract">A review.  Sigma (σ) receptors, once considered a type of opioid receptor are now recognized as representing a unique receptive entity and at least two different types of σ receptors have been identified σ1 and σ2 receptors.  Evidence suggests that these receptors might be targeted and exploited for the development of agents potentially useful for the treatment of several central disorders.  This review primarily describes some of our efforts to understand those structural features that contribute to σ2 receptor binding, and some recent work by other investigators is also included.  Despite an inability to formulate a unified pharmacophore model for α2 binding due to the diversity of structure-types that bind at the receptor, and to the conformational flexibility of these ligands, significant progress has been made to ward the development od some very high affinity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQAG2gQdALrVg90H21EOLACvtfcHk0ljYgrkF5JlFUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFCksLg%253D&md5=863bf7ddc28bafbe45a21d852d85954f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1590%2FS1516-93322005000100002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS1516-93322005000100002%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520characteristics%2520of%2520%25CF%25832%2520receptor%2520ligands%26jtitle%3DRev.%2520Bras.%2520Cienc.%2520Farm.%26date%3D2005%26volume%3D41%26spage%3D1%26epage%3D12%26doi%3D10.1590%2FS1516-93322005000100002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sorger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheunemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vercouille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roghani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schliebs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brust, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span> </span><span class="NLM_article-title">A new <sup>18</sup>F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1016/j.nucmedbio.2007.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1016%2Fj.nucmedbio.2007.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=18312828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=185-195&author=D.+Sorgerauthor=M.+Scheunemannauthor=U.+Grossmannauthor=S.+Fischerauthor=J.+Vercouilleauthor=A.+Hillerauthor=B.+Wenzelauthor=A.+Roghaniauthor=R.+Schliebsauthor=P.+Brustauthor=O.+Sabriauthor=J.+Steinbach&title=A+new+18F-labeled+fluoroacetylmorpholino+derivative+of+vesamicol+for+neuroimaging+of+the+vesicular+acetylcholine+transporter&doi=10.1016%2Fj.nucmedbio.2007.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter</span></div><div class="casAuthors">Sorger, Dietlind; Scheunemann, Matthias; Grossmann, Udo; Fischer, Steffen; Vercouille, Johnny; Hiller, Achim; Wenzel, Barbara; Roghani, Ali; Schliebs, Reinhard; Brust, Peter; Sabri, Osama; Steinbach, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-195</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">With the aim of producing selective radiotracers for in vivo imaging of the vesicular acetylcholine transporter (VAChT) using positron mission tomog. (PET), here, we report synthesis and anal. of a new class of conformationally constrained vesamicol analogs with moderate lipophilicity.  The sequential ring opening on trans-1,4-cyclohexadiene dioxide enabled an approach to synthesize 6-arylpiperidino-octahydrobenzo[1,4]oxazine-7-ols [morpholino vesamicols].  The radiosynthesis of the [18F]fluoroacetyl-substituted deriv. ([18F]FAMV) was achieved starting from a corresponding bromo precursor [2-Bromo-1-[7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazin-4-yl]-ethanone] and using a modified com. computer-controlled module system with a radiochem. yield of 27 ± 4%, a high radiochem. purity (99%) and a specific activity of 35 GBq/μmol.  In competitive binding assays using a PC12 cell line overexpressing VAChT and [3H]-(-) vesamicol, 2-fluoro-1-[7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazin-4-yl]-ethanone (FAMV) demonstrated a high selectivity for binding to VAChT (Ki: 39.9 ± 5.9 nM) when compared to its binding to sigma1/2 receptors (Ki > 1500 nM).  The compd. showed a moderate lipophilicity (logD(pH7) = 1.9) and a plasma protein binding of 49%.  The brain uptake of [18F]FAMV was about 0.1% injected dose per g at 5 min after injection and decreased continuously with time.  Notably, an increasing accumulation of radioactivity in the lateral brain ventricles was obsd.  After 1 h, the accumulation of [18F]FAMV, expressed as ratio to the cerebellum, was 4.5 for the striatum, 2.0 for the cortical and 1.5 for the hippocampal regions, measured on brain slices using ex vivo autoradiog.  At the present time, 75% of [18F]FAMV in the plasma was shown to be metabolized to various hydrophilic compds., as detected by high-performance liq. chromatog.  The degrdn. of [18F]FAMV was also detected in brain exts. as early as 15 min post injection (p.i.) and increased to 50% at 1 h postinjection.  In conclusion, although the chem. properties of [18F]FAMV and the selectivity of binding to VAChT appear to be promising indicators of a useful PET tracer for imaging VAChT, a low brain extn., in combination with only moderate specific accumulation in cholinergic brain regions and an insufficient in vivo stability prevents the application of this compd. for neuroimaging in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY3NDgGQ_kbLVg90H21EOLACvtfcHk0ljYgrkF5JlFUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2huro%253D&md5=44127cdc164bfe771602eb27bbba1d20</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DSorger%26aufirst%3DD.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DGrossmann%26aufirst%3DU.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DVercouille%26aufirst%3DJ.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DRoghani%26aufirst%3DA.%26aulast%3DSchliebs%26aufirst%3DR.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DSabri%26aufirst%3DO.%26aulast%3DSteinbach%26aufirst%3DJ.%26atitle%3DA%2520new%252018F-labeled%2520fluoroacetylmorpholino%2520derivative%2520of%2520vesamicol%2520for%2520neuroimaging%2520of%2520the%2520vesicular%2520acetylcholine%2520transporter%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D185%26epage%3D195%26doi%3D10.1016%2Fj.nucmedbio.2007.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Saidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothari, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillai, M. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unnikrishnan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzouz, Z.</span><span> </span><span class="NLM_article-title">Cyclopentadienyl technetium (<sup>99m</sup>Tc) tricarbonyl piperidine conjugates: biodistribution and imaging studies</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1002/jlcr.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=10.1002%2Fjlcr.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmt1Sjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=603-618&author=M.+Saidiauthor=K.+Kothariauthor=M.+R.+A.+Pillaiauthor=A.+Hassanauthor=H.+D.+Sarmaauthor=P.+R.+Chaudhariauthor=T.+P.+Unnikrishnanauthor=A.+Kordeauthor=Z.+Azzouz&title=Cyclopentadienyl+technetium+%2899mTc%29+tricarbonyl+piperidine+conjugates%3A+biodistribution+and+imaging+studies&doi=10.1002%2Fjlcr.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies</span></div><div class="casAuthors">Saidi, Mouldi; Kothari, K.; Pillai, M. R. A.; Hassan, Amri; Sarma, H. D.; Chaudhari, P. R.; Unnikrishnan, T. P.; Korde, A.; Azzouz, Zohra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-618</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Synthesis of organometallic complexes of 99mTc using the precursor ligands N-methylpiperidino-4[(bispentahaptocyclopentadienyl)iron] carboxylate and N-(isopropyl)-piperidino-4[(bispentahaptocyclopentadienyl)iron]carboxylate is described.  The labeling method involved reaction of the ligands with 99mTcO4- in the presence of Mn(CO)5Br in DMF at 150° for 1 h in an oil bath.  The purifn. of the complexes was carried out by preparative TLC using ether/n-Bu Me amine (95:5) solvent system.  The purified complexes were characterized by HPLC using acetonitrile:water (80:20) solvent system in a PRP-1 column in which both the complexes were eluted as single peaks.  Biodistribution studies carried out in rats showed 2.4 ± 0.14 and 1.1 ± 0.42% of the injected activity in the brain tissue 5 min p.i. for cytectrene I and II, resp.  The brain to blood activity ratio was > 15:1 for both the complexes at 5 min p.i.  Scintigraphic studies in rabbits showed significant uptake of the activity in the brain with fast clearance from blood.  The complexes warrant further investigation as agents for brain imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGgAnqDg5SmrVg90H21EOLACvtfcHk0lhG-swmmOo8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmt1Sjt7g%253D&md5=670c9c22adab89bb2a45bb3a275de891</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.491%26sid%3Dliteratum%253Aachs%26aulast%3DSaidi%26aufirst%3DM.%26aulast%3DKothari%26aufirst%3DK.%26aulast%3DPillai%26aufirst%3DM.%2BR.%2BA.%26aulast%3DHassan%26aufirst%3DA.%26aulast%3DSarma%26aufirst%3DH.%2BD.%26aulast%3DChaudhari%26aufirst%3DP.%2BR.%26aulast%3DUnnikrishnan%26aufirst%3DT.%2BP.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DAzzouz%26aufirst%3DZ.%26atitle%3DCyclopentadienyl%2520technetium%2520%252899mTc%2529%2520tricarbonyl%2520piperidine%2520conjugates%253A%2520biodistribution%2520and%2520imaging%2520studies%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2001%26volume%3D44%26spage%3D603%26epage%3D618%26doi%3D10.1002%2Fjlcr.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01378">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38685"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01378">10.1021/acs.jmedchem.5b01378</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">General information and some parts of the evaluation of the radiotracers in <a class="ref internalNav" href="#sec5">Experimental Section</a>, purity of key target compounds, the HPLC chromatograms of <b>20a</b>–<b>25a</b> and [<sup>99m</sup>Tc]<b>20b</b>–<b>25b</b>, <b>29a</b>–<b>30a</b>, and [<sup>99m</sup>Tc]<b>29b</b>–<b>30b</b>, X-ray crystallographic data for compound <b>31a</b>, <i>in vitro</i> evaluation of [<sup>99m</sup>Tc]<b>21b</b> and [<sup>99m</sup>Tc]<b>24b</b> in C6 glioma tumor cell line, biodistribution and blocking studies of [<sup>99m</sup>Tc]<b>25b</b> in male ICR mice, small animal NanoScan SPECT/CT imaging of [<sup>99m</sup>Tc]<b>20b</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystal information file of compound <b>31a</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_002.cif">CIF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_001.pdf">jm5b01378_si_001.pdf (929.84 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_002.cif">jm5b01378_si_002.cif (17.98 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01378/suppl_file/jm5b01378_si_003.csv">jm5b01378_si_003.csv (2.42 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01378&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01378%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-3%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01378" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992f8b0fb33c64","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
